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The Treatment of Rib Fractures with Thoracic Epidural Analgesia 
 
 
 
Courtney D. Jensen 
 
University of Connecticut, 2015 
 
 
Rib fractures are detected in nearly 300,000 patients admitted to U.S. trauma centers each 
year. Among these patients, a mortality rate of about 10% can be expected. It is often 
pain, rather than structural damage, that precipitates the high risk of mortality. Focusing 
rib fracture care on effective pain management improves treatment outcomes. The 
purpose of this investigation was to explore the efficacy and cost-effectiveness of one 
mode of pain management – thoracic epidural analgesia (TEA) – in the treatment of 
patients with rib fractures. Methods: Four years of patient records were obtained from a 
Level II trauma center in an urban-suburban setting. There were 1,008 patients with ≥ 1 
fractured rib in the registry. These patients were retrospectively analyzed, evaluating 
relationships between TEA and mortality, risk of complications, use of mechanical 
ventilation, length of stay in the hospital and intensive care unit, and total treatment cost. 
Results: The severity of injuries among patients receiving TEA was significantly worse, 
but there was no significant difference in mortality between patients treated with TEA 
(0.6%) and those receiving alternative treatments (2.0%; p=0.233). There was a trend that 
the administration of TEA decreased odds of mortality by 87% (p=0.071). Similarly, the 
use of TEA predicted a $12k reduction in total patient charges (p<0.001) and a $2,600 
reduction in hospital expenses (p<0.001). Discussion: This investigation suggests the use 
of TEA can improve patient survival while reducing patient billing and hospital costs. 
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Chapter 1: Introduction 
The human body has 24 ribs, comprising 12 bilateral pairs. The 7 most superior 
pairs are considered “true ribs” because they are connected to the sternum directly 
through their own costal cartilage. Pairs 8–10 are called “false ribs” because their anterior 
articulation is only through the cartilage of the 7th pair. Ribs 11 and 12 are known as 
“floating ribs” because they are not connected to the sternum at all (Figure 1.1). 
 
Figure 1.1: Anatomy of the rib cage 
 
 
In the U.S., rib fractures are the most commonly treated chest injury.1-3 Each year, 
nearly 300,000 patients fracture 1 or more ribs as a result of blunt thoracic trauma.4 The 
true prevalence may actually be higher as some fractures go undetected at admission.2,3,5 
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Among these patients, the characteristics of their injuries are diverse and the degree of 
damage is inconsistent. Although the mean number of fractures is typically 4–6 ribs6-10, 
the range is broad. Additionally, forces large enough to break ribs frequently result in 
associated injuries such as pulmonary contusions and flail chest.3,6,11  
 
A pulmonary contusion is a bruise on the lung tissue marked by capillary damage 
and consequent micro-hemorrhages within the alveoli.12 The amount of bleeding depends 
on the severity of the contusion.13 If enough blood and fluid accumulate, it can lead to a 
pulmonary edema, obstruct gas exchange, and promote hypoxic conditions.14,15 In more 
severe cases, bronchorrhea (production of watery sputum) may develop.16 The patient can 
also experience pulmonary consolidation (a region of compressible lung tissue filled with 
liquid) or atelectasis (the partial or full collapse of a lung).17 Most studies report 27–40% 
of patients who fracture at least 1 rib also present with a pulmonary contusion.3,6,7,9,11 
 
Flail chest is a potentially lethal condition in which a section of the rib cage 
becomes detached from the chest wall. For this to occur, there must be at least 3 
consecutive ribs fractured in at least 2 places, creating an “incompetent” segment of the 
chest wall. This means that the detached segment’s movement is opposite that of the 
intact portion.18,19 During inhalation, while the rib cage expands outward, the flail 
segment moves inward, owing to the relationship between ambient pressure and the 
pressure inside of the lungs.20 This motion has been coined “paradoxical respiration”21-25, 
although that is technically a misnomer; it would be more appropriately called 
paradoxical ventilation, as it is not a cellular event, but a mechanical one. Some authors 
have found flail segments to be present in as few as 2–3% of rib fracture cases26 while 
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others have reported incidences over 20%.11,27 Typically, among patients who present 
with at least 1 fractured rib, the incidence of flail chest falls in between those 
amounts.3,6,9,28-30 Both flail chest and a pulmonary contusion can be seen in Figure 1.2. 
 
Figure 1.2: Illustration of a flail segment with a pulmonary contusion 
 
 
Other injuries that regularly accompany rib fractures are pneumothorax and 
hemothorax. Pneumothorax is an accumulation of air in the pleural cavity, which 
separates the lung from the chest wall. This occurs in 15–40% of blunt thoracic trauma 
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cases and may interfere with breathing.2,3,31-33 Hemothorax is the accumulation of blood 
in the pleural cavity; incidence is similar to pneumothorax. 2,3,31-33 Hemopneumothorax is 
a combination of both conditions.31,32 
 
The number of fractured ribs as well as the presence of associated injuries affects 
the risk of mortality.8,10 Among large samples of patients admitted to trauma centers with 
at least 1 fractured rib, the overall mortality rate is about 10%.2,3,5,10 In the presence of 8 
or more fractures, this rate can exceed 30%.10 When pulmonary contusions and flail 
segments are both present, mortality may exceed 40%.34 
 
The risk of mortality is influenced by the amount of pain a patient experiences. In 
the presence of multiple rib fractures, that pain is often exacerbated by coughing and 
deep breathing. To minimize these symptoms, many patients actively avoid coughing and 
adopt a pattern of shallow breathing (i.e., splinting).35,36 These alterations in ventilatory 
behavior impede the clearance of airway secretions, which results in the retention of 
sputum.11,37-39 In turn, lung compliance is commonly affected and a mismatch between 
ventilation and perfusion begins to develop.37,40 Combined with insufficient clearance of 
airway secretions, patients are placed at an elevated risk of secondary complications (e.g., 
pneumonia), which increases the likelihood of respiratory failure and the need for 
intubation and ventilatory support.38,41 Once patients require mechanical ventilation, the 
risk of mortality is drastically elevated.42-45 Effective pain control is thus critical to the 
successful treatment of a patient with multiple rib fractures.41,46,47 
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There are a variety of ways to manage a patient’s pain. Those who fracture 1 or 2 ribs and 
have minimal pain can be treated with oral analgesic drugs47 and experience a low risk of 
complications and mortality.1,10 Among patients who fracture 3 or more ribs and whose 
pain is greater, systemic analgesia is unlikely to be sufficient and regional modes are 
more likely to be used.10,47 Thoracic epidural analgesia (TEA) is one mode of regional 
analgesia.37,47  
 
TEA is a relatively complex procedure in which the analgesia is installed into the 
epidural space (Figures 1.3 and 1.4). Typically, it involves a combination of opioids (e.g., 
hydromorphone or fentanyl) and local anesthetic (e.g., bupivacaine or lidocaine). The 
synergistic effect may produce superior analgesia while helping to avoid adverse effects 
related to either elevated dosing of either mode of administration by itself.48 
 
Figure 1.3: Transverse view of a vertebra, the articulated ribs, and the epidural space 
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Figure 1.4: Sagittal view of a vertebral column and the epidural space 
 
 
Chapter 2: Rib fracture care: a systematic review of thoracic epidural 
analgesia. This chapter includes a comprehensive search for articles related to the 
use of TEA in patients with rib fractures. In it, I describe the etiology and 
characteristics of rib fracture injuries, outline the history of their treatment, and 
evaluate the current body of research, appraising study quality and comparing key 
findings. The primary outcomes evaluated concern the efficacy of TEA in terms of 
mortality, length of stay (LOS) in the intensive care unit (ICU) and hospital, the use 
of mechanical ventilation, improvement in patient pain levels, effect on respiratory 
function, and incidence of complications and adverse events (e.g., pneumonia, 
respiratory failure). Wherever possible, comparisons are drawn to other treatments. 
This chapter provides further introductory material on TEA and serves and as an 
assessment of its clinical value. 
 
 7 
 Chapter 3: The efficacy of thoracic epidural analgesia in the treatment of rib 
fractures. This chapter evaluates clinical outcomes of TEA administration at a Level II 
trauma center. It describes the demographics and injury characteristics of patients 
admitted, assesses the effectiveness of TEA in regard to mortality, pulmonary 
complications, use of mechanical ventilation, and LOS in the ICU and hospital, and 
evaluates the relationships between predictors of mortality to provide perspective on the 
management of patients with rib fractures. 
 
 Chapter 4: The cost-effectiveness of thoracic epidural analgesia in rib fracture 
care. This chapter analyzes financial outcomes related to the care of patients with rib 
fractures, evaluating the cost-effectiveness of TEA administration. The primary outcomes 
are the cost of treatment both to the patient and to the hospital. It assesses the predictors 
of cost and identifies interrelationships between patient demographics, injury 
characteristics, and the mode of treatment. 
 
Chapter 5: Conclusion. This chapter summarizes all important findings from 
Chapters 2, 3, and 4, notes limitations in the field, and advises future directions for 
research. 
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Chapter 2: Rib Fracture Care: A Systematic Review of Thoracic 
Epidural Analgesia (Part 1: Abridged Version) 
 
ABSTRACT 
 
Each year, nearly 300,000 patients are admitted to trauma centers with rib 
fractures. About 10% of these patients die and more than a third develop pulmonary 
complications. Much of the morbidity and mortality is a consequence of pain (and the 
effect pain has on pulmonary mechanics). Effective pain management is thus critical to 
successful treatment outcomes. There are a variety of ways to manage pain. Thoracic 
epidural analgesia (TEA) is one method. In this paper, we review the safety and efficacy 
of TEA among patients with rib fractures.  
 
INTRODUCTION 
 
In the U.S., 10-15% of all patients admitted to trauma centers and a quarter of all 
trauma-related deaths are the result of blunt thoracic trauma.2,10 Blunt thoracic trauma 
commonly results in chest wall injuries; the most common of these is rib fractures.1,2 
Each year, nearly 300,000 patients with rib fractures visit U.S. trauma centers.4 The true 
prevalence may be higher as not all fractures are detected upon admission.2,5,49 
 
Patients who only fracture 1 or 2 ribs are typically treated with oral analgesic 
drugs (NSAIDs, acetaminophen, or hydrocodone)47 and have low incidences of 
complications and mortality.1,10 If pain relief is not sufficient, other systemic modes (e.g., 
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intravenous narcotics or dilaudid) may be administered.47 When a patient fractures 3 or 
more ribs, the risk of complication increases.1 In this situation, the pain can be more 
harmful than the injury itself, as more severe pain often precipitates secondary 
complications.10,19,37 
 
As the number of fractured ribs increases, the pain experienced with breathing is 
exacerbated. In an effort to avoid that pain, patients experience splinting.35,36 This can 
impede chest physiotherapy and cause ineffective coughing, resulting in insufficient 
clearance of airway secretions and retention of sputum.11,37-39 In turn, lung compliance is 
commonly reduced and patients experience a mismatch in ventilation and perfusion.37,40 
The combination of these deficits (poor lung compliance and inadequate clearance of 
secretions) puts patients on a course toward secondary complications (e.g., atelectasis, 
pneumonia) and eventually respiratory failure and the need for intubation and ventilatory 
support.38,41 The ultimate consequence of this is a mortality rate of about 10% among all 
patients admitted with rib fractures.2 
 
A primary way to prevent these complications, thus lowering the risk of mortality, 
is to control the patient’s pain level.41,46,47 Accomplishing this with systemic narcotics 
can result in over-sedation and worsening of pulmonary toilet. Thus, when multiple ribs 
are fractured, regional modes of analgesia often become the mainstay, with systemic 
deliveries used as a supplemental treatment.47 There are several types of regional 
analgesia, most notably thoracic epidural analgesia, intercostal nerve block, intrapleural 
nerve block, and thoracic paravertebral block.37,47 This paper focuses on thoracic epidural 
analgesia (TEA), comparing its safety and effectiveness to alternative treatments. 
 10 
 
History of thoracic trauma treatment 
 
Interest in chest wall trauma and its consequences (such as flail chest) is not new 
to medicine. Rudimentary descriptions appeared in the Edwin Smith Surgical Papyrus 
(circa 1600 BC), in the Iliad (circa 850 BC) and in 5th century writings by 
Hippocrates.18,50 The first documented treatment, which was practiced for several 
centuries, was wrapping the chest wall in linens.51 That approach didn’t change until the 
1930s, when physicians began inserting pins, hooks, screws, and wires to stabilize the 
chest wall internally (incorrectly assuming that chest wall instability was the most lethal 
concern). Unfortunately, these treatments failed to reduce mortality.52,53 In the 1950s, 
artificial ventilation was introduced. Although initially promising, higher incidences of 
comorbidities (including pneumonia) were soon reported.43,52,54 In the 1970s, more 
conservative techniques, such as simple pain control, were attempted. When the 
outcomes of these treatments were compared to the outcomes of mechanical ventilation, 
researchers were encouraged; it appeared to be the pain itself – more than the structural 
changes – that precipitated morbidity.24,44,45,55,56 In the 1990s, researchers went a step 
further, investigating the efficacy of different types of pain management.53 The question 
was no longer whether pain management was of paramount importance, but which modes 
of management were the most effective.42  
 
Today, we still don’t have an answer to this question, owing to the number of 
options as well as outcomes to consider. It is not merely life or death, but 
cardiopulmonary function, incidence of complications, and degree of pain relief on top of 
the cost, duration, and safety of the treatment. The most beneficial agent would be one 
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that maximizes pain control while minimizing side effects. Regional modes of pain 
control have emerged as the most effective interventions, but there are several methods 
available and no single treatment accomplishes all of the desired outcomes.37,42,47 Despite 
this, TEA is often regarded as the most reliable technique to relieve pain and improve 
pulmonary outcomes in patients with multiple fractured ribs.42  
 
Presentation of injury 
 
The majority of patients admitted to trauma centers for rib fractures are injured in 
motor vehicle collisions while around a quarter of the incidence results from falls.6,26,27,57 
Regardless of the mode of injury, there is no consistent presentation of damage. In 
addition to differing numbers and locations of ribs fractured, the trauma commonly 
results in associated injuries, such as pulmonary contusions. Thus, when a patient 
presents with fractured ribs, the characteristics of his or her injury (e.g., unilateral or 
bilateral fractures, upper or lower ribs, chest tube placement, presence of associated 
injuries) affect the course of recovery and the likelihood of mortality.8 
 
Mortality 
 
In an assessment of 64,750 patients across 268 trauma centers in the National 
Trauma Data Bank (NTDB), the mortality rate among patients with rib fractures was 
10%.10 Smaller studies have reported lower mortality rates. For example, a Turkish 
hospital reported a mortality rate of 5.7% among rib fracture patients treated between 
1999 and 2001.58 However, this group included 68 children (age 5 to 12), 103 adolescents 
(age 13 to 17), 235 adults (age 18 to 59), and 142 elderly patients (age 60 to 78). No 
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children or adolescents died; 100% of deaths were among patients age 18 or older. Thus, 
the mortality rate among adults was 8.2%. Other hospitals have found success with more 
aggressive approaches to therapy. Using a “multidisciplinary clinical pathway”, which 
involves respiratory therapy, physical therapy, nutrition services, and several pain 
management techniques (oral pain medications, IV pain medications, and epidural 
analgesia), one hospital decreased the mortality from 13% to 4%.59 The treatment is 
extensive, however, and studies have not yet quantified the individual contribution of 
each component. 
 
In general, a mortality rate of about 10% can be expected (ranging from 3% to 
13%) and is often the result of secondary lung complications.46,60,61 The best predictors of 
mortality include number of fractured ribs (representing injury severity)2, presence of 
additional injuries (e.g., flail segments)26, and age.6 
   
Complications 
 
Between a third and half of all patients with rib fractures experience pulmonary 
complications (e.g., pneumonia, pneumothorax, atelectasis, adult respiratory distress 
syndrome)2,10 The risk of complication increases significantly with each additional rib 
fractured.6,10 Thresholds at which morbidity significantly increases have been found at 3 
or more ribs1 and at 6 or more ribs.10 The most commonly reported complication is 
pneumonia; its incidence depends on the age of the patient and severity of the injury.10,46 
In general, much higher rates can be expected among elderly patients compared to young 
patients (e.g., 34% vs. 17%).6  
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Pain 
 
 Pain is a primary risk factor for morbidity and mortality among patients who 
present with chest wall trauma.58,62,63 In the presence of pain, patients typically alter 
ventilation (to avoid exacerbation of that pain) by restricting breathing and decreasing 
tidal volume.35,36 This impedes chest physiotherapy and pulmonary toilet, often causing 
ineffective coughing, which results in insufficient clearing of airway secretions and 
retention of sputum.11,37-39 In turn, this leads to atelectasis, which reduces lung 
compliance and functional residual capacity, resulting in a mismatch of ventilation and 
perfusion. Parenchymal lung infection can also develop in the presence of bacterial 
colonization.37,40,57 Patients who cannot effectively cough, clear secretions, or re-inflate 
areas of the lung compromised with atelectasis are at a higher risk for pulmonary 
complications such as secondary pneumonia with pulmonary consolidation.38,41,54,64 This 
leads to respiratory failure and the need for intubation and ventilatory support.38,41 The 
ultimate consequence of these secondary complications is a high risk of mortality.38 
Contrarily, if the patient’s pain is not exacerbated with normal ventilation and coughing 
(thus an adequate tidal volume is maintained and coughing can occur without 
exacerbation of symptoms), the risk of pulmonary complications (e.g., atelectasis, 
pneumonia, and the need for mechanical ventilation) is reduced.56,65,66 For this reason, 
effective pain management is critical to restoration of pulmonary function and the 
avoidance of morbidity and mortality.39,67,68 Pain management is accomplished through 
systemic and regional anesthetics and analgesics.41 Because the relief of pain is a primary 
goal of treatment, it is often the severity of the pain – rather than the severity of the injury 
– that guides the choice of treatment. If pain can be managed with oral and/or IV 
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narcotics, it often is; if conservative treatments do not provide adequate pain control, 
patients are often treated with local analgesia.6,11,47  
 
Modes of analgesia 
 
 Analgesia is the primary treatment in the management of patients with chest wall 
trauma.58,69 A variety of treatment options exist; some are systemic (e.g., oral and 
intravenous anti-inflammatory agents, intravenous opioids, and narcotic dermal patches) 
while others are local agents (e.g., intercostal nerve blocks, intrapleural nerve blocks, 
thoracic paravertebral blocks, and TEA).8,47,70 The 3 most effective (and commonly 
delivered) local treatments are: narcotic infusions and continuous local anesthetic via 
epidural catheter, intrapleural infusions of local anesthetic via catheter, and intercostal 
nerve block via injection.42,71 Less common modes of therapy have been attempted, 
including intrathecal opioids72, narcotic dermal patches73, epidural steroid injections74, 
and transcutaneous electrical nerve stimulation.75 Because the focus of this review is on 
TEA, we will only mention alternative treatments briefly except when directly comparing 
them to TEA. 
 
Oral non-narcotic analgesic drugs 
 
 NSAIDs, codeine, or acetaminophen may be sufficient if only 1 or 2 ribs are 
fractured. There is no central nervous system or cardiovascular depression, but the degree 
of analgesia is limited. Although there is a shortage of data regarding their use in 
treatment of patients who have multiple rib fractures, the common understanding is that 
they may be effective supplements to a treatment, but not effective when used in 
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isolation.37,47 
 
Systemic analgesia 
 
This is often the first line of therapy to manage pain from rib fractures.37 There 
are several modes of delivery: intermittent, on-demand injections76, intravenous (IV) 
patient-controlled analgesia77,78, continuous IV infusion36, and less commonly, dermal 
patches of lidocaine on the fracture site, which has proven ineffective.47,73 While a 
continuous IV infusion of systemic opioids will reduce pain and improve vital capacity, it 
can result in cough suppression and hasten the onset of respiratory complications (e.g., 
respiratory depression and hypoxemia), possibly owing to paradoxical breathing, 
obstructive apnea, or a reduction in sigh-breaths.36 Even when using conservative doses, 
morphine may still compromise pulmonary mechanics (most notably a reduction of 
spontaneous deep breathing).79 Systemic use of opioids (or ketamine) can also 
compromise evaluations of the head and abdomen.47 On top of the side effects, systemic 
analgesia remains less effective than regional techniques at controlling pain.37 Thus, 
systemic opioids may be helpful in conjunction with a regional treatment, but not as a 
treatment for multiple fractured ribs per se.76,77 
 
Regional analgesia 
 
 Regional analgesia is often supplemented with a small dose of either NSAIDs or 
opioids and pain reduction is typically strong and immediate.28,47 There is little sedation, 
so evaluation of head and abdominal injuries is easier. A major disadvantage is the 
technical complexity of the procedures, leading to occasional errors in the administering 
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of the treatments. They can also be painful while the needle is entering (or catheter is 
being installed), toxicity is a possibility, and the patients require more intensive 
monitoring and care by the physicians and nurses.47 There are a variety of modes; the 
four most common are TEA, thoracic paravertebral block, intercostal block, and 
intrapleural block.37 This paper focuses on TEA. 
 
Thoracic epidural analgesia  
 
Narcotic infusions and continuous local anesthetic can be delivered through 
thoracic or lumbar epidural catheters. Opioid receptors exist in the spinal cord that can 
alter the perception of pain without needing stimulation of receptors in the brain.36 Once 
injected, the anatomy of the epidural space restricts the geography throughout which the 
analgesia can spread.42 These boundaries are made up by the dura (the outermost 
membrane surrounding the spinal cord) and the periosteum, which lines the bones of the 
vertebral canal. Superiorly (in the upper-cervical region), the dura and periosteum fuse. 
This prevents the analgesic from migrating above the foramen magnum.  Posterior 
migration is limited by the ligamenta flava (ligaments that connect the vertebrae, 
bordering the interior of the spinal canal).42 After inserting the catheter into this area, 
local anesthetics and narcotics are administered, blocking the anterior and posterior nerve 
roots crossing this space. The anesthetic/analgesic agents diffuse across the dura and 
begin to block sensory nerves. Motor nerves are affected to a lesser degree. It takes a 
large dose to achieve the desired effect. A possible side effect of a large dose of local 
anesthetics is dilation of the arteries and veins (especially the veins). There are techniques 
to safely avoid or treat the resulting hypotension.68,80 
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In 1982, Rawal and colleagues81 showed thoracic epidural morphine to be a more 
effective treatment than intercostal nerve block following cholecystectomy. The epidural 
patients experienced prolonged pain relief and did not experience respiratory depression, 
while those receiving intercostal nerve block did. Since then, TEA has emerged as one of 
the most researched and seemingly effective treatments for patients who present with 
multiple fractured ribs.47,70  
 
According to most reports, the downsides of epidural analgesia are not 
ineffectiveness (relative to other treatments), but risk of side effects. It has been 
successful in both lumbar and thoracic routes using opioids, local anesthetics, or a 
combination, especially in patients over the age of 60. Among this group, epidural 
analgesia decreases mortality and pulmonary complications.82 Among patients with chest 
wall trauma, it relieves pain better than systemic opioids36,78 and intrapleural analgesia.83 
It is an effective treatment in a variety of pulmonary measures (e.g., dynamic lung 
compliance, airway resistance, functional reserve capacity, vital capacity, pulmonary 
gasses).84 If the patient has paradoxical chest wall movement, epidural analgesia reduces 
it and restores shallow breathing to near-normal levels.85 There may also be immune 
system benefits, as epidural analgesia reduces plasma levels of interleukin-8, a 
chemokine that increases inflammation following acute lung injury.78 Overall, patients 
who are treated with epidural analgesia develop fewer complications than patients who 
are intubated and receive mechanical ventilation44,45,53 and they spend fewer days in the 
hospital and the ICU.53  
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Comparing the different treatments 
 
 Each treatment has a unique set of advantages, disadvantages, and 
contraindications. Patients must be treated according to what is currently regarded as the 
best medical practice. For this reason, controlled trials that truly randomize patients to 
different treatment groups are infrequently conducted. It is unlikely that a review board 
would approve a randomization model that distributes patients evenly throughout the 
treatment groups based on criteria such as the presence of upper-rib fractures. Thus, most 
data available are retrospective comparisons of two groups of patients who have similar 
injuries and were treated with different techniques. Among this body of research, there is 
wide variation in which treatment option is used.86 
 
 When hemodynamic and respiratory function are concerns, systemic analgesia is 
often avoided.38 Systemic opioids can also impair assessment of a patient’s mental 
status.38 For these reasons, regional techniques are often preferred.38 According to a 2000 
meta-analysis by Rogers and colleagues87, TEA can reduce the rate of mortality by more 
than 30% and decrease the incidence of comorbidities by 15% (stroke) to 55% 
(pulmonary embolism). Likewise, a 2003 meta-analysis by Block and colleagues88 
(which analyzed more than 100 studies) found epidural treatment to be superior to opioid 
treatments. More specifically, use of epidural catheter treatments (as compared to 
systemic opioids) has demonstrated improvements in subjective pain management7, 
pulmonary function36,78,89, and better clinical outcomes.11,82 Despite this, in a 2003 
narrative review on pain management, Karmakar and Ho37 concluded that no single mode 
of analgesia could be confidently recommended. Contrasting this review, Simon and 
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colleagues published pain management guidelines for blunt thoracic trauma in 200590, 
stating that the preferred mode of analgesic for patients with multiple rib fractures was 
via epidural. The inconsistencies in recommendations may be responsible for the low 
rates (below 20%) of epidural use among eligible patients (patients without 
contraindications to epidural placement).7,8,59 In 2005, Flagel et al.10 found only 2% of 
patients with at least 1 fractured rib to be treated with epidural analgesia (1,295 of 
64,750). Most recently, in 2014, Dehghan et al.26 found epidural catheters were only used 
in 8% of patients who were admitted with flail injuries (263 of 3,467). 
 
Rationale for this review 
 
The most recent review of TEA as a treatment for patients with multiple rib 
fractures was published by Carrier and colleagues in 2009.46 In it, they performed a meta-
analysis of 8 studies related to TEA (7 in English, 1 in Turkish). They identified 3 studies 
that compared TEA with local anesthetics to parenteral opioids78,91,92, 2 studies that 
compared TEA with local anesthetics to intrapleural analgesia83,93, and 3 studies that 
compared epidural analgesia with opioids to parenteral opioids.36,89,94 When analyzing 
those studies collectively, Carrier and colleagues reported no significant differences 
between epidural analgesia and other analgesic modalities in mortality, length of stay in 
the ICU, or length of stay in the hospital. When evaluating duration of mechanical 
ventilation, they found some benefit to using epidural anesthesia with local anesthetics. 
However, that treatment was associated with a greater risk of hypotension.  
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These findings must be interpreted cautiously. Out of the 8 studies analyzed, only 
6 were randomized trials, one of which was a poster presentation. Of the remaining 
studies, 1 assigned treatment based on injury severity and 1 is in Turkish, with no 
mention of randomization in English. Furthermore, only 4 studies provided sufficient 
details about catheterization methods in English. Carrier and colleagues rank their 8 
studies in terms of quality, admitting, “Only four of the eight studies included in our 
review were of high methodological quality.” These were: Bulger et al., 200411; Luchette 
et al., 199483; Moon et al., 199978; and Shinohara et al., 1994.93 
 
A similar admission is made in a 2007 review of the literature by Parris95, who 
also found 4 studies to be satisfactory for inclusion. These were: Bulger et al., 200411; 
Moon et al., 199978; Mackersie et al., 199136; and Ullman et al., 1989.89 Curiously, only 
half of the “high methodological quality” studies overlap between the two most recent 
reviews. 
 
One example of a study that Carrier and colleagues regarded as high quality and 
Parris did not is a 1994 investigation by Luchette et al.83 This study did not address 
clinical outcomes (days in ICU, days in hospital, duration on mechanical ventilation, 
incidence of pneumonia) as much as variables thought to affect clinical outcomes (pain, 
pulmonary function). There is no mention of blinding and patients were permitted into 
the study with associated injuries that were not explained or controlled for (and would 
likely affect patient-perceived pain level).  It is important to consider the impact such 
limitations might have on the validity of Carrier et al.’s conclusions. 
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Regarding these conclusions, although no original studies were published between 
the two reviews, Parris’s interpretation of the data was slightly different from Carrier et 
al.’s: “On limited evidence from moderate quality studies, epidural analgesia/anaesthesia 
offers some benefits over intravenous analgesia but further studies are needed to 
strengthen this conclusion.” 
 
What seems consistent between the two reviews is not their interpretation of the 
findings, but their appraisal of the quality of available literature. According to Parris, “the 
limited quantity and quality of evidence illustrates the difficulties in studying this patient 
group and determining the most relevant outcomes.” In terms of quantity, several studies 
went unreported, but in terms of quality, he makes a valid point. He elaborates on that 
point: “All four studies looked at slightly different patient groups, different treatment 
regimens and outcomes with consistently poor reporting of timing of placement of 
epidural catheters and administration of intravenous analgesics.”  
 
Although a new systematic review may be in order just to reconcile the 
conclusions of the previous attempts, it is also an ideal time to do so as new studies 
evaluating the safety and/or effectiveness of TEA have been published since 2009. 
According to our search, there are 10 studies that merit consideration, which were not 
considered in either of the aforementioned reviews: 4 published prior to 2009, 6 
published since. 
 
Prior to 2009: Wisner (1990)82 compared epidural narcotics (87% lumbar, 13% 
thoracic) to a variety of analgesic modes, but most commonly intravenous/intramuscular 
(IV/IM) narcotics among patients who had sustained thoracic trauma. Wu and colleagues 
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(1999)7 compared TEA to IV analgesia in patients with at least 3 fractured ribs. Bulger 
and colleagues (2000)6 compared treatment outcomes of elderly Patients (≥ 65 y) with at 
least 1 fractured rib to younger patients (18-64 y) with at least 1 fractured rib; epidural 
catheters were compared to other treatment modalities (e.g., pleural block, IV/IM 
narcotics, oral narcotics, ketorolac, Tylenol). Kieninger et al. (2005)96 compared epidural 
analgesia to IV narcotics in older patients with rib fractures.  
 
Since 2009: Mohta and colleagues (2009)29 compared TEA to thoracic 
paravertebral infusion in patients with at least 3 fractured ribs. Hashemzadeh and 
colleagues (2011)61 compared TEA to intercostal block in patients with multiple fractured 
ribs. Kim and colleagues (2011)97 reported the complications that arose in patients who 
underwent surgical reduction and fixation of fractured ribs, and were treated with TEA. 
Hakim & Latif (2012)28 evaluated TEA compared to lumbar epidural analgesia (both 
lidocaine) in patients admitted with blunt chest trauma. Yeh and colleagues (2012)8 
compared TEA to IV and oral narcotics in patients with at least 3 fractured ribs. Waqar 
and colleagues (2013)9 compared TEA to IV opioids among patients with multiple 
fractured ribs. 
 
Objectives of this review 
 
In this review, we complete a comprehensive search for articles related to the use 
of TEA in patients with rib fractures. In doing so, we attempt to identify the value of 
TEA as it relates to mortality, length of stay in the ICU and hospital, use of mechanical 
ventilation, improvement in subjective pain levels, effect on respiratory function, and 
incidence of pneumonia and other complications/adverse events (e.g., sepsis, acute 
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respiratory distress syndrome, respiratory failure). Wherever possible, we make 
comparisons to other treatments. 
 
METHODS 
 
Search strategy 
 
An electronic search was conducted using PubMed on March 29, 2014.  Two 
search terms were used: 
 
1) (thoracic) AND (catheter* OR epideral* OR "epidural analgesia" OR 
"Analgesia, Epidural"[MAJR]) AND pain AND (fracture*) AND (rib OR ribs) 
 
2) (("thoracic catheter" OR "thoracic 
epidural" OR "thoracic catheters" OR 
"thoracic epidurals" OR "thoracic 
paravertebral catheter" OR "Analgesia, 
Epidural"[MAJR] OR "epidural analgesia") 
AND pain AND fracture* AND (rib OR 
ribs)) 
 
After running each search, the PubMed 
Advanced Search Builder tool was used to 
combine their results, eliminating duplicate 
studies. 
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Search results  
 
This search yielded 63 total articles; 14 of these presented original research about the 
effectiveness of TEA in English.7,8,11,25,29,39,41,61,82,83,91,93,96,98 
 
Additional articles 
 
After completing the search, we reviewed the source lists of all relevant articles and 
found an additional 16 original trials that weren’t identified by our search term; 15 of 
these were in English.6,9,10,28,30,36,65,66,78,84,85,89,94,97,99 
 
Study Selection, Validity Assessment, and Eligibility Criteria 
 
The quality of each study is evaluated and assigned a rating based on a 14-point 
scale.  The instrument for assessing study quality is the Quality Assessment of Controlled 
Intervention Studies, available on the NIH website.100 
 
Items 1 through 3 address randomization and treatment allocation. Items 4 and 5 
involve blinding. Item 6 evaluates the similarity of treatment groups at baseline. Items 7 
through 9 assess drop out and adherence. Items 10 and 11 address internal study validity. 
Item 12 evaluates power calculations/sample size. Item 13 involves pre-specification of 
study outcomes. And item 14 asks if all study participants are analyzed in the groups they 
were assigned. 
 
All studies published in English are characterized in tables. The findings of 
studies with higher quality assessments are given more consideration. 
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Extraction and Synthesis of Data 
 
Data were carefully extracted from all 29 articles. Tables were generated, 
characterizing primary outcomes where available. The outcomes are: demographic 
information (sex, age), type of study (RCT, review, etc.), injury characteristics (number 
of ribs fractured, ISS, presence of flail chest and pulmonary contusion), type of treatment 
(TEA, IV, etc.), mortality, ICU length of stay, hospital length of stay, use and duration of 
mechanical ventilation, changes in subjective pain levels, changes in respiratory function, 
incidence of pneumonia and other complications/adverse events (sepsis, acute respiratory 
distress syndrome, respiratory failure). 
 
Principle Summary Measures 
 
Because there are inherent differences in the type and quality of the data 
published, and vast differences in the methods of their acquisition, we do not attempt to 
meta-analyze the findings. At this stage in the research, such a summation would be little 
more than data alchemy, and worthy of distrust. Instead, we merely present the findings 
in tables, evaluate the quality of the relevant claims, and provide an overall appraisal of 
the state of the evidence. 
 
RESULTS 
 
Research supporting TEA 
 
16 studies have reported epidural analgesia to be an effective treatment for 
patients with fractured ribs. Of these, 5 do not include a comparison group, 3 compare 
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TEA to mechanical ventilation (one is a duplicate of another study), 4 compare TEA to 
IV opioid treatments, and the remaining 4 compare TEA to other regional techniques. 
 
In 2005, Flagel and colleagues10 compared the use of epidural analgesia to all 
alternative treatments (they did not specify which treatments these were). In evaluating 
the NTDB, they found 9% of patients (n = 64,750) to present with at least 1 fractured rib. 
Among these patients, 2% (n = 1,295) received epidural analgesia; the rest (63,455) 
received alternative treatments. No information is provided about what these forms are or 
how they were administered. Nor were the methods of epidural catheterization (including 
type and concentration of analgesia) described. Inclusionary and exclusionary criteria 
were not reported and numerous baseline variables were absent from the results. This 
includes age (overall and in each treatment group), gender (overall and in each treatment 
group), mean number of fractured ribs (overall and in each treatment group), and the 
incidence of flail segments and pulmonary contusions in individual treatment groups. 
Among all patients with rib fractures, epidural analgesia was used in 2% of cases. The 
more ribs fractured, the more commonly epidural analgesia was used (R2 = 0.96). Use of 
this treatment jumped 50% in the presence of 6 or more fractured ribs (compared to 
treatments of patients with 5 or fewer). Despite greater numbers of rib fractures in the 
group receiving epidural analgesia, ISS was slightly lower, and odds of surviving were 
much better (more than 96% survived, compared to a 10% overall mortality rate). 
Epidural analgesia had no effect on the incidence of pneumonia. 
 
All original studies in English that support the use of TEA as a treatment for rib 
fractures are seen in Table 2.1.  
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Table 2.1: Research Supporting TEA 
Author N Age (y) # Ribs ISS Associated Trauma Complications Mortality Pulmonary Outcomes LOS (d) Pain Relief 
No Comparator 
Abouhatem et 
al., 198425 
19 
53  
(20–80) 
5  
37% flail segment; 
16% pulmonary 
contusion 
Reported 
bradycardia 
(n=2) and hypo-
tension (n=3) 
  
Treatment 
duration: 8 
(2–17) 
94.7% exp. 
pain relief; 
42.1% exp. 
“excellent” 
pain relief. 
Doss et al., 
199941 
57 21–26        
100% exp. 
pain relief 
Govindarajan 
et al., 200239 
27 48±16 4 (2–8)   
No morbidity 
among sample 
 
Ventilatory markers 
improved 
Hospital: 5 
(4–7) 
Improved pain 
relief at rest 
and during 
coughing 
Johnston et al., 
198099 
6 49 5.3±1.5   
Hypotension: 
mean BP fall of 
15 mmHg after 
treatment 
 
1 patient required 
mechanical ventilation 
7–10 (n=5)  
Worthley, 
198530 
161 46.1±16.8   
16.1% flail segment; 
 9.9% pulmonary 
contusion. 
2 cardiac arrest, 
1 epi infection 
reported. 
1.2% 
14 subjects needed 
mechanical ventilation 
  
Mechanical Ventilation 
Dittmann et al., 
197585 
Epi=16; 
MV=32 
Epi=55.1 Epi=5.4    
Epi=7.1%; 
MV=21.9% 
Epi: ventilatory markers 
improved; 1 patient was 
intubated; 1 contracted 
pneumonia. 
 
Epi: pain relief 
claimed, but 
no data 
reported. 
Dittmann et al., 
197884 
Epi=49; 
MV=51 
Epi=55.7;
MV=44.7 
Epi=6.8; 
MV=6.5 
   
Epi=6.1%; 
MV=13.7%
. 
Epi: ventilatory markers 
improved; 3 patients 
needed ventilation. 
Epi=4.5 (2–
11); MV=9.8. 
 
Dittmann et al., 
198265 
Epi=112; 
MV=155 
Epi=57.5; 
MV=45.2 
Epi=6.8; 
MV=6.6 
 
Epi: 1% pulmonary 
contusion. MV: 32% 
pulmonary contusion 
 
Epi=4.5%; 
MV=24.5% 
 
ICU: epi=6.1, 
MV=13.5; 
Hospital: 
epi=16.8, 
MV=26.2 
 
IV Treatment 
Pierre et al., 
200594 
Epi=11. 
IV=11. 
Epi=53; 
IV=53 
Epi=4.5, 
IV=3.8 
     
Hospital: 
epi=10.8, 
IV=15.9; 
ICU: epi=3.1, 
IV=6.6 
Epi had better 
pain outcomes 
at 24 and 36 hr 
Ullman et al., 
198989 
Epi=15. 
IV=13. 
Epi=46.1±
4.6, 
IV=53.0±
6.0 
Epi=7.3
±0.6, 
IV=6.6±
1.1 
Epi=19.5
±2.0, 
IV=25.3
±2.9 
 
2 epi patients 
experienced 
urinary retention. 
 
Epi group spent 3.1 days 
on ventilation; IV group 
spent 18.2. Epi group had 
better improvements in 
tidal volume. 
Hospital: 
epi=14.9, 
IV=47.7. 
ICU: epi=5.9, 
IV=18.7 
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Author N Age (y) # Ribs ISS Associated Trauma Complications Mortality Pulmonary Outcomes LOS (d) Pain Relief 
Waqar et al., 
20139 
Epi=47. 
IV=38. 
Epi=54±1
7, 
IV=45±22 
Epi=6.4
±2.1, 
IV=5.2±
2.5 
Epi=23.6
±10.3, 
21.0±6.7 
Epi: 19% flail segment. 
IV: 13% flail segment. 
“Complications” 
were reported to 
be 8% among epi 
patients and 18% 
among IV 
patients. 
Epi: 4%; 
IV: 2.6% 
13% of epi patients 
contracted pneumonia; 
26% of IV patients 
contracted pneumonia. 
Hospital: 
epi=19±3.1, 
IV= 21±4.1; 
ICU: 
epi=12±2.4, 
IV=14±3.5 
Pain relief 
superior in epi 
patients at all 
time points 
Wisner, 199082 
Epi=52. 
IV/IM=167
. 
Epi=71.0±
1.1, 
IV/IM=69.
4±0.6 
 
Epi=15.7
±1.0, 
IV/IM=1
4.6±0.8 
  
Epi=4%, 
IV/IM=16
% 
8% of epi patients 
contracted pneumonia. 
19% of IV/IM patients 
contracted pneumonia. 
 
Epi associated 
with improved 
pain control 
Other Regional Techniques 
Gibbons et al., 
197366 
Epi=27. 
Other=30. 
    
Hypotension in 
44% of epi 
patients; 
circulatory arrest 
in 7% 
No reported 
deaths in 
epi; 7% 
mortality in 
other group 
Epi: 22% of patients 
needed ventilation. Other: 
43% needed ventilation 
  
Hashemzadeh 
a et al., 201161 
Epi=30. 
Intercostal 
block=30. 
Epi=45.5±
15.4, 
Intercostal
=65.5±7.2 
      
Trauma unit: 
epi=5.7±2.0, 
intercostal=7.
7±3.7; ICU: 
epi=1.6±1.0, 
intercostal=1.
9±1.4 
 
Luchette et al., 
199483 
Epi=9. 
Intrapleural 
cath=10. 
Epi=56±1
8.3, 
Intrapleura
l=51±10.9 
 
Epi=21.7
±5.5, 
intrapleu
ral=19.4
±5.7 
 
Mild to moderate 
hypotension 
experienced by 
epi subjects. 
 
No differences in vital 
capacity, minute 
ventilation, and respiratory 
rate; epi patients improved 
more in tidal volume and 
negative inspiratory force. 
Mechanical ventilation 
needed in 78% of epi 
subjects and 70% of 
intrapleural subjects. 
 
Pain 
management 
better in epi 
group by 
visual analog 
and lower use 
of 
supplemental 
morphine 
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Research not supporting TEA 
 
Epidural analgesia is not always shown to be the most effective modality. Among 
patients admitted with rib fractures, the outcomes of TEA administration have been 
inconsistent.7,82,96 Whereas 16 studies have reported positive outcomes with epidural 
analgesia, 10 have reported either comparable or poorer outcomes for patients with 
fractured ribs. Out of these, 2 were not designed to evaluate the efficacy of TEA, 6 
compared TEA to IV treatments, and 2 compared TEA to other regional techniques. 
 
Methods not designed to evaluate epidural analgesia 
 
In 2004, Balcı and colleagues91 evaluated patients with flail injuries. There were 3 
different treatments: 13 patients received TEA (35.1%), 16 received intercostal nerve 
blockade (43.2%), and 8 received narcotic or nonnarcotic parenteral analgesia (21.6%). 
This study was not designed to assess the effectiveness of TEA; it was a side note in a 
protocol investigating surgical fixation. The authors report that all patients receiving 
epidural analgesia or intercostal nerve blockades needed additional parenteral analgesia 
and repeated doses to address pain. They do not report pain outcomes or data concerning 
treatment repetition, but note that pain control was inadequate and opioid drugs were the 
most commonly used option to increase the analgesic effect. Across the whole sample, 
mortality was 20.3%, the duration of mechanical ventilation ranged from 1.5 to 22 days, 
and the length of hospital stay ranged from 9 to 32 days. The authors concluded that 
surgical fixation was a successful treatment for patients with traumatic flail chest but 
thoracic epidural catheters were potentially problematic “not only because of the angle of 
the spinal processes and the smaller space but also because it was difficult to put patients 
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with flail chest in the proper position to place the catheter, thus we do not advise its 
routine use.” 
 
In 2000, Bulger and colleagues6 compared outcomes of elderly Patients (≥ 65 y) 
with at least 1 fractured rib to younger patients (18-64 y) with at least 1 fractured rib. 
There were 277 elderly patients (74 ± 6 yr, 3.6 ± 2.5 fractured ribs, 17% had a flail 
segment, ISS = 20.7 ± 12.7) and 187 younger patients (39 ± 13 yr, 4.0 ± 2.9 fractured 
ribs, 11% had a flail segment, ISS = 21.4 ± 13.4). The mean duration spent in the ICU 
was 6.1 ± 10.0 days for elderly patients and 4.0 ± 9.4 days for young patients (p < .05). 
The mean hospital stay was 15.2 ± 16.5 days for elderly patients and 11.0 ± 13.1 days for 
young patients (p < .01). As the number of fractured ribs increased, so did the odds of 
contracting pneumonia, adult respiratory distress syndrome, and mortality. 22% of the 
elderly patients died compared to 10% of the young patients (p < .001). Elderly patients 
and patients with more severe injuries were most likely to receive epidural catheters.  
Despite greater chest injury in the catheter group, mortality rates were lower (11% in 
epidural group, 25% in those not receiving epidurals). Despite a lower mortality rate 
among patients receiving epidural analgesia, that treatment was associated with more 
pulmonary complications and longer stays in the ICU and hospital. A possible 
explanation for both of these outcomes is the greater injury severity of those receiving 
epidurals. Additionally, basic treatment logistics might explain some of the length of 
stay: once a catheter is applied, it is generally left in place for 4–5 days. 
 
Compared to other treatments 
 
 31 
To date, 6 studies have failed to find TEA to be superior to IV treatments and 2 
have failed to find TEA superior to other regional techniques. In one of the studies 
involving regional analgesia, patients received both treatments. That study is described 
below. The remaining studies are characterized in Table 2.2. 
 
Compared to other regional techniques 
 
In 1994, Shinohara and colleagues93 compared thoracic epidural block to 
intrapleural block among 17 patients with multiple unilateral rib fractures (5.7 ± 1.4) and 
hemopneumothorax. Both intrapleural and thoracic blocks were installed in all patients. 
On the first day, when a patient complained of pain, that patient received treatment 
through one of the two blocks (randomly chosen). On the second day, when a patient 
complained of pain, the other block was used. The intervention group is considered to be 
those who received intrapleural block prior to thoracic block and the comparison group 
consisted of those who received thoracic block prior to intrapleural block. There were no 
significant differences in pain relief; no subject required additional analgesia during 
treatment; there were no cases of pneumonia or mortality. 
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Table 2.2: Research not supporting TEA 
Author N Age (y) # Ribs ISS Associated Trauma Complications Mortality Pulmonary Outcomes LOS (d) Pain Relief 
IV Treatment 
Bulger et al., 
200411 
Epi=22, 
IV=24 
Epi=49±1
8, 
IV=46±16 
Epi=7.2
±3.2, 
IV=6.8±
3.3 
Epi=26 
± 8; 
IV=25±8 
Epi=38% flail segment; 
IV = 21% flail segment. 
Epi=complicatio
ns in 27%, 
IV=complication
s in 33% 
Epi: 9.1%; 
IV: 4.2% 
Epi=7.6 days on 
mechanical ventilation; 
IV=9.1 days on mechanical 
ventilation. Epi=18% 
pneumonia. IV=38% 
pneumonia. 
Hospital: 
Epi=18 ± 16;  
IV=16 ± 13. 
ICU: Epi=10 
± 15; IV= 23 
± 26. 
3 epi patients 
and 3 IV 
patients failed 
to experience 
pain relief and 
switched 
groups. 
Kieninger et 
al., 200596 
Epi=53, 
IV=134 
Epi=77.7±
10.2, 
IV=77.3±
10.5 
 
Epi=10.3
±3.6, 
IV=8.3±
3.9 
 
Epi=58% 
experienced 
cardiopulmonary 
comorbidities, 
IV=68% 
experienced 
cardiopulmonary 
comorbidities 
Epi=5.6%, 
IV=1.5% 
 
Epi=8.6 ± 4.6, 
IV=5.6 ± 5.1 
 
Mackersie et 
al., 199136 
Epi=15, 
IV=17 
Epi=49.3±
19, 
IV=47.8±
14 
Epi=4.2
±1.0, 
IV=4.8±
1.7 
Epi=20±
7.6, 
IV=16±7
.2 
 
Nausea/vomiting 
present in 46% of 
epi cases and 
29% of IV cases. 
 
Epi group experienced 
better inspiratory capacity 
improvement. 
 
No cases of pneumonia 
Hospital: 
epi=8.7±4.2, 
IV=7.1±6.2 
Epidural group 
experienced a 
trend of better 
pain reduction 
Moon et al., 
199178 
Epi=13, 
IV=11 
Epi=37, 
IV=40 
 
Epi=26.6
, 
IV=23.4 
   
Ventilatory function was 
better in epi patients 
 
Epi group 
experienced 
better pain 
relief while 
coughing; not 
at rest 
Wu et al., 
19997 
Epi=25, 
IV=39 
Epi=56±1
7, 
IV=45±22 
Epi=5.6
±2.1, 
IV=4.4±
1.5 
Epi=21.6
±10.3, 
IV=21.9
±6.7 
 
Epi: 4% 
experienced 
cardiac 
complications, 
4% neurologic. 
IV: 13% cardiac 
complications, 
18% neurologic. 
0% across 
total 
sample 
Epi: 26% were intubated, 
12% contracted 
pneumonia. IV: 5% were 
intubated, 10% contracted 
pneumonia. 
ICU: 
epi=4.4±4.1, 
IV=2.5±3.5 
Epi group 
experienced 
superior pain 
relief 
Yeh et al., 
20128 
Epi=34, 
IV=153 
Epi=48.8±
18.4, 
IV=69.6±
10.1 
Epi=5.0
±2.0, 
IV=5.6±
2.3 
Epi=23.1
±9.3, 
IV=21.5
±9.3 
    
Hospital: 
epi=7, IV=5; 
ICU: epi=1, 
IV=0 
 
Other Regional Techniques 
Mohta et al., 
200929 
Epi=15, 
Paravertebr
al 
Epi=38.9±
14.9, 
para=40.4
Epi=4.9
±1.8, 
para=4.9
Epi=15.9
±7.1, 
para=13.
Epi=7% flail segment, 
para=27% flail segment 
Hypotension 
higher in epi 
(40%) than para 
0% both 
groups 
Ventilatory mechanics 
improved comparably in 
both groups.  Epidural 
Hospital: 
epi=10.1, 
para=11.7; 
No difference 
in visual 
analog 
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Author N Age (y) # Ribs ISS Associated Trauma Complications Mortality Pulmonary Outcomes LOS (d) Pain Relief 
infusion=1
5 
±14.8 ±1.4 6±5.6 (7%); fever 
higher in para 
(20%) than epi 
(13%); 1 patient 
developed 
anesthetic 
toxicity in para 
group 
pneumonia=1, para 
pneumonia=2 
ICU: epi=6.3, 
para=6.8 
improvement 
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Study Quality 
 
The studies evaluating the efficacy of TEA span a broad range of quality. 
Among the 16 studies showing TEA to be an efficacious treatment, 8 involved a 
comparison group. Among the10 studies that reported either poorer or comparable 
outcomes, 2 were not designed to evaluate the efficacy of TEA. Thus, among all studies 
with methods sufficient to answer this question, 8 supported the use of TEA against 
alternative treatments and 8 have failed to support it. The studies that favored TEA met 
an average of 4.9 of the 14 criteria outlined by the NIH’s Quality Assessment of 
Controlled Intervention Studies tool.100 Among the studies that do not favor TEA, they 
meet an average of 8.0 criteria (Table 2.3). 
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Table 2.3: Study quality of all trials evaluating TEA 
Author 
Random 
Design 
Adequate 
Random 
Methods 
Concealed 
Treatment 
Allocation 
Subjects & 
Providers 
Blinded 
Evals. of 
Subjects 
Blinded 
Similar 
Baseline 
Values 
Total 
Dropout 
<20% 
No Group 
Dropout 
Difference  
Adherence 
to Protocol 
Confounding 
Treatments 
Controlled 
Validly, 
Reliably 
Assessed 
Sample 
Size >80% 
Power 
Pre-
Specified 
Measures 
Analyzed 
in Group 
Assigned 
Studies supporting TEA 
Abouhatem et 
al., 198425 
no no no no no NA YES NA YES YES 
Not 
Described 
Not 
Described 
YES NA 
Doss et al., 
199941 
no no no no no NA YES NA YES YES 
Not 
Described 
Not 
Described 
Not 
Described 
NA 
Govindarajan et 
al., 200239 
no no no no no NA YES NA YES YES YES 
Not 
Described 
YES NA 
Johnston et al., 
198099 
no no no no no NA YES NA partial partial 
Not 
Described 
Not 
Described 
YES NA 
Worthley, 198530 no no no no no NA YES NA partial partial YES 
Not 
Described 
YES NA 
Dittmann et al., 
197585 
no no no no no 
Not 
Described 
YES YES 
Not 
Described 
no 
Not 
Described 
Not 
Described 
YES YES 
Dittmann et al., 
197884 
no no no no no no YES YES YES partial 
Not 
Described 
Not 
Described 
YES YES 
Dittmann et al., 
198265 
no no no no no no YES YES YES partial 
Not 
Described 
Not 
Described 
YES YES 
Pierre et al., 
200594 
YES 
Not 
Described 
Not 
Described 
Not 
Described 
Not 
Described 
Not 
Described 
Not 
Described 
Not 
Described 
Not 
Described 
Not  
Described 
Not 
Described 
Not 
Described 
YES 
Not 
Described 
Ullman et al., 
198989 
no no no no no No YES YES YES YES YES 
Not 
Described 
YES YES 
Waqar et al., 
20139 
no no no no no no YES YES YES partial 
Not 
Described 
Not 
Described 
YES YES 
Wisner, 199082 no no no no no no YES YES YES YES 
Not 
Described 
Not 
Described 
YES YES 
Flagel et al., 
200510 
no no no no no no YES YES 
Not 
Described 
Not  
Described 
Not 
Described 
Not 
Described 
YES YES 
Gibbons et al., 
197366 
no no no no no no YES YES 
Not 
Described 
no 
Not 
Described 
Not 
Described 
YES YES 
Hashemzadeh a 
et al., 201161 
YES 
Not 
Described 
no no no no YES YES YES YES YES 
Not 
Described 
YES YES 
Luchette et al., 
199483 
YES 
Not 
Described 
no no no YES YES YES YES YES YES 
Not 
Described 
YES YES 
Studies not supporting TEA 
Bulger et al., 
200411 
YES YES no no no YES YES YES YES YES YES partial YES YES 
Kieninger et al., 
200596 
no no no no no no YES YES YES YES 
Not 
Described 
Not 
Described 
YES YES 
Mackersie et al., 
199136 
YES YES no no no YES YES YES YES YES YES 
Not 
Described 
YES YES 
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Author 
Random 
Design 
Adequate 
Random 
Methods 
Concealed 
Treatment 
Allocation 
Subjects & 
Providers 
Blinded 
Evals. of 
Subjects 
Blinded 
Similar 
Baseline 
Values 
Total 
Dropout 
<20% 
No Group 
Dropout 
Difference  
Adherence 
to Protocol 
Confounding 
Treatments 
Controlled 
Validly, 
Reliably 
Assessed 
Sample 
Size >80% 
Power 
Pre-
Specified 
Measures 
Analyzed 
in Group 
Assigned 
Moon et al., 
199178 
YES YES no no no Partial YES YES YES YES YES 
Not 
Described 
YES YES 
Wu et al., 19997 no no no no no no YES YES YES YES YES 
Not 
Described 
YES YES 
Yeh et al., 20128 no no no no no no YES YES YES YES YES 
Not 
Described 
YES YES 
Mohta et al., 
200929 
YES no no no no YES YES YES YES YES YES 
Not 
Described 
YES YES 
Balcı et al., 
200491 
no no no no no NA YES NA YES YES YES 
Not 
Described 
YES YES 
Bulger et al., 
20006 
no no no no no no YES YES YES YES YES 
Not 
Described 
YES YES 
Shinoharaet al., 
199493 
YES no no no no 
Not 
Described 
YES YES YES YES YES 
Not 
Described 
YES YES 
NIH Quality Assessment of Controlled Intervention Studies (available online: http://www.nhlbi.nih.gov/health-
pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/rct)
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Risks of TEA 
 
Treating with epidural analgesia is not without risks. It’s more technically 
complex than the administration of IV analgesia, which puts the patient at a higher risk of 
complications.38 Although infrequent, these include inadvertent dural puncture (1 in 200–
526)101-103 and spinal cord injury (when done in the thoracic region)38,47, direct neural 
injury (1 in 167,000)103,104, transient neurological injury (1 in 6,700)103,104, catheter-
related infection (1 in 770–3,300)28,84,103,105, deep epidural infection (1 in 
45,000)30,56,103,104, hypotension (1 in 33–143)30,47,106, cardiac arrest (1 in 10,140)107, 
hematoma (1 in 150,000–190,000)68,103,108, abscesses in the epidural space (1 in 
1,000)103,109-111, nausea, vomiting36,37, central nervous system toxicity (1 in 833–
10,000)106, respiratory depression (1 in 63–416)56,106, pruritis and urinary retention in the 
presence of an opioid38, and motor block compromising mobilization (1 in 33).47,106 
 
Individual outcomes associated with TEA 
 
Mortality 
 
4 studies found epidural analgesia to be associated with a lower mortality rate 
compared to an alternative treatment; 2 compared TEA to a variety of alternative 
treatments6,10, 1 compared TEA to IV/IM narcotics82, and 1 compared TEA to mechanical 
ventilation (which is not a valid comparison as patients requiring mechanical ventilation 
are typically regarded as having failed other treatments).65 
 
 38 
No study found epidural analgesia to be associated with a higher mortality rate compared 
to an alternative treatment. 
 
8 studies found no difference in mortality rate when using epidural analgesia 
compared to an alternative treatment: 4 compared to IV treatments7,9,11,96, 1 to mechanical 
ventilation85, 1 compared to intercostal nerve block or parenteral narcotics66, 1 compared 
to thoracic paravertebral anesthesia29, and 1 compared to intrapleural anesthesia93 
 
Pain management 
 
7 studies found epidural analgesia to be associated with better pain management 
compared to an alternative treatment: 4 compared to IV treatment7,9,78,94, 1 compared to 
IV/IM narcotics82, 1 compared to intercostal block61, and 1 compared to intrapleural 
anesthesia.83  
 
No study found epidural analgesia to be inferior at reducing pain compared to an 
alternative treatment. 
 
3 studies found no difference in pain management when using epidural analgesia 
compared to an alternative treatment: 1 compared to IV treatment36, 1 compared to 
thoracic paravertebral anesthesia29, and 1 compared to intrapleural anesthesia.93 
 
Duration of stay in the ICU 
 
6 studies found epidural analgesia to be associated with shorter stays in the ICU 
compared to an alternative treatment: 3 compared to IV treatment9,89,94, 2 compared to 
mechanical ventilation65,84, and 1 compared to intercostal block.61 
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2 studies found epidural analgesia to be associated with longer stays in the ICU 
compared to an alternative treatment: 1 compared to oral and IV treatment8 and 1 
compared to a variety of alternative treatments.6 
 
4 studies found no difference in ICU duration when using epidural analgesia 
compared to an alternative treatment: 3 compared to IV treatments7,11,78 and 1 compared 
to thoracic paravertebral anesthesia.29 
 
Duration of stay in the hospital 
 
4 studies found epidural analgesia to be associated with shorter stays in the 
hospital compared to an alternative treatment: 3 compared to IV treatment9,89,94 and 1 
compared to mechanical ventilation.65 
 
3 studies found epidural analgesia to be associated with longer stays in the 
hospital compared to an alternative treatment: 1 compared to IV treatment96, 1 compared 
to oral and IV treatment8, and 1 compared to a variety of treatments.6  
 
5 studies found no difference in hospital duration when using epidural analgesia 
compared to an alternative treatment: 4 compared to IV treatment7,11,36,78, 1 compared to 
thoracic paravertebral anesthesia29,  
 
Incidence of pneumonia  
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2 studies found epidural analgesia to be associated with a lower incidence of 
pneumonia compared to an alternative treatment: 1 compared to IV treatment11 and 1 
compared to IV/IM treatment.82 
 
1 study found epidural analgesia to be associated with a higher incidence of 
pneumonia compared to a variety of treatments.6 
 
6 studies found no difference in the incidence of pneumonia when using epidural 
analgesia compared to an alternative treatment: 3 compared to IV treatments7,9,36, 1 
compared to thoracic paravertebral anesthesia29, 1 compared to intrapleural anesthesia93, 
and 1 compared to a variety of treatments.10 
 
Cardiopulmonary outcomes 
 
Studies comparing epidural analgesia to alternative treatments have yielded 
variable results regarding cardiopulmonary outcomes.36,61,78,83,89,93  
 
 
DISCUSSION 
 
Discrepancies in findings 
 
The treatment for rib fracture pain has not been standardized; not just mode (e.g., 
oral, IV, epidural, etc.), but location (e.g., lumbar vs. thoracic epidural).7 This might be a 
consequence of discrepant findings in the literature. One explanation for the lesser 
success in many of the studies comparing TEA to other treatments is that the data often 
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come from retrospective reviews in which patients were not randomly assigned 
treatments.   
 
Counting an abstract, there are 11 studies that randomized patients to a treatment 
group.11,25,28,29,36,61,78,83,93,94,98 There are 18 studies that did not randomize patients to a 
treatment group.6-10,30,39,41,65,66,82,84,85,89,91,96,97,99 Only studies in the English language have 
been included. 
 
When treatment is not randomly assigned, the criteria for assignment is often 
based on injury severity (and sometimes age), with the more severe cases and older 
patients more commonly receiving epidural catheters.6,7 For example, Flagel et al.10 
found use of epidural analgesia to increase by 50% among patients who fracture 6 or 
more ribs (compared to patients who fracture 5 or fewer). 
 
In the 2012 study by Yeh et al.8, the 34 patients who received TEA fractured more 
total ribs (7.1 vs. 5.0; p < .001), had a higher incidence of bilateral rib fractures (32.4% 
vs. 15.0%; p = .026), and showed a trend of having more common upper rib fractures 
(47.1% vs. 30.1%; p = .070). Thus, when the patients receiving TEA require longer stays 
in the hospital (median of 7 vs. 5 days; p < .001) and ICU (median of 1 vs. 0 days; p = 
.001), it seems likely to be related more to injury severity than mode of treatment.  
 
Waqar and colleagues (2013) reported that patients who received TEA (54 ± 17 
yr, 6.4 ± 2.1 fractured ribs, 19% having a flail segment, ISS = 23.6 ± 10.3) were 
significantly older and had significantly more fractured ribs than patients in the IV group 
(45 ± 22 yr, 5.2 ± 2.5 fractured ribs, 13% having a flail segment, ISS = 21.0 ± 6.7). It was 
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despite this severity that patients receiving thoracic epidurals had significantly shorter 
periods of time on analgesia (4.25 ± 1.2 days compared to 5.5 ± 3.2 days), and 
significantly shorter stays in the hospital (19 ± 3.1 days compared to 21 ± 4.1 days) and 
the ICU (12 ± 2.4 days compared to 14 ± 3.5 days).  
 
Similarly, in the 1999 study by Wu and colleagues7, patients assigned thoracic 
epidural treatment (56 ± 17 yr, 5.6 ± 2.1 fractured ribs) were significantly older and had 
significantly more fractured ribs than the patients who were assigned IV treatment (45 ± 
22 yr, 4.4 ± 1.5 fractured ribs). 
 
Additionally, the methods of catheterization are not always described, so one 
cannot know how differences in administration technique might impact outcomes. There 
are 11 studies that describe the methods of catheterization thoroughly.7,25,28-30,39,78,83,85,89,93 
There are 16 studies in which the methods of catheterization are either absent or 
incompletely described.6,8-11,36,41,61,65,66,82,94,96-99 Dittmann et al.’s 1978 study84 provides 
minimal detail concerning methods, but cite their 1975 paper85 for further methodological 
instruction. However, in the brief details they do provide (namely bupivacaine 
concentration), the methods between the two papers are incongruent. Balci et al.91 do not 
discuss catheterization methods, but they only discuss methods of analgesia briefly as a 
tertiary outcome. Studies not in the English language have been omitted from these lists. 
 
Lastly, confounding variables such as age are often, but not always accounted for. 
Among the studies evaluating TEA outcomes in English, 2 failed to report age41,66 and 
other researchers claim age to be insignificant despite very large differences 
(Hashemzadeh et al.’s groups had differences of 20 years; p = .19).61 
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Summary of evidence 
 
To date, 16 studies have shown TEA to be effective at improving treatment 
outcomes in patients with rib fractures; 8 of these involved a comparison group. 
Opposing these findings, 10 studies have reported either poorer outcomes or comparable 
outcomes associated with TEA use; 2 of these were not designed to evaluate the efficacy 
of TEA. Thus, out of all studies with methods sufficient to answer this question, 8 have 
supported the use of TEA against alternative treatments and 8 have failed to show a 
benefit of TEA. Studies that favor TEA scored 4.9 out of the 14 criteria outlined by the 
NIH’s Quality Assessment of Controlled Intervention Studies tool.100 Among the studies 
that do not favor TEA, they meet an average of 8.0 criteria.  
 
A trend that appeared consistently was a low mortality among TEA patients 
despite a relatively large number of ribs being fractured. Much of the remaining 
outcomes are too inconsistent to characterize. 
 
Owing to the complexity of administration, TEA may put the patient at a slightly 
elevated risk of treatment-associated complications such as dural puncture, epidural 
infection, abscesses in the epidural space, and hematoma. Nausea, vomiting, and 
hypotension have also been seen. 
 
Limitations 
 
Much of the available literature either evaluates the NTDB or quantifies groups of 
patients from individual hospitals. Little of this work controls for influential variables 
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such as injury severity; less of it randomizes the treatment options. In general, greater 
injury severity associates with more likely use of TEA. Groups are analyzed accordingly 
and described incompletely. 
 
Conclusions 
 
Based on limited evidence, TEA may lower mortality among patients with 
multiple fractured ribs. As a first step, more hospitals should quantify their data registries, 
controlling for injury severity (particularly number of fractured ribs, presence of flail 
segment, and injury severity score), and evaluate the effectiveness and safety of TEA 
among patients with rib fractures. 
 
Disclaimers 
 
This study is associated with no source of funding. It is a collaboration between St. 
Vincent Hospital in Indianapolis, Sum Integral in Chicago, and The University of 
Connecticut. 
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Chapter 2: Rib Fracture Care: A Systematic Review of Thoracic 
Epidural Analgesia (Part 2: Unabridged Version)  
 
ABSTRACT 
 
Each year, nearly 300,000 patients are admitted to trauma centers with rib 
fractures. About 10% of these patients die and more than a third develop pulmonary 
complications. Much of the morbidity and mortality is a consequence of pain (and the 
effect pain has on pulmonary mechanics). Effective pain management is thus critical to 
successful treatment outcomes. There are a variety of ways to manage pain. Thoracic 
epidural analgesia (TEA) is one method. In this paper, we review the safety and 
effectiveness of TEA among patients with rib fractures. We describe the pathophysiology 
of rib fracture injuries, outline the history of their treatment, and evaluate the current 
body of research. In doing so, we appraise the quality of all studies published concerning 
TEA for rib fractures, compare key findings between studies, integrate all relevant 
outcomes in tables, describe the implications of those outcomes, and note limitations in 
the field. This paper is meant to serve both as an introduction to TEA for rib fractures and 
as an updated assessment of its clinical value. 
 
INTRODUCTION 
 
In the U.S., as many as 10-15% of all patients admitted to trauma centers are the 
result of blunt thoracic trauma.2 Blunt thoracic trauma commonly results in chest wall 
injuries, with the most common injury being rib fractures.1,2 Rib fractures result in nearly 
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300,000 annual admissions to trauma centers in the U.S.4 Patients who have only 
fractured 1 or 2 ribs are typically treated with oral analgesic drugs (NSAIDs, 
acetaminophen, or codeine)47 and have low incidences of complications and mortality.1,10 
If pain relief is not sufficient, other systemic modes (e.g., intravenous morphine or 
dilaudid) may be administered.47 When a patient fractures 3 or more ribs, there is an 
increased risk of comorbidities.1 In this situation, the pain may be more harmful than the 
injury itself, as more severe pain often precipitates secondary complications.10,19,37 
 
In the presence of 3 or more fractured ribs, the pain experienced with breathing 
frequently alters pulmonary mechanics. In an effort to avoid that pain, the patients’ 
breaths become shallow.35,36 This can impede chest physiotherapy and cause ineffective 
coughing, which results in insufficient clearance of airway secretions and retention of 
sputum.11,37-39 In turn, lung compliance is commonly reduced and the patients experience 
a mismatch in ventilation and perfusion.37,40 The combination of these deficits (poor lung 
compliance and inadequate clearance of secretions) puts patients on a course toward 
secondary complications (e.g., atelectasis, sepsis, pneumonia) and eventually respiratory 
failure and the need for intubation and ventilatory support.38,41 The ultimate consequence 
of this is a mortality rate that may exceed 10% among all patients admitted with rib 
fractures.2 
 
A primary way to avoid these complications, thus lowering the risk of mortality, 
is to control the patient’s pain level.41,46,47 When multiple ribs are fractured, regional 
modes of analgesia generally become the mainstay, while systemic deliveries are used as 
supplemental treatments.47 There are several types of regional analgesia, most notably 
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thoracic epidural analgesia, intercostal nerve block, intrapleural nerve block, and thoracic 
paravertebral block.37,47 This paper focuses on thoracic epidural analgesia (TEA), 
comparing its safety and effectiveness to alternative treatments. 
 
History of thoracic trauma treatment 
 
Interest in chest wall trauma and its consequences (such as flail chest) is not new 
to medicine. Rudimentary descriptions appeared in the Edwin Smith Surgical Papyrus 
(circa 1600 BC), in the Iliad (circa 850 BC) and in 5th century writings by 
Hippocrates.18,50 The first documented treatment, which was practiced for several 
centuries, was wrapping the chest wall in linens.51 That approach didn’t change until the 
1930s, when physicians began inserting pins, hooks, screws, and wires to stabilize the 
chest wall internally (assuming chest wall instability was the most lethal concern). 
Unfortunately, these treatments failed to reduce the risk of mortality.52,53 In the 1950s, 
artificial ventilation was introduced. Although initially promising, higher incidences of 
comorbidities (including pneumonia) were soon reported.43,52,54 In the 1970s, more 
conservative techniques, such as simple pain control, were attempted. When the 
outcomes of these treatments were compared to the outcomes of mechanical ventilation, 
researchers were encouraged; it appeared to be the pain itself, more than the structural 
changes, precipitating morbidity.24,44,45,55,56 In the 1990s, researchers went a step further, 
investigating the efficacy of different types of pain management.53 The question was no 
longer whether pain management was of paramount importance, but which modes of 
management were the most effective.42  
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Today, we still don’t have an answer to this question, in part owing to the number 
of outcomes to consider. It is not merely life or death, but cardiopulmonary function, 
incidence of comorbidities, and degree of pain relief on top of the cost, duration, and 
safety of the treatment. The most beneficial agent would be one that maximizes pain 
control, blocks the phrenic nerve response, and minimizes side effects. Regional modes 
of pain control have emerged as the most useful interventions, but there are several 
methods available and no single treatment accomplishes all of the desired outcomes 
absent the accompaniment of risk.37,42,47 However, TEA is often regarded as the most 
reliable technique to relieve pain and improve pulmonary outcomes in patients with 
multiple fractured ribs.42 In this review, we discuss the use of TEA on patients with rib 
fractures, including the etiology and characteristics of rib fracture injuries, the risk of 
morbidity and mortality, and the differences between treatment options. 
 
Admission to the trauma unit 
 
Mayberry and colleagues19 found blunt thoracic trauma to account for 8% of all 
trauma admissions while Zeilgler and Agarwal2 estimate that it accounts for 10 to 15% as 
well as 25% of all trauma-related deaths in the U.S. (supported by Flagel et al.10). Among 
patients admitted with chest wall trauma, 55% require immediate surgery and 94% of 
them present with associated injuries.2 As many as 39% of patients admitted for blunt 
thoracic trauma112 and 7%113 to 10%2 of all patients admitted to trauma centers can be 
expected to have fractured ribs, making it the most common chest injury.1,2 The 
prevalence of rib fractures in trauma patients may be higher as not all fractures are 
detected upon admission.2,5 
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The majority of patients admitted to trauma centers for rib fractures are injured in 
motor vehicle collisions while upwards of a quarter of the incidence results from 
falls.2,5,6,19,26,34,82,114 Regardless of the mode of injury, there is no consistent presentation 
of damage. In addition to differing numbers and locations of ribs fractured, forces large 
enough to break them commonly result in associated injuries, such as pulmonary 
contusions. Thus, when a patient presents with fractured ribs, the characteristics of his or 
her injury (e.g., unilateral or bilateral fractures, upper or lower ribs, chest tube placement, 
presence of associated injuries) affect the course of recovery and likelihood of mortality.8 
 
 Among all patients who present with blunt thoracic trauma, 24% are admitted 
to the intensive care unit (ICU); among blunt thoracic trauma patients who present with 
rib fractures, 44% are admitted to the ICU.5 On average, the patients who are admitted 
with rib fractures stay in the ICU for 4 to 8 days and remain in the hospital for 7 to 16 
days; durations of each increase per rib fractured.2,5,10 There ceases to be a relationship 
for longer ICU and hospital stays with 8 or more fractures (p = 0.19).10 Among patients 
with 1 or more rib fractures, 60% require mechanical ventilation for an average duration 
of 13 days; as more ribs are fractured, the odds that this treatment will be necessary 
increase.10    
 
Mortality 
 
Cameron and colleagues5 evaluated data from 25 Australian hospitals from 1992 
to 1993, finding 2,584 patients who had sustained blunt trauma, 21% of whom had 
fractured ribs. Of the patients with rib fractures, 9.8% died (compared to 7.6% in all 
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trauma patients; p = .07). In a sample of 711 patients with fractured ribs admitted to the 
York Hospital Trauma Center between 1987 and 1992, there was an 11.8% mortality 
rate.2 Among 64,750 patients with rib fractures in the National Trauma Data Bank 
(NTDB; 268 trauma centers from 1994 from 2003), the mortality rate was 10%.10 
Predictors of mortality include number of fractured ribs (as a surrogate measure for injury 
severity)2, presence of additional injuries (e.g., flail segments)26, and age.6   
 
Number of fractured ribs 
 
The risk of mortality is greatly affected by the number of ribs fractured, 
significantly increasing with each additional rib.10 In the sample by Ziegler and Agarwal2, 
mortality was 5% among patients with 2 or fewer fractured ribs and 27% among patients 
who fractured 7 or more ribs. Flagel and colleagues10 found a similar threshold, in which 
2 or fewer fractured ribs associated with 6% mortality while 7 ribs associated with 15% 
and 8 or more associated with more than 34% (Figure 2.1).  
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Figure 2.1 
 
Among 464 patients across the lifespan, Bulger and colleagues6 found an odds 
ratio for mortality of 1.19 for each additional rib fractured (p < .001). Overall, mortality 
typically ranges from 3% to 13% and is often the result of secondary lung 
complications.46,60,61 
 
Presence of a flail segment 
 
Among patients who present with flail injuries, the mortality rate may be as high 
as 16% (when flail injuries are combined with pulmonary contusions, risk of mortality 
increases to 42%).34 Balcı and colleagues91 analyzed 1,069 patients who were admitted to 
a Turkish trauma center for blunt thoracic trauma between 1991 and 2000. Of those 
patients, 688 had rib fractures and 64 had flail injuries. According to these records, 6% of 
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all blunt trauma and 9.3% of all rib fractures result in flail injury. These percentages may 
be uncharacteristically high. Dehghan and colleagues26 evaluated medical records in the 
NTDB from 2007 to 2009. They included men and women age 16 or older who were 
treated at Level 1 or Level 2 trauma centers, had been admitted for blunt thoracic trauma, 
and had injury severity scores of 9 or greater. This resulted in a sample of 354,945 
patients, of whom only 3,467 (1%) had a documented flail injury. The severity of the 
injury is still to be noted however: 59% of patients in this sample required intubation and 
mechanical ventilation, 44% required chest tubes, 21% required tracheostomy, and 16% 
died (agreeing with Clark et al.34). 
 
Age 
 
In addition to injury severity, age is another variable that affects the likelihood of 
mortality.  In a sample of 541 patients, Cameron et al.5 found the mean age of patients 
admitted for rib fractures to be 47.5 years, the mean age of survivors to be 46.6 years and 
the mean age of patients who died to be 55.2 years. Although the age differences did not 
reach significance, it is a trend that appears regularly in the literature. This trend was 
duplicated by Flagel and colleagues10 when they reviewed the NTDB from 1994 to 2003. 
Although the discrepancy was narrower (mean age of survivors was 47 years while the 
mean age of non-surviving patients was 52 years), their larger sample (64,661 men and 
women with at least 1 fractured rib) led to significance (p = .02). Bulger et al.6 analyzed 
the trauma registry of Harborview Medical Center for patients with rib fractures admitted 
between 1986 and 1996. Patients were separated by age: those 65 and older (n = 277, 74 
± 6 years, 3.6 ± 2.5 fractured ribs) were compared to a control group of patients age 18 to 
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64 (n = 187, 39 ± 13 years, 4.0 ± 2.9 fractured ribs). They found patients in the elderly 
group to have more than twice the risk of mortality than patients in the control group 
(22% compared to 10%; p < .001). Sharma and colleagues3 found a similar trend when 
they analyzed 1,475 records of patients admitted to a trauma center with blunt chest 
trauma between 1995 and 2004. Rib fractures were present in 56% of adults (age 18 to 
64), and 65% of elderly patients (age 65 and older) and mortality was found in 9% of 
adults and 18% of elderly patients. Wisner82 found age to be a significant predictor of 
mortality among 307 elderly patients (70.1 ± 0.4 years) admitted to the University of 
California, Davis medical center between 1980 and 1987. There was a 13% mortality rate 
in the sample and for each additional year of age, the odds of mortality increased by a 
factor of 1.15 (p < .0001). The only predictor more significant was injury severity score. 
Similarly, Yeh et al.8 found age to be among the strongest predictors of complications (p 
= .05) in a sample of 187 men and women with multiple fractured ribs admitted to a 
trauma center between 2004 and 2009. Of note, injury severity score was not a significant 
predictor (p = .89). 
 
Morbidity 
 
Ziegler and Agarwal2 found 35% of patients with fractured ribs experienced 
pulmonary complications (e.g., pneumonia, pneumothorax, atelectasis, adult respiratory 
distress syndrome) while nearly half of all patients with rib fractures in the NTDB 
developed pulmonary complications.10 The risk of complication increases significantly 
with each additional rib fractured.6,10 For each additional rib, Bulger and colleagues6 
found the odds ratio for pneumonia to be 1.16 among their total sample (n = 464) and 
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1.27 among elderly patients (age ≥ 65; n= 277) (p < .001). Lee and colleagues1 found a 
threshold in which morbidity increased significantly when 3 or more ribs were fractured. 
Flagel and colleagues10 found thresholds for pneumonia at 6 or more fractures and acute 
respiratory distress syndrome at 7 or more. Flagel and colleagues also found an inflexion 
point for the use of epidural catheters at 6 fractures. Although epidural analgesia was 
only used in 2% of cases, and was related to the total number of ribs fractured (R2 = 
0.96), its use increased by 50% at 6 rib fractures (as seen in Figure 2.2). 
 
Figure 2.2 
 
 
The most commonly evaluated pulmonary complication is pneumonia, which can 
be expected in 3% to 60% of patients10,46 depending on the number of fractured ribs and 
the age of the patient. The risk of pneumonia is typically higher among elderly patients. 
Bulger et al.6 found pneumonia to occur in 31% of their elderly cohort and 17% of their 
younger control group (p < .01). 
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Pain 
 
 Pain is a primary risk factor for morbidity and mortality among patients who 
present with chest wall trauma.58,62,63 In the presence of pain, patients typically alter 
ventilation (in an effort to avoid exacerbation of that pain) by restricting breathing 
(particularly decreases in tidal volume; breaths become more shallow).35,36 This impedes 
chest physiotherapy and pulmonary toilet, often causing ineffective coughing, which 
results in insufficient clearing of airway secretions and retention of sputum.11,37-39 In turn, 
this leads to atelectasis (collapse or closure of the lung), which reduces lung compliance 
and functional residual capacity, resulting in a mismatch of ventilation and perfusion. 
Parenchymal lung infection can also develop in the presence of bacterial 
colonization.37,40,57 Patients who cannot effectively cough, clear secretions, or re-inflate 
areas of the lung compromised with atelectasis are at a higher risk for pulmonary 
complications such as aspiration, acute hemopneumothorax, and secondary pneumonia 
with pulmonary consolidation.38,41,54,64 This respiratory failure leads to the need for 
intubation and ventilatory support.38,41 The ultimate consequence of these secondary 
complications is a high risk of mortality.38 Contrarily, if the patient’s pain is not 
exacerbated with normal ventilation and coughing (thus an adequate tidal volume is 
maintained and coughing can happen without exacerbation of symptoms), the risk of 
pulmonary complications (e.g., pneumonia, atelectasis, sepsis, and the need for 
mechanical ventilation) is reduced.56,65,66 For this reason, effective pain management is 
critical to restoration of pulmonary function and the avoidance of morbidity and 
mortality.39,67,68 Pain management is accomplished through systemic and regional 
anesthetics and analgesics.41 Because the relief of pain is a primary goal of treatment, it is 
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often the severity of the pain – rather than the severity of the injury – that guides the 
choice of treatment. If pain can be managed with oral and/or IV narcotics, it often is; if 
conservative treatments do not provide adequate pain control, patients are often treated 
with local analgesia.6,11,47  
 
Modes of analgesia 
 
 Analgesia is the primary treatment in the management of patients with chest wall 
trauma.58,69 A variety of treatment options exist; some are systemic (e.g., oral and 
intravenous anti-inflammatory agents, intravenous opioids, narcotic dermal patches); 
others are local agents (intercostal nerve blocks, intrapleural nerve blocks, thoracic 
paravertebral blocks, and TEA.8,47,70 The 3 most effective (and commonly delivered) 
local treatments are: narcotic infusions and continuous local anesthetic via epidural 
catheter, intrapleural infusions of local anesthetic via catheter, and intercostal nerve block 
via injection.42,71 Less common modes of therapy have been attempted, including 
intrathecal opioids73, epidural steroid injections74, and transcutaneous electrical nerve 
stimulation (TENS).75 All forms of analgesia will be discussed, beginning with systemic 
approaches. 
 
Systemic narcotics 
 
As we established earlier, breathing in the presence of pain often alters pulmonary 
mechanics.  Muscle spasms and voluntary splinting can lead to the development of 
atelectasis and prevent the normal function and mobilization of secretions.78,82,83,115 
Systemic opioids may assist in reducing these problems, but there are other complications 
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they do not address. For example, although there is a limited body of research on this, it 
appears that function of the phrenic nerve can be compromised by an afferent intercostal 
nerve reflex. In the presence of such a reflex, there would be a reduction in the 
contractility and tone of the diaphragm.42 When the intercostal muscles are stimulated, 
messages get sent to respiratory neurons in the medulla (via proprioceptive afferent 
neurons). These respiratory neurons are responsible for activity of the phrenic nerves. 
The messages being sent (via stimulation of the intercostal muscles) are inhibitory; they 
inhibit the activity of the respiratory neurons in the medulla. The consequence of this is 
dysfunction of the diaphragm.116 Again, the literature investigating this is limited, but if 
the analgesic treatment is opioids per se, that regimen does not appear to prevent this 
from occurring. However, local anesthetics appear to block the relevant afferent nerves, 
thus inhibiting the reflexive blockade of phrenic nerve activity. Function of the 
diaphragm is thus improved (or rather, dysfunction is avoided).42 Ultimately, systemic 
narcotics can help relieve pain, but may contribute to other problems (e.g., hypoxia, 
atelectasis) and result in the necessitation of mechanical ventilation. Systemic narcotics 
can be taken orally, intravenously, or through dermal patches. 
 
Oral non-narcotic analgesic drugs 
 
 NSAIDs, codeine, or acetaminophen may be sufficient if only 1 or 2 ribs are 
fractured. There is no central nervous system or cardiovascular depression, but the degree 
of analgesia is limited. Although there is a shortage of data regarding their use in 
treatment with patients who have multiple rib fractures, the common understanding is 
that they may be effective supplements to a treatment, but not effective when used in 
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isolation.37,47 
 
Other systemic analgesic drugs 
 
These are often the first-line therapy to manage pain from rib fractures.37 There 
are several modes of delivery: intermittent, on-demand injections76, intravenous (IV) 
patient-controlled analgesia77,78, continuous IV infusion36, and less commonly, dermal 
patches of lidocaine on the fracture site, which has proven ineffective.47,73 While a 
continuous IV infusion of systemic opioids will reduce pain and improve vital capacity, it 
can result in cough suppression and hasten the onset of respiratory complications (e.g., 
respiratory depression and hypoxemia), possibly owing to paradoxical breathing, 
obstructive apnea, or a reduction in sigh-breaths.36 Even when using conservative doses, 
morphine may still compromise pulmonary mechanics (most notably a reduction of 
spontaneous deep breathing).79 Systemic use of opioids (or ketamine) can also 
compromise evaluations of the head and abdomen.47 On top of the side effects, systemic 
analgesia remains less effective than regional techniques at controlling pain.37 Thus, 
systemic opioids may be helpful in conjunction with a regional treatment, but not as a 
treatment for multiple fractured ribs per se.76,77 
 
Regional analgesia  
 
 When treating multiple fractured ribs, regional analgesia is the mainstay. Often 
supplemented with a small dose of either NSAIDs or opioids, pain reduction is typically 
strong and immediate. There is little sedation, so evaluation of head and abdominal 
injuries is easier. Among the downsides, the procedures are technically complex, leading 
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to occasional errors in the administering of the treatment, they can be painful while the 
needle is entering (or catheter is being installed), toxicity is a possibility, and they require 
more intensive monitoring and care by the physicians and nurses.47 There are a variety of 
modes; the four most common (thoracic epidural analgesia, thoracic paravertebral block, 
intercostal block, and intrapleural block)37 are discussed below. 
 
Thoracic epidural analgesia  
 
Narcotic infusions and continuous local anesthetic can be delivered through 
thoracic (or lumbar) epidural catheters. Opioid receptors exist in the spinal cord that can 
alter the perception of pain without needing stimulation of receptors in the brain36 and the 
anatomy of the epidural space restricts the geography in which analgesics can spread.42 
These boundaries are made up by the dura (the outermost membrane surrounding the 
spinal cord) and the periosteum, which lines the bones of the vertebral canal. Superiorly 
(in the upper-cervical region), the dura and periosteum fuse. This prevents the analgesic 
from migrating north of the foramen magnum.  Posterior migration is limited by the 
ligamenta flava (ligaments that connect the vertebrae, bordering the interior of the spinal 
canal).42 The catheter is inserted into this area. Local anesthetics and narcotic analgesics 
are administered, which block the nerve roots (anterior and posterior) crossing this space. 
The anesthetic/analgesic agents diffuse across the dura and begin to block sensory nerves. 
Motor nerves are affected to a lesser degree. It does take a large dose to achieve the 
desired effect. And a side effect of the dose of local anesthetics is dilation of the arteries 
and veins (especially the veins). There are techniques to safely avoid or treat the resulting 
hypotension however.68,80 
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In 1982, Rawal and colleagues81 showed thoracic epidural morphine to be a more 
effective treatment than intercostal nerve block following cholecystectomy (upper-
abdominal surgery) as measured by: postoperative pain (magnitude and duration), 
number of patients requiring supplemental narcotics (40% of patients receiving the 
epidural compared to 100% of patients receiving the nerve block), pre- and post-surgery 
peak expiratory flow (10% reduction in performance among patients receiving epidurals; 
25% reduction in those receiving the intercostal block), and blood gas analyses (PaO2-
PaCO2 profile was best in epidural patients). Overall, the longer duration of pain relief 
absent of the degree of respiratory depression experienced by the intercostal block made 
epidural analgesia a more favorable therapy among patients who were admitted with 
thoracic trauma. Since then, TEA has emerged as one of the most researched and 
seemingly effective treatments for patients who present with multiple fractured ribs.47,70  
 
According to most reports, the downsides of epidural analgesia are not 
ineffectiveness (relative to other treatments), but risk. It has been successful in both 
lumbar and thoracic routes using opioids, local anesthetics, or a combination, especially 
in patients over the age of 60. Among this group, epidural analgesia decreases mortality 
and pulmonary complications.82 Among patients with chest wall trauma, it relieves pain 
better than systemic opioids36,78 and intrapleural analgesia.83 And it is an effective 
treatment in a variety of pulmonary measures (e.g., dynamic lung compliance, airway 
resistance, functional reserve capacity, vital capacity, pulmonary gasses).84 If the patient 
has paradoxical chest wall movement, epidural analgesia reduces it and restores shallow 
breathing to near-normal levels.85 There may also be immune system benefits, as epidural 
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analgesia reduces plasma levels of interleukin-8, a chemokine that increases 
inflammation following acute lung injury.78 Overall, patients who are treated with 
epidural analgesia develop fewer complications than patients who are intubated and 
receive mechanical ventilation44,45,53 and they spend fewer days in the hospital and the 
ICU.53 All studies that compare the effectiveness of TEA to another treatment (as well as 
the risk profile associated with use of TEA) will be discussed later in this review. 
 
Thoracic paravertebral block 
 
 In this procedure, a local anesthetic (i.e., bupivacaine) is injected alongside the 
thoracic vertebrae, producing a “multidermatomal ipsilateral somatic and sympathetic 
nerve blockade in contiguous thoracic dermatomes”.37 Use of the procedure in patients 
with multiple fractured ribs was first characterized in 1979 by Eason and Wyatt.117 To 
date however, few researchers have evaluated its use on these patients.70,118-123 There are 
several ways of conducting a thoracic paravertebral block: repeated injections118, 
scheduled dosing through an indwelling catheter117,123, and continuous infusion.70,122 This 
treatment is successful in improving arterial blood gases and respiratory parameters70,118 
and is not as technically challenging to perform as some of the alternate treatments.117,121 
Although very few studies have been published on the use of this treatment, the data that 
are available suggest a low risk of complications (including a low risk of hypotension 
compared to thoracic epidural.118,124 Other possible side effects are vascular puncture, 
pleural puncture, and pneumothorax.37,124 Overall, this has been found to be as good of an 
analgesic as TEA29 and is also less technically complex, with minimal hemodynamic 
disturbance and no concern of urinary retention or pruitis.125 However, there is a small 
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risk for pneumothorax and a possibility of toxicity owing to the rapid absorption of local 
anesthetic.47 
 
Intercostal nerve block 
 
In 1966, Ablondi and colleagues126 were the first to suggest continuous intercostal 
nerve blocks. The anatomy of the ribs and posterior intercostal membrane allow injected 
solutions to be contained around the intercostal nerve and spread to the superior and 
inferior intercostal spaces. This is a very effective method to control pain and improve 
respiratory dynamics66,127, but results are short lived. Improvements in respiratory 
measurements such as forced expiration begin to wane 6 hours after treatment128 and the 
analgesic effect only lasts 4-8 hours (if the long-acting anesthetic is used)47, thus 
necessitating repeated injections to sufficiently control pain.129 Typically, as a matter of 
preference, patients are averse to routine injections and the likelihood of experiencing 
pneumothorax, aesthetic toxicity, or intravascular injection is a product of the number 
(and total volume) of injections.47 This can be remedied with the installation of catheters 
so that the nerve block can be administered continuously, and this has been seen to 
control pain from multiple fractured ribs effectively.76,77,130 But catheter placement is a 
challenge and they’re misplaced regularly.130-132 According to work done by Mowbray 
and colleagues133, only 54.5% of the catheters were installed properly. Thus, multiple 
injections remains the common delivery system, which is painful, time-consuming, and 
puts the patient at risk of anesthetic toxicity (owing to rapid absorption of local 
anesthetics from the intercostal space and the large doses needed for effectiveness).47 Use 
of intercostal nerve block in patients with multiple rib fractures associates with a 1.4% 
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incidence of pneumothorax for each individual block and 5.6% when multiple blocks are 
administered simultaneously.134 
 
Intrapleural block 
 
This technique was characterized first by Reiestad and Kvalheim in 1984135 as a 
mode of post-operative pain management, and furthered by Reistad and Stromskag in 
1986136 as a method of managing pain following upper-abdominal surgery and 
mastectomy. In 1987, Rocco, Reiestad and colleagues137 discussed continuous intercostal 
nerve block and intrapleural analgesia for pain from fractured ribs. And the following 
year, Stromskag, Reiestad and colleagues138 described its value in controlling pain in 
patients who had multiple fractured ribs. A catheter is placed in the intrapleural space and 
local anesthetic agents are infused through it. The treatment can be administered through 
continuous administration or by an intermittent bolus. The mechanism of pain relief is not 
clear, but it’s likely to involve the prevention of intercostal nerve transmission. 
 
In regional anesthetic trials involving patients undergoing thoracic surgery, the 
least consistent method of administering anesthesia/analgesia is through intrapleural 
infusion.42 Shafei and colleagues127 found intermittent intrapleural bupivacaine to be a 
superior treatment (in terms of postoperative pain management) to intercostal blocks (and 
to the cryofreezing of intercostal nerves). But Bachman-Mennenga and colleagues139 did 
not find this to be true when comparing intrapleural local anesthetics to intercostal nerve 
block, thoracic local epidural analgesia, and systemic opioids. Instead, they found 70% of 
patients receiving the intraplueral anesthetic to need supplemental opioids to manage pain 
(significantly worse than the alternative treatments, in which 1-2 patients in each group 
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required supplemental opioids). Short and colleagues140 found intrapleural analgesia to be 
comparable to systemic opioids in pain reduction among patients who had sustained blunt 
chest trauma and Shinohara and colleagues93 found it to be comparable to epidural 
analgesia. But Luchette and colleagues83 found intrapleural analgesia to be less effective 
than epidural analgesia in patients with chest wall trauma (in terms of both pain relief and 
pulmonary function). In their findings, the epidural analgesia demonstrated 
improvements in inspiratory force and tidal volume, which suggests the intercostal 
afferent nerve messages (those which inhibit the respiratory neurons in the medulla) are 
interrupted. Part of the benefit may come from avoiding dysfunction of the diaphragm in 
this way. Even if there’s no interruption to the intercostal-phrenic nerve arc, the 
pulmonary improvements are significant. Luchette and colleagues suggested that epidural 
anesthetic may be a more dependable option than intrapleural administration.   
 
Today, intrapleural blocks are less commonly used in treating multiple rib 
fractures not just because of the inconsistency of their effectiveness, but because of side 
effects. One notable side effect is the possibility of a chest drain, which can cause loss of 
local anesthetic.141,142 Furthermore, it’s a difficult procedure to perform.143 Instillation of 
the anesthetic can result in paralysis of the phrenic nerve and/or aggravate 
bronchospasm.144,145 There is a risk for symptomatic pneumothorax.130,146 If blood is in 
the pleural space, the local anesthetic will be diluted, resulting in a poor block.37 The rate 
of absorption may be rapid (leading to a high plasma concentration and thus a potential 
risk for anesthetic toxicity)143,147, but the effect is unpredictable, and thus larger doses 
may be necessary.37 Toxicity is also a possibility. If the anesthetic is combined with 
epinephrine, it is not toxic; without epinephrine, toxic serum levels may result regardless 
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of administration technique.127,148,149 Lastly, the technical complexity results in possible 
side effects (parenchymal injection, etc.).37,47   
 
Alternative treatments 
 
Less common treatment options have been attempted, including intrathecal 
opioids72, narcotic dermal patches73, transcutaneous electrical nerve stimulation75, and 
epidural steroid injections.74 
 
Intrathecal opioids 
 
The pain from multiple fractured ribs can be treated by administration of 
intrathecal morphine through the lumbar route, which some researchers have found to be 
effective72 and others haven’t.150 In addition to inconsistent findings on effectiveness, 
intrathecal morphine is associated with a high risk of complications. Nausea, headaches, 
drowsiness, urinary retention, and respiratory depression were all common in Dickson 
and Sutcliffe’s 1986 study.150 
 
Narcotic dermal patches 
 
Ingalls and colleagues73 evaluated the effectiveness of a dermal lidocaine (5%) 
patch on 58 adult patients with traumatic rib fractures in a randomized, double-blind, 
placebo-controlled trial. Patients in the intervention group (n = 33, 72.7% male, 54.8 ± 
3.1 years, 5.3 ± 0.4 fractured ribs, ISS = 17.3 ± 1.3) had a lidocaine patch placed on the 
skin directly over the fracture site within 24 hours of admission. Patches were replaced 
every 12 hours for 72 hours (or until the patient was discharged). Patients in the control 
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group (n = 25, 76% male, 49.7 ± 4.0 years, 4.9 ± 0.4 fractured ribs, ISS = 17.9 ± 1.3) 
received the same treatment, but were given placebo patches. Patients in both groups 
were allowed morphine and hydrocodone/acetaminophen as needed to control pain 
levels. Although the lidocaine group did have better pain scores (5.6 ± 0.4 vs. 6.0 ± 0.3; p 
=. 39), lower supplemental IV narcotic use (0.23 units vs. 0.26 units; p = .56), lower 
supplemental oral narcotic use (4 units vs. 7 units; p = .11), and a shorter length of stay 
(7.8 ± 1.1 days vs. 6.2 ± 0.7 days; p = .28), none of these achieved statistical significance. 
 
Transcutaneous Electrical Nerve Stimulation (TENS) 
 
 The electrical stimulation causes endorphins to be released in the spinal cord. 
Among patients with multiple fractured ribs, Sloan and colleagues75 found subjective 
pain relief (as well as improvements in arterial blood gases and peak expiratory flow 
rates) in TENS treatment compared to NSAID administration. Otherwise, the data on use 
of TENS is very limited. 
 
Thoracic epidural steroid injection 
 
Epidural steroids have been used in patients suffering from numerous sources of 
pain (e.g., discogenic or radicular spinal pain, spinal compression fractures, pelvic pain, 
zoster-related pain, postherpetic neuralgia).74,151,152 
 
Rauchwerger and colleagues74 investigated a single-shot thoracic epidural steroid 
injection in 2 patients who presented with pain from rib fractures. It was presented as a 
treatment option in hospital settings in which long-term treatment is unavailable. Both 
patients were in their 50s (one man, one woman) and both were initially treated with 
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morphine. After ineffective pain relief, both were treated with .125% bupivacaine 
injections combined with 80 mg triamcinolone. Both patients experienced pain relief. 
 
Intercostal nerve blocks have a short duration of pain relief, require multiple 
injections, and put the patient at a risk of pneumothorax.153,154 The use of intrapleural and 
paravertebral blocks is typically limited to patients with unilateral fractures.74 Epidural 
catheter use is limited to inpatients/hospital settings where continuous support for 
catheter management is available (to avoid hypotension, anesthetic toxicity, etc.).74 
Epidural steroid injections may be a good alternative, and the analgesia may outlast the 
durations of local anesthetics, but no data exist that compare this therapy to any of the 
aforementioned typical treatments.74  
 
Comparing the different treatments 
 
 Each treatment has a unique set of advantages, disadvantages, and 
contraindications. And patients must be treated according to what is currently regarded as 
the best medical practice. For this reason, controlled trials that truly randomize patients to 
different treatment groups are infrequently conducted. It is unlikely that a review board 
would approve an urn randomization model that distributes patients evenly throughout 
the treatment groups based on criteria such as the presence of upper-rib fractures. Thus, 
most data available are retrospective comparisons of two groups of patients who have 
similar injuries and were treated with different techniques. Among this body of research, 
there is wide variation in which treatment option is used.86 
 
 When hemodynamic and respiratory function are concerns, systemic analgesia is 
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often avoided.38 Systemic opioids can also impair assessment of a patient’s mental 
status.38 For these reasons, regional techniques are often preferred.38 According to a 2000 
meta-analysis by Rogers and colleagues87, TEA can reduce the rate of mortality by more 
than 30% and decrease the incidence of comorbidities by 15% (stroke) to 55% 
(pulmonary embolism). Likewise, a 2003 meta-analysis by Block and colleagues88 
(which analyzed more than 100 studies) found epidural treatment to be superior to opioid 
treatments. More specifically, use of epidural catheter treatments (as compared to 
systemic opioids) has demonstrated improvements in subjective pain management7, 
pulmonary function36,78,89, and better clinical outcomes.11,82 Despite this, in a 2003 
narrative review on pain management, Karmakar and Ho37 concluded that no single mode 
of analgesia could be confidently recommended. Contrasting this review, Simon and 
colleagues published pain management guidelines for blunt thoracic trauma in 200590, 
stating that the preferred mode of analgesic for patients with multiple rib fractures was 
via epidural. The inconsistencies in recommendations may be responsible for the low 
rates (below 20%) of epidural use among eligible patients (patients without 
contraindications to epidural placement).7,8,59 In 2005, Flagel et al.10 found only 2% of 
patients with at least 1 fractured rib to be treated with epidural analgesia (1,295 of 
64,750). And most recently, in 2014, Dehghan et al.26 found epidural catheters were only 
used in 8% of patients who were admitted with flail injuries (263 of 3,467). 
 
Rationale for this review 
 
The most recent review of TEA as a treatment for patients with multiple rib 
fractures was published Carrier and colleagues in 2009.46 In it, they performed a meta-
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analysis of 8 studies related to TEA (7 in English, 1 in Turkish). They identified 3 studies 
that compared TEA with local anesthetics to parenteral opioids78,91,92, 2 studies that 
compared TEA with local anesthetics to intrapleural analgesia83,93, and 3 studies that 
compared epidural analgesia with opioids to parenteral opioids.36,89,94 When analyzing 
those studies collectively, Carrier and colleagues reported no significant differences 
between epidural analgesia and other analgesic modalities in mortality, length of stay in 
the ICU, or length of stay in the hospital. When evaluating duration of mechanical 
ventilation, they found some benefit to using epidural anesthesia with local anesthetics. 
However, that treatment was associated with a greater risk of hypotension.  
 
These findings must be interpreted cautiously. Out of the 8 studies analyzed, only 
5 are known to be randomized trials. Of the remaining studies, 1 assigned treatment based 
on injury severity, 1 is a poster presentation which does not specify randomization (or 
whether it was prospective or retrospective), and 1 is in Turkish, with no mention of 
randomization in English. Furthermore, only 4 studies provided sufficient details about 
catheterization methods in English. Carrier and colleagues rank their 8 studies in terms of 
quality, admitting, “Only four of the eight studies included in our review were of high 
methodological quality.” These were: Bulger et al., 200411; Luchette et al., 199483; Moon 
et al., 199978; and Shinohara et al., 1994.93 
 
A similar admission is made in a 2007 review of the literature by Parris95, who 
also found 4 studies to be satisfactory for inclusion. These were: Bulger et al., 200411; 
Moon et al., 199978; Mackersie et al., 199136; and Ullman et al., 1989.89 Curiously, only 
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half of the “high methodological quality” studies overlap between the two most recent 
reviews. 
 
One example of a study that Carrier and colleagues regarded as high quality and 
Parris did not is a 1994 investigation by Luchette et al.83 This study did not address 
clinical outcomes (days in ICU, days in hospital, duration on mechanical ventilation, 
incidence of pneumonia) as much as variables thought to affect clinical outcomes (pain, 
pulmonary function). There is no mention of blinding (blinded to the nurses providing 
care, etc.). And patients were permitted into the study with associated injuries that were 
not explained or controlled for (and would likely affect patient-perceived pain level).  It 
is important to consider the impact such limitations might have on the validity of Carrier 
et al.’s conclusions. 
 
Regarding these conclusions, although zero original studies were published 
between the two reviews, Parris’s interpretation of the data was slightly different from 
Carrier et al.’s: “On limited evidence from moderate quality studies, epidural 
analgesia/anaesthesia offers some benefits over intravenous analgesia but further studies 
are needed to strengthen this conclusion.” 
 
What seems consistent between the two reviews is not their interpretation of the 
findings, but their appraisal of the quality of available literature. According to Parris, “the 
limited quantity and quality of evidence illustrates the difficulties in studying this patient 
group and determining the most relevant outcomes.” In terms of quantity, perhaps Parris 
didn’t look very hard. In terms of quality, he makes a valid point. And he elaborates on 
that point: “All four studies looked at slightly different patient groups, different treatment 
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regimens and outcomes with consistently poor reporting of timing of placement of 
epidural catheters and administration of intravenous analgesics.”  
 
Although a new systematic review may be in order just to reconcile the 
conclusions of the previous attempts, it is also an ideal time to do so as new studies 
evaluating the safety and/or effectiveness of TEA have been published since 2009. 
According to our search, there are 10 studies that merit consideration, which were not 
considered in either of the aforementioned reviews: 4 published prior to 2009, 6 
published since. 
 
Prior to 2009: Wisner (1990)82 compared epidural narcotics (87% lumbar, 13% 
thoracic) to a variety of analgesic modes, but most commonly intravenous/intramuscular 
narcotics among patients who had sustained thoracic trauma. Wu and colleagues (1999)7 
compared TEA to IV analgesia in patients with at least 3 fractured ribs. Bulger and 
colleagues (2000)6 compared treatment outcomes of elderly Patients (≥ 65 y) with at least 
1 fractured rib to younger patients (18-64 y) with at least 1 fractured rib; epidural 
catheters were compared to other treatment modalities (e.g., pleural block, IV/IM 
narcotics, oral narcotics, ketorolac, Tylenol). Kieninger et al. (2005)96 compared epidural 
analgesia to IV narcotics in older patients with rib fractures.  
 
Since 2009: Mohta and colleagues (2009)29 compared TEA to thoracic 
paravertebral infusion in patients with at least 3 fractured ribs. Hashemzadeh and 
colleagues (2011)61 compared TEA to intercostal block in patients with multiple fractured 
ribs. Kim and colleagues (2011)97 reported the complications that arose in patients who 
underwent surgical reduction and fixation of fractured ribs, and were treated with TEA. 
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Hakim & Latif (2012)28 evaluated TEA compared to lumbar epidural analgesia (both 
lidocaine) in patients admitted with blunt chest trauma. Yeh and colleagues (2012)8 
compared TEA to IV and oral narcotics in patients with at least 3 fractured ribs. Waqar 
and colleagues (2013)9 compared TEA to IV opioids among patients with multiple 
fractured ribs. 
 
Objectives of this review 
 
In this review, we complete a comprehensive search for articles related to the use 
of TEA in patients with rib fractures. In doing so, we attempt to identify the value of 
TEA as it relates to mortality, length of stay in the ICU and hospital, use of mechanical 
ventilation, improvement in subjective pain levels, effect on respiratory function, and 
incidence of pneumonia and other complications/adverse events (e.g., sepsis, acute 
respiratory distress syndrome, respiratory failure). Wherever possible, we make 
comparisons to other treatments. 
 
 
METHODS 
 
Search strategy 
 
An electronic search was conducted using PubMed on March 29, 2014.  Two 
search terms were used: 
 
1) (thoracic) AND (catheter* OR epideral* OR "epidural analgesia" OR 
"Analgesia, Epidural"[MAJR]) AND pain AND (fracture*) AND (rib OR ribs) 
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2) (("thoracic catheter" OR "thoracic 
epidural" OR "thoracic catheters" OR 
"thoracic epidurals" OR "thoracic 
paravertebral catheter" OR "Analgesia, 
Epidural"[MAJR] OR "epidural 
analgesia") AND pain AND fracture* 
AND (rib OR ribs)) 
 
After running each search, the PubMed 
Advanced Search Builder tool was used to 
combine their results, eliminating 
duplicate studies. 
 
 
 
Search results  
 
This search yielded 63 total articles; 14 of these presented original research about the 
effectiveness of TEA in English.7,8,11,25,29,39,41,61,82,83,91,93,96,98 
 
Additional articles 
 
After completing the search, we reviewed the source lists of all relevant articles 
and found an additional 16 original trials that weren’t identified by our search term; 15 of 
these were in English.6,9,10,28,30,36,65,66,78,84,85,89,94,97,99 
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The study by Pierre and colleagues94 was a poster presentation. The 1982 study by 
Dittmann et al.65 was a duplicate of a German-language article published by the same 
authors in 1980.155 The studies by Dittmann and colleagues from 197585 and 197884 
quantify the same sample (the 1978 study is an expansion on the 1975 sample). These 
articles were included (the 1980 German article was replaced by the 1982 English version 
and Dittmann et al.’s 1975 and 1978 publications are treated as separate articles), 
bringing the total number of original studies evaluating TEA in patients with chest wall 
trauma to 33 (29 in English).  
 
Extraction and Synthesis of Data 
 
All 29 articles were read in full with data carefully extracted. Tables were 
generated, characterizing primary outcomes where available. The outcomes are: 
demographic information (sex, age), type of study (RCT, review, etc.), injury 
characteristics (number of ribs fractured, ISS, presence of flail chest and pulmonary 
contusion), type of treatment (TEA, IV, etc.), mortality, ICU length of stay, hospital 
length of stay, use and duration of mechanical ventilation, changes in subjective pain 
levels, changes in respiratory function, incidence of pneumonia and other 
complications/adverse events (sepsis, acute respiratory distress syndrome, respiratory 
failure). 
 
Principle Summary Measures 
 
Because there are inherent differences in the type and quality of the data 
published, and vast differences in the methods of their acquisition, we do not attempt to 
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meta-analyze the findings. At this stage in the research, such a summation would be little 
more than data alchemy, and worthy of distrust. Instead, we merely present the findings 
in tables, evaluate the quality of the relevant claims, and provide an overall appraisal of 
the state of the evidence. 
 
 
RESULTS 
 
Research supporting TEA 
 
16 studies have reported epidural analgesia to be an effective treatment for 
patients with fractured ribs. Out of these, 8 do not include a comparison group, 4 compare 
TEA to IV opioid treatments, and the remaining 4 compare TEA to other regional 
techniques. 
 
No comparison group 
 
In 1984, Abouhatem et al.25 investigated 19 patients (mean age of 53 yr) with 
multiple fractured ribs (mean of 5; 37% had a flail segment) who underwent TEA 
(bupivacaine). Gender and ISS are not reported. No inclusion or exclusion criteria are 
described. All but one patient experienced satisfactory pain relief (quantification not 
provided). Treatment lasted 2-17 days (mean of 8 days) and then patients were 
discharged from the ICU. Bradycardia occurred in 2 patients and hypotension occurred in 
3 patients. No other data were reported. They concluded that TEA was an effective way 
to treat pain following multiple rib fractures. 
 
 76 
In 197585 and in 197884, Dittmann and colleagues evaluated epidural analgesia. 
There was a comparison group, but that group was not treated with an alternative form of 
analgesia. Rather, they were given mechanical ventilation. Both articles came from the 
same database, but the 1978 study expanded on the sample from 1975. 
 
In the 1975 study, Dittmann et al. assessed 48 patients with multiple fractured ribs 
who were admitted to the ICU at the university hospital of Basle, Switzerland between 
May 1972 and August 1974. 16 of those patients received epidural analgesia, but the 
authors only characterized 14 of them (100% male, mean age of 55.1 yr, mean num. of 
fractured ribs = 7.36).  These patients received thoracic or high lumbar epidural analgesia 
of bupivacaine (.25% with adrenaline 1:200,000). The initial dose was 3 mL to 10 mL 
depending on age, bodyweight, and pain level of the patient. Catheters were left in 
position for 3 to 8 days. While under analgesia, inhalation therapy (tidal volumes of 15 
mL/kg) was conducted. Patients also exhaled against resistance for 5 of every 60 minutes. 
There were 32 subjects assigned intubation and mechanical ventilation. Methods for 
mechanical ventilation are not described. The age, gender, and number of fractured ribs 
of these patients are not disclosed. ISS, flail segments, and pulmonary contusions are not 
reported for either group. The authors unnecessarily present findings by year. During the 
first year, 2 patients received epidural analgesia and were never described. During the 
second year, 14 patients received epidural analgesia and were characterized. 13 of these 
patients received adequate treatment per se; 1 patient was intubated (30 hours following 
initial injury). Pain control was purported to be successful in all patients (“All the patients 
after EA felt immediately better”) but no data were provided to support this claim. Data 
were provided in pulmonary measures, where patients receiving epidural analgesia 
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exhibited improvements. Partial pressure of oxygen in the arterial blood (PaO2): pre-
treatment = 63.0 mmHg; post-treatment = 74.7 mmHg. Vital capacity: pre-treatment = 
10.6 ml/kg; post-treatment = 20.5 ml/kg. The one patient in this group who was intubated 
(“despite good analgesia”) had poor vital capacity (fell under 13 mL/kg). The authors 
attribute this to his age (57), bodyweight (obese), and poor cooperation with the protocol. 
After 8 days of mechanical ventilation, he developed pneumonia; 21 days after the initial 
injury, he died. Mortality rate was thus 7.1%. During the first year of treatment, 17 
patients received intubation and mechanical ventilation; 4 died (23.5%). During the 
second year, 15 patients were intubated and ventilated. These patients also received 
Droperidol and Diazepam for sedation and IV morphine for analgesia (it is unclear if 
patients from the first year received this treatment); 3 of these patients died (20%). 
 
In 1978, Dittmann et al.84 published further findings on the 1975 sample. At this 
time, 100 consecutive patients had been admitted at the University of Basle’s Division of 
Intensive Care. They were assigned either epidural analgesia (n=49, mean age of 55.7 
years with an average of 6.8 fractured ribs) or mechanical ventilation (n=51, mean age of 
44.7 years (according to abstract) or 47.3 (according to page 195) with an average of 6.5 
fractured ribs). Gender, ISS, and presence of flail segments and pulmonary contusions 
were not reported. The treatment methods are not well reported. The authors cite their 
1975 paper and provide minimal additional detail. However, what is reported is 
incongruent with the 1975 study: epidural analgesia is bupivacaine .5% rather than .25%.  
The rest of the treatment is described vaguely as IPPB-inhalation and physiotherapy. 
Patients in the mechanical ventilation group presented with nearly 3 times as many 
“associated fractures and major injuries” (98 compared to 35). Among patients receiving 
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epidural analgesia, the average length of stay in the ICU was 4.5 days (range: 2 to 11 
days). This was briefer than the duration stayed by patients who were treated with 
mechanical ventilation (9.8 days). However, 3 of the 49 patients receiving epidural 
analgesia had to be intubated and ventilated. All 3 died (6.1% overall mortality rate). The 
authors claim “none of the total EA group showed any evidence of pneumonia”, but they 
present a case study within the article that is a duplicate of the 1975 patient who died in 
the epidural analgesia group. And in the 1975 paper, it states he acquired pneumonia after 
8 days of ventilation; in the 1978 paper, he doesn’t contract pneumonia. The researchers 
also chose 6 of the 49 epidural patients on whom to evaluate pulmonary measures. 
Selection criteria were never specified. 5 of these patients were male, they had a mean 
age of 58.6 years and an average of 8.5 fractured ribs (2.9 years older than the sample 
they came from; 1.7 more fractured ribs on average than the sample they came from). 
They had a PaO2 of 8.3 kPa before treatment and 8.5 kPa after treatment. They had a vital 
capacity of 23.6 mL/kg before the treatment and 28.5 ml/kg after the treatment. 
Functional residual capacity pre-treatment was 2473 mL and post-treatment was 2637 
mL. Airway resistance before the treatment was 0.481 kPas/L and after the treatment was 
0.378 kPas/L. Dynamic lung compliance was 1.08 mL/kPA before the treatment and 1.94 
mL/kPA after the treatment. The implication (particularly by VC and Cdyn) are that the 
hypventilated portions of the lung may be better ventilated under epidural analgesia. 
 
In 1982, Dittmann and colleagues once again compared epidural analgesia to 
mechanical ventilation.65 This may have been another expansion on the 1970s sample. 
The epidural analgesia group included 112 patients (mean age of 57.5 yr, mean number 
of fractured ribs = 6.8, 1% had pulmonary contusions). The mechanical ventilation group 
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consisted of 155 patients (45.2 yr, num. of rib fractures = 6.6, 32% had pulmonary 
contusions). Despite being an average of 12.3 years younger and fracturing .2 fewer ribs, 
they had 32 times the incidence of pulmonary contusions (perhaps this was a 
documentation error). Gender, ISS, and presence of flail segments were not reported. 
Neither were the treatment methods (epidural catheterization, medication, dose, or 
ventilation methods). Patients were included in the study if they had multiple fractured 
ribs, were conscious and cooperative, had a vital capacity above 15 ml/kg (or reached that 
value “after a few hours of optimal conservative management”), and “if venous 
admixture proved the pulmonary lesion (by contusion, atelectasis or aspiration) to be of 
minor importance.” No exclusionary criteria were described. The patients who received 
mechanical ventilation remained in the ICU for longer (13.1 days on page 91; 13.5 days 
on page 90) than patients who received epidural analgesia (6.1 days). Patients who 
received mechanical ventilation stayed in the hospital for longer (26.2 days) than patients 
who received epidural analgesia (16.8 days).  Among patients receiving mechanical 
ventilation, 38 patients died (24.5%; 22 deaths because of pulmonary complications, 16 
attributed to non-pulmonary causes). Among patients receiving epidural analgesia, there 
were 5 patient deaths (4.5%; 1 because of pulmonary complications, 4 attributed to non-
pulmonary causes). Although level of significance is never mentioned with the reporting 
of any outcome, the magnitude of the differences is large and in favor of TEA (despite 
those patients being 12.3 years older). 
 
In 1999, Doss and colleagues41 investigated epidural analgesia (ropivacaine) on 
57 patients (68% male, 21-62 yr; no mean provided) with multiple fractured ribs. They do 
not report how many fractured ribs the patients had, if flail segments were present, or the 
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ISS. Inclusion and exclusion criteria are not described. The authors report that all patients 
experienced “excellent pain relief” and none had respiratory depression. But they do not 
describe how data were collected or what those data were. 
 
In 2002, Govindarajan and colleagues39 investigated epidural buprenorphine on 
27 patients (85.2% male, 48 ± 16 yr, a mean of 4 fractured ribs; range: 2-8, no SD 
provided). The authors don’t report the number of subjects with flail segments or the ISS. 
The average length of hospital stay was 5 days (range: 4-7 days, no SD provided), but 
findings are only reported for the first 3 days of treatment.  During these 3 days, 
respiratory rate decreased and ventilatory function improved (compared to pre-analgesia 
data). From pre-analgesia to the third day of treatment: vital capacity went from 21.9 ± 
3.19 ml/kg to 35.1 ± 2.56 ml/kg, resting respiratory rate went from 22.2 ± 2.08 
breaths/min to 17.9 ± 1.49 breaths/min, resting tidal volume went from 2.86 ± .53 ml/kg 
to 5.77 ± .76 ml/kg, and resting minute volume went from 63.4 ± 3.88 ml/kg to 103.52 ± 
3.72 ml/kg. Improvements were also found in magnitude of pain at rest and during 
coughing and deep breathing. At baseline, 89% of subjects reported severe pain at rest 
and 100% during coughing; on the third day of treatment, 78% of subjects reported no 
pain at rest and 41% during coughing. No patient required additional analgesics during 
the treatment. No patient developed hypotension, respiratory depression, or urinary 
retention. No patient experienced a catheter-related complication. 
 
In 1980, Johnston & McCaughey99 evaluated epidural morphine on 6 subjects 
(mean age of 49 yr) with multiple fractured ribs (1 patient had 3 fractured ribs, 1 patient 
had 4 fractured ribs. 3 patients had 6 fractured ribs, 1 patient had 7 fractured ribs). The 
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authors do not report gender, the presence of additional injury (e.g., flail segment), or 
ISS. No exclusionary criteria are noted. The effect of analgesia began within 2-3 min and 
lasted 6.67 h (range: 3-50 h). In all patients but one, doses were repeated for 7-10 days; 
the other subject required mechanical ventilation. To evaluate blood pressure, the two 
patients who were given bupivacaine were compared to two patients who received 
morphine. The average fall in blood pressure after bupivacaine administration was 15 
mmHg (15 min after treatment). The average fall in blood pressure after morphine 
treatment was 0.2 mmHg. The only other result reported is that one patient (out of 6) 
required mechanical ventilation. That patient had other non-thoracic injuries as well. 
 
In 1985, Worthley30 evaluated the safety and effectiveness of patients admitted to 
the Royal Adelaide Hospital ICU (from 1975 to 1981) with chest wall trauma. Patients 
were excluded if they had sustained spinal trauma, were unconsciousness or 
uncooperative, or had a preexisting chronic neurological disease or a skin infection where 
epidural catheter would be inserted. 161 patients received TEA (76.4% male, 46.1 ± 16.8 
yr, 16.1% had a flail segment, 9.9% had a pulmonary contusion). The mean number of 
fractured ribs and injury severity scores were not reported. TEA was bupivacaine (.5% 
with adrenaline 1/200,000). A 5 mL initial dose was used and was adjusted based on 
specific criteria such that doses would accommodate individual patient need.  147 of 161 
patients were managed successfully using only TEA. Mechanical ventilation was used in 
14 patients after the initiation of epidural catheters. 5 of these 14 patients had flail 
segments (36%) compared to 21 (14%) patients with flail segments in the 147 patients 
who were managed with epidural analgesia alone. 4 of the 14 patients who received 
mechanical ventilation (29%) had a pulmonary contusion compared to 12 of the 147 
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successful patients (8%). Two patients died (1.2%), both from respiratory failure. The 
side effects to epidural treatment included 2 cardiac arrests and one epidural infection. 
 
Compared to IV treatments 
 
Numerous studies have demonstrated superior pain relief and greater 
improvement in pulmonary tests when using epidural analgesia compared to IV opioids 
among patients with fractured ribs.7,36,78 Epidural analgesia has also shown to be a 
favorable treatment among patients recovering from thoracic surgery.68,156 
 
Pierre and colleagues presented a poster in 200594 that compared investigated the 
differences between lumbar epidural morphine and IV morphine in patients with multiple 
fractured ribs. 11 patients received epidural morphine (mean age of 53 yr, average, 4.5 
fractured ribs, ISS = 19.8) and 11 patients received IV morphine (mean age of 53 yr, 3.8 
fractured ribs, ISS = 17.6). Gender and percentage of patients with flail segments were 
not reported. The only inclusionary criterion mentioned is that the subjects were adults 
and they had multiple fractured ribs; no exclusionary criteria were mentioned. The 
duration spent on analgesic was similar (epidural: 3.5 days, patient-controlled analgesia: 
3.7 days). Subjects in the epidural group spent significantly less time in the hospital (10.8 
days vs. 15.9 days) and in the ICU (3.1 days vs. 6.6 days). The epidural group also 
experienced better pain reduction at 24 and 36 hours. No further information is provided. 
 
In 1989, Ullman and colleagues89 compared thoracic epidural morphine to IV 
morphine in patients with multiple fractured ribs. 15 patients received epidural morphine 
(73.3% male, 46.1 ± 4.6 yr, 7.3 ± 0.6 fractured ribs, ISS = 19.5 ± 2.0) and 13 patients 
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received IV morphine (84.6% male, 53.0 ± 6.0 yr, 6.6 ± 1.1 fractured ribs, ISS = 25.3 ± 
2.9). The presence of flail segments was not noted. Patients receiving epidural analgesia 
spent shorter durations on ventilators (3.1 days vs. 18.2 days), spent less total time in the 
hospital (14.9 days vs. 47.7 days) and spent less time in the ICU (5.9 days vs 18.7 days). 
All of these are significant. At baseline, there was no difference between groups in tidal 
volume. However, the group receiving epidural analgesia exhibited better improvements 
in tidal volume (at 24 hours). That difference was significant. There were no differences 
between groups in vital capacity, either at baseline or following treatment. 5 patients in 
the IV group (38.5%) required trachestomy while it was only required by 1 patient in the 
epidural group (6.7%). This difference was significant. There were no complications 
related to the catheter placement. 2 patients in the epidural group experienced urinary 
retention but there was no nausea, vomiting, pruritus, or respiratory depression. 
 
In 2013, Waqar and colleagues9 compared TEA (bupivacaine) to IV opioids 
among patients with multiple fractured ribs. There were 47 patients in the epidural group 
(75% male, 54 ± 17 yr, 6.4 ± 2.1 fractured ribs, 19% had a flail segment, ISS = 23.6 ± 
10.3) and 38 patients in the IV group (76% male, 45 ± 22 yr, 5.2 ± 2.5 fractured ribs, 
13% had a flail segment, ISS = 21.0 ± 6.7). Subjects in the epidural group were 
significantly older and had significantly more fractured ribs. Despite this, pain relief was 
superior in the epidural group at all time points (data aren’t reported).  Patients in the 
epidural group had significantly shorter periods of time on analgesia (4.25 ± 1.2 days 
compared to 5.5 ± 3.2 days), significantly shorter stays in the hospital (19 ± 3.1 days 
compared to 21 ± 4.1 days), and the ICU (12 ± 2.4 days compared to 14 ± 3.5 days). 
There were no differences between groups in mortality or morbidity (cardiac, pulmonary, 
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or neurological complications). There were no complications related to epidural 
placement in any subject. 
 
In 1990, Wisner82 compared epidural narcotics (87% lumbar, 13% thoracic; 
methods not described) to a variety of analgesic modes, but most commonly intravenous 
and intramuscular (IV/IM) narcotics (methods not described) among patients who had 
sustained thoracic trauma. There were 52 patients in the epidural narcotic group (42.3% 
male, 71.0 ± 1.1 yr, ISS = 15.7 ± 1.0) and 167 patients in the IV/IM group (44.3% male, 
69.4 ± 0.6 yr, ISS = 14.6 ± 0.8). Number of fractured ribs and the presence of a flail 
segment were not reported. At baseline, the IV/IM analgesia group was similar to the 
epidural group. The only significant differences were found in the Abbreviated Injury 
Scores. The degree of thoracic injury was higher (more severe) in patients treated with 
epidural analgesia. The degree of abdominal injury was higher (more severe) in patients 
treated with IV/IM analgesia. There was a significant difference in mortality rate: patients 
receiving epidural analgesia had a 4% rate compared to those receiving IV/IM analgesia 
who had a 16% rate. With all other covariates held constant, the risk of mortality was 
38% lower among patients receiving epidural analgesia compared to patients receiving 
IV/IM treatments. There was an increased incidence of pneumonia in the IV/IM group 
compared to the epidural group. No major complications were associated with epidural 
use or placement.  No cases of urinary retention or pruritus were found. When using 
logistic regression analyses to determine predictors of pulmonary complication, treatment 
type was significant (epidural analgesia predicted a decreased likelihood that pulmonary 
complications would develop when compared to IV/IM analgesia). Epidural analgesia 
was also associated with improved pain control (11 patients initially treated with an 
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alternate form of analgesia had to be switched to epidural analgesia; 6 of them were 
initially receiving IV/IM analgesia). There was a very strong trend (p=.052) that patients 
who received epidural analgesia had longer hospital stays, but data aren’t reported. On 
average, patients were on mechanical ventilation for 4.4 days, but differences between 
groups are not presented. 
 
Compared to other regional techniques 
 
In 2005, Flagel and colleagues10 compared the use of epidural analgesia to all 
alternative treatments (they did not specify which treatments these were). In evaluating 
the NTDB, they found 9% of patients (n = 64,750) to present with at least 1 fractured rib. 
Among these patients, 2% (n = 1,295) received epidural analgesia; the rest (63,455) 
received alternative treatments. No information is provided about what these forms are or 
how they were administered. Nor were the methods of epidural catheterization (including 
type and concentration of analgesia) described. Inclusionary and exclusionary criteria 
were not reported and numerous baseline variables were absent from the results. This 
includes age (overall and in each treatment group), gender (overall and in each treatment 
group), mean number of fractured ribs (overall and in each treatment group), and the 
incidence of flail segments and pulmonary contusions in individual treatment groups. 
Among all patients with rib fractures, epidural analgesia was used in 2% of cases. The 
more ribs fractured, the more common epidural analgesia was used (R2 = 0.96). Use of 
this treatment jumped 50% in the presence of 6 or more fractured ribs (compared to 
treatments of patients with 5 or fewer). Despite greater number of rib fractures in the 
group receiving epidural analgesia, ISS was slightly lower, and odds of surviving were 
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much better (more than 96% survived, compared to a 10% overall mortality rate). 
Epidural analgesia had no effect on the incidence of pneumonia. 
 
In 1973, Gibbons et al.66 compared epidural analgesia (bupivacaine) to intercostal 
nerve block or parenteral narcotics (bupivacaine) in patients with fractured ribs and 
respiratory failure. If fractures were below the 5th rib, TEA was used (n=27). If fractures 
were on the 5th rib or above, subjects were assigned to the comparison group, in which 
either intercostal nerve block or parenteral narcotics was used (n=30). The patient 
characteristics (gender, age, number of fractured ribs, whether flail segments were 
present, and ISS) are not described. In the thoracic epidural group, hypotension 
developed in 12 patients. In 2 of these patients, the severity of the hypotension resulted in 
circulatory arrest. 6 patients required tracheobronchial suction and 6 patients ultimately 
required artificial ventilation. All patients recovered and all ultimately experienced 
satisfactory pain relief. In the Intercostal nerve block (or parenteral narcotic) group, 2 
patients required tracheobronchial suction, 13 required artificial ventilation at some point 
in the recovery (compared to 6), and 2 patients died (“during resuscitation of aortic 
rupture”). No other data are reported. 
 
In 2011, Hashemzadeh and colleagues61 compared TEA (marcaine) to intercostal 
block (marcaine) among patients with multiple fractured ribs. 30 patients were 
randomized to the thoracic epidural group (95% male, 45.5 ± 15.4 yr) and 30 patients 
were randomized to the intercostal block group (90% male, 65.5 ± 7.2 yr). The authors 
collect but don’t report number of fractured ribs and incidence of flail segments. They do 
report percentage of coexisting disease (10% of epidural subjects, 20% of intercostal 
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block subjects). They also report pain scores at rest and during coughing, but don’t 
specify if those values are pre- or post-treatment or change scores. There were significant 
differences in pain scores both during rest and while coughing (p = .03 and .00 
respectively) with thoracic epidural subjects reporting less pain. It is unknown if these are 
baseline, post-treatment, or change values. Subjects in the thoracic epidural group had 
shorter stays in the trauma unit (5.7 ± 2.0 days) than subjects in the intercostal group (7.7 
± 3.7 days; p = .04). Thoracic subjects also had shorter ICU stays (1.6 ± 1.0 days) than 
intercostal subjects (1.9 ± 1.4 days; p = .05). At baseline, respiratory rate, heart rate, 
oxygen saturation, and mean arterial pressure were not different. Minute volume (p= .03), 
tidal volume (p = .04), and vital capacity (p = .08) were lower in the intercostal subjects. 
Following treatment, these differences vanished (p = .67, .41, and .93 respectively). 
Before treatment, there was no difference in PaO2 (thoracic epidural subjects had a non-
significantly lower value; p = .20). Following treatment, thoracic epidural subjects had 
significantly higher values (p = .01). There was no difference in PaCO2. The authors say 
there was no difference in the incidence of respiratory complications, but they do not 
report those rates or disclose what the complications were. The descriptions of findings in 
the discussion often cannot be reconciled with the reports found in the tables. It may be 
difficult to attribute superior outcomes to type of treatment when the intercostal group 
was 20 years older (p = .35) with twice the rate of coexisting disease (p = .19). Despite 
the lack of significance, the magnitude of the differences is considerable. 
 
In 1994, Luchette and colleagues83 compared thoracic epidural catheters 
(bupivacaine) to intrapleural catheters (bupivacaine) in patients with multiple fractured 
ribs. There were 9 subjects randomized to the thoracic epidural group (56 ± 18.3 yr, ISS 
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= 21.7 ± 5.5) and 10 randomized to the intrapleural catheter group (51 ± 10.9 yr, ISS = 
19.4 ± 5.7). Gender, number of fractured ribs, and presence of flail segment were not 
reported. The researchers quantified three days of recovery. All data are displayed in 
graphs; exact values are not reported. At baseline, subjects in the epidural group had 
higher mean pain scores (visual analog score; not significant). During all 3 days of 
recovery, pain was significantly lower in the group receiving epidural analgesia (both at 
rest and during movement or coughing; < .05). Subjects in the epidural group also 
required less supplemental morphine at all time points (p < .05). Regarding pulmonary 
function tests, vital capacity, minute ventilation, and respiratory rate were not different 
between the two treatments. But tidal volume and negative inspiratory force improved 
significantly more in the epidural analgesia group (on day 3) than in the intrapleural 
group. Side effects/complications: mechanical ventilation was required in 78% of 
epidural subjects and 70% of intrapleural subjects. There was no bupivacaine toxicity, 
neurological deficit, dural perforation, catheter-related infections, or pneumothoraces. 
The most common complication was a “mild to moderate” (exact magnitude not 
reported) fall in blood pressure when thoracic epidurals were administered. Blood 
pressure was restored in 6 out of 9 patients with a lactated Ringer’s solution; epinephrine 
was used in the other 3. 
 
Research comparing different locations of epidural analgesia 
 
In 2012, Hakim & Latif28 investigated if TEA (lidocaine) is better than lumbar 
epidural analgesia (lidocaine) among patients who are admitted with blunt chest trauma. 
27 patients received thoracic epidurals (63.0% male, 39.1 ± 13.5 yr, 3.7% had a flail 
 89 
segment, VAS for pain: 67.3 ± 7.4) and 28 patients received lumbar epidurals (53.6% 
male, 41.3 ± 9.3 yr, 3.6% had a flail segment, VAS for pain: 62.9 ± 9.7). Number of 
fractured ribs was not reported. Duration of epidural analgesia: both groups had a mean 
of 3 days. Range in the lumbar group was 3-4 days; range in the thoracic group was 2-4 
days (p = .057). Mean values are only presented as integers; no SDs are provided.  
Duration of ICU stay: both groups had a mean of 5 days. Range in the lumbar group was 
5-7 days; range in the thoracic group was 4-9 days (p = .227). 17.9% of lumbar patients 
and 22.2% of thoracic patients received mechanical ventilation (p = .686). Mechanical 
ventilation lasted 5 days in the lumbar group and 6 days in the thoracic group (p= .141). 
25% of lumbar patients and 22.2% thoracic patients developed pneumonia (p = .808). 
Both groups experienced initial reductions (first 24 hours) in pain scores, heart rate, 
respiratory rate, and mean arterial pressure (p < .05) relative to pre-randomization values. 
During this same time, SaO2, PaO2, PaO2/FiO2, PaCO2, MIF, VT, and FEV1% were 
elevated (p < .05). There were no significant differences between groups in pain scores, 
cardiopulmonary variables, total morphine use, or incidence of treatment-related side 
effects. The most common side effects were urinary retention (42.9% in lumbar, 40.7% in 
thoracic), pruritus (60% in lumbar, 55.6% in thoracic), and nausea/vomiting (25% in 
lumbar, 29.6% in thoracic). 
 
Research not supporting TEA 
 
Epidural analgesia is not always shown to be the most effective modality. Among 
patients admitted with rib fractures, the outcomes of TEA administration have been 
inconsistent.7,82,96 Whereas 16 studies have reported positive outcomes with epidural 
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analgesia, 10 have reported either poorer or comparable outcomes for patients with 
fractured ribs. Out of these, 2 were not designed to evaluate the efficacy of TEA, 6 
compared TEA to IV treatments, and 2 compared TEA to other regional techniques. 
 
Methods not designed to evaluate epidural analgesia 
 
In 2004, Balcı and colleagues91 enrolled 64 patients who had flail injuries in a 
study that evaluated 3 different therapies: Group 1 (n=27, 74.1% male, 34.6 ± 8.4 yr, 
100% had a flail segment, 14.8% bilateral flail, 48.1% had a pulmonary contusion, ISS = 
21.0 ± 7.4) underwent open fixation of rib fractures, Group 2 (n=19, 78.9% male, 30.7 ± 
8.4 yr, 100% had a flail segment, 11.1% bilateral flail, 42.1% had a pulmonary contusion, 
ISS = 18.2 ± 7.8) managed the injuries using intermittent positive pressure, and Group 3 
(n=18, 72.2% male, 31.7 ± 11.1 yr, 100% had a flail segment, 11.1% bilateral flail, 
44.4% had a pulmonary contusion, ISS = 18.6 ± 8.3) managed the injuries with 
synchronized intermittent mandatory ventilation. Among the patients who were not 
treated surgically (i.e., Groups 2 and 3), 13 patients received TEA (35.1%), 16 received 
intercostal nerve blockade (43.2%), and 8 received narcotic or nonnarcotic parenteral 
analgesia (21.6%). This study was not designed to look at TEA; it was just a side note in 
a protocol investigating surgical fixation. Epidural analgesia (0.10% bupivacaine and 10 
mg·mL–1 fentanyl) was described as patient-controlled, but a dose of 4 mL·h–1 was used. 
No further information is provided about the methods of catheterization. The authors 
report that all patients receiving epidural analgesia or intercostal nerve blockades needed 
additional parenteral analgesia and repeated doses to address pain. They do not report 
pain outcomes or data concerning treatment repetition, but note that pain control was 
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inadequate and opioid drugs were the most commonly used option to increase the 
analgesic effect. Across the whole sample, mortality was 20.3%, the duration of 
mechanical ventilation ranged from 1.5 to 22 days, and the length of hospital stay ranged 
from 9 to 32 days. The authors concluded that surgical fixation was a successful 
treatment for patients with traumatic flail chest but thoracic epidural catheters were 
potentially problematic “not only because of the angle of the spinal processes and the 
smaller space but also because it was difficult to put patients with flail chest in the proper 
position to place the catheter, thus we do not advise its routine use.” 
 
In 2000, Bulger and colleagues6 compared outcomes of elderly Patients (≥ 65 y) 
with at least 1 fractured rib to younger patients (18-64 y) with at least 1 fractured rib. 
There were 277 elderly patients (57% male, 74 ± 6 yr, 3.6 ± 2.5 fractured ribs, 17% had a 
flail segment, ISS = 20.7 ± 12.7) and 187 younger patients (70% male, 39 ± 13 yr, 4.0 ± 
2.9 fractured ribs, 11% had a flail segment, ISS = 21.4 ± 13.4). Elderly patients had more 
sternal fractures (6% vs. 2%) and fewer cases of pneumothorax (34% vs. 44%). No 
inclusionary or exclusionary criteria were specified. The mean duration spent in the ICU 
was 6.1 ± 10.0 days for elderly patients and 4.0 ± 9.4 days for young patients (p < .05). 
The mean hospital stay was 15.2 ± 16.5 days for elderly patients and 11.0 ± 13.1 days for 
young patients (p < .01). The mean ventilator duration was 4.3 ± 9.3 days for elderly 
patients and 3.1 ± 9.2 days for young patients (p = .16). Ventilatory support was required 
in 57% of the young group and 52% of the elderly group. Elderly patients experienced 
more pulmonary complications: pneumonia (31% vs. 17%), late pulmonary effusion 
(41% vs. 14%), and adult respiratory distress syndrome (9% vs. 5%). As the number of 
fractured ribs increased, so did the odds of contracting pneumonia and adult respiratory 
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distress syndrome (especially in the elderly group). 22% of the elderly patients died 
compared to 10% of the young patients (p < .001). As the number of fractured ribs 
increased in both groups, so did risk of mortality. Elderly patients and patients with more 
severe injuries were most likely to receive epidural catheters.  Despite greater chest injury 
in the catheter group, mortality rates were lower (11% in epidural group, 25% in those 
not receiving epidurals). Other treatments included rib block, pleural block, PCA, IV/IM 
narcotics, oral narcotics, ketorolac, and Tylenol. Among patients who received epidural 
catheters, the duration of treatment was 6.3 days for elderly patients and 4.3 days for 
younger patients. Despite a lower mortality rate among patients receiving epidural 
analgesia, that treatment was associated with more pulmonary complications and longer 
stays in the ICU and hospital. A possible explanation for both of these outcomes is the 
increased injury severity of those receiving epidurals. Additionally, basic treatment 
logistics might explain some of the length of stay: once a catheter is applied, it is 
generally left in place for 4–5 days. 
 
Compared to IV treatments 
 
In 2004, Bulger and colleagues11 compared epidural analgesia (bupivicaine, 
morphine, and fentanyl) to IV opioids (morphine, hydromorphone, and fentanyl) in 
patients with multiple fractured ribs. 22 patients received epidural analgesia (77% male, 
49 ± 18 yr, 7.2 ± 3.2 fractured ribs, 38% had a flail segment, ISS = 26 ± 8) and 24 
patients received IV opioids (76% male, 46 ± 16 yr, 6.8 ± 3.3 fractured ribs, 21% had a 
flail segment, ISS = 25 ± 8). Although the IV group experienced a higher risk of 
pneumonia and longer duration spent on mechanical ventilation, there were no 
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differences in length of hospital stay or mortality. Epidural catheter treatment lasted 4.4 
days and complications occurred in 6 (27%) patients (mostly pruritus, which was 
experienced by 5 patients). The length of IV treatment is not reported, but 8 (33%) 
patients experienced complications (mostly vomiting and pruritus; 6 and 5 patients 
respectively). Degree of pain relief is not reported. Pain is only characterized at baseline 
(via ISS and AISS for head and chest). Pain relief is not reported relative to treatment 
arm. However, the authors do report that 3 epidural patients and 3 IV patients each failed 
to experience adequate pain relief and switched treatment groups. The unadjusted 
pneumonia rate in the epidural group was 18% while it was 38% in the IV group (p = 
.15). After adjusting for pulmonary injury, risk of pneumonia in IV patients increased 6-
fold (OR, 6.0; 95% CI, 1.0-35; P = .05). Unadjusted, patients in the IV group spent 9.1 
days on ventilation compared to epidural patients who spent 7.6 days. Unadjusted 
incident rate ratio: 1.19 (95% CI, 0.97-1.45; P = .09), indicating a 19% increase in 
ventilator duration for the IV opioid group. If data are stratified based on the presence of 
a pulmonary contusion, there is a 2-fold increase in ventilator days for the IV group (IRR, 
2.0; 95% CI, 1.6-2.6; P < .001). No differences were found in length of hospital stay or 
mortality between the two groups. Although there was a trend for patients in the epidural 
group to have a higher rate of acute respiratory distress syndrome (p = .15), no significant 
differences. 
 
In 2005, Kieninger and colleagues96 compared epidural analgesia (methods not 
specified) to IV narcotics (methods not specified) in older patients (>55 yr) with fractured 
ribs. 53 patients were in the epidural group (34% male, 77.7 ± 10.2 yr, 58.5% had a 
cardiopulmonary comorbidity, ISS = 10.3 ± 3.6) and 134 patients were in the IV group 
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(40.3% male, 77.3 ± 10.5 yr, 16.4% had a cardio-pulmonary comorbidity, ISS = 8.3 ± 
3.9). ISS was significantly different between groups (p = .001). AIS for chest was also 
significantly higher in the epidural group (2.86 vs. 2.16; p < .0001). Number of fractured 
ribs and the presence of flail segments were not noted. The authors found the length of 
hospital stay to be significantly longer for patients receiving epidurals (8.6 ± 4.6 days) 
compared to those receiving IV narcotics (5.6 ± 5.1 days) (p = .007). The rest of the 
findings focus on the incidence of cardiopulmonary complications (effusion, infiltrate, 
and/or pneumonia) and presence of comorbidities (history of myocardial infarction, 
arrhythmia, heart failure, chronic obstructive pulmonary disease, tobacco use). 122 total 
patients (65%) had cardio-pulmonary comorbidities. 31 (58%) of these patients were in 
the epidural group; 91 (68%) were in the IV group. The difference was not significant 
(p=.226). 96 patients developed a cardiopulmonary complication. This was more 
common in the epidural group, even when stratified by ISS and AISS. If patients had 
cardiopulmonary comorbidities, they fared worse with epidural treatment regardless of 
ISS and AIS. A total of 5 patients (2.6%) died.  3 of these patients (5.6%) were in the 
epidural group. 2 (1.5%) were in the IV group. The difference was not significant (p = 
.324). 
 
In 1991, Mackersie and colleagues36 compared epidural administration of fentanyl 
to an IV administration among patients with multiple fractured ribs. 15 patients were 
randomized to the epidural group (49.3 ± 19 yr, 4.2 ± 1.0 fractured ribs, ISS = 20 ± 7.6) 
and 17 patients were randomized to the IV group (47.8 ± 14 yr, 4.8 ± 1.7 fractured ribs, 
ISS = 16 ± 7.2). Gender and incidence of flail segments were not reported. Subjects 
receiving the epidural treatment experienced longer hospital stays (8.7 ± 4.2 days) than 
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subjects receiving IV treatment (7.1 ± 6.2 days). The duration of analgesia administration 
was longer in the epidural group (84 ± 37 hours) than in the IV group (82 ± 33 hours). 
The cost of epidural treatment ($21,000 ± $10,000) was more expensive than the cost of 
IV treatment ($15,000 ± $16,000). Subjects in the IV group used more total fentanyl (90 
± 34 μg/kg/hour) than subjects in the epidural group (78 ± 22 μg/kg/hour). These 
differences (volume of analgesia used, length of hospital stay, and the length and cost of 
treatment) did not reach significance.  Both groups improved significantly in vital 
capacity. Only the epidural group improved significantly in maximum inspiratory 
pressure (17 ± 20 cm H2O compared to 5.3 ± 19 cm H2O in the IV group). There was no 
change in respiratory rate, tidal volume, or minute ventilation in either group. Arterial 
PaO2 did not change in the epidural group (0.8 ± 19) but fell in the IV group (-19 ± 14).  
Arterial PaCO2 did not change in the epidural group (1.8 ± 5.9) but was increased in the 
IV group (5.6 ± 4.2). The two groups were significantly different in arterial changes in 
PaO2. Both groups experienced significant pain reductions at rest and during coughing 
and deep breathing. The epidural group experienced a trend (p=.08) toward greater pain 
reductions during coughing and deep breathing. Nausea scores trended upward in both 
groups (epidural: 7.5 ± 16, IV: 7.2 ± 34). Nausea/vomiting was present in 46% of 
epidural cases and 29% of IV cases. The IV group experienced no change in pruritus 
(visual analog scale; -1.1 ± 11), but the epidural group significantly increased (10.3 ± 19).  
There were no complications resulting from epidural placement. Neither group had any 
cases of pneumonia. No patient developed respiratory failure.  No patient required 
bronchoscopy. 
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In 1999, Moon and colleagues78 compared TEA (lidocaine) to IV opioids 
(morphine) among patients with multiple fractured ribs. There were 13 patients 
randomized to the epidural group (61.5% male, 37 yr, ISS = 26.6; SDs not reported) and 
11 patients randomized to the IV group (54.5% male, 40 yr, ISS = 23.4; SDs not 
reported). Number of fractured ribs and percentages of patients with flail segments were 
not reported. During the first 24 hours, the epidural group experienced significantly better 
pain relief (while coughing; not at rest) than the systemic group. Differences vanished at 
day 2 and returned at day 3. Need for supplemental oxygen was not different between 
groups (data not reported). Neither was forced expiratory volume (data not reported). But 
maximal inspiratory force was: patients receiving the opioids systemically experienced a 
gradual decline (-15%) throughout the course of the study while the patients receiving 
TEA experienced a gradual improvement (+23%). By day 3, the difference between 
groups was significant. Similarly, tidal volume gradually declined in the systemic opioid 
group (reaching 56% of original value by day 3) and gradually increased in the thoracic 
epidural group (+45%) with the difference between groups reaching significance on the 
third day. Interleukins 1β and 2 as well as TNF-α didn’t fluctuate throughout the course 
of the study. 
 
In 1999, Wu and colleagues7 compared TEA (bupivacaine and fentanyl) to IV 
analgesia (morphine) in patients with at least 3 fractured ribs. There were 25 patients in 
the epidural group (52% male, 56 ± 17 yr, 5.6 ± 2.1 fractured ribs, ISS = 21.6 ± 10.3) and 
39 patients in the IV group (51% male, 45 ± 22 yr, 4.4 ± 1.5 fractured ribs, ISS = 21.9 ± 
6.7). Presence of a flail segment was not reported. Patients in the epidural group were 
significantly older than those in the IV group (p = .04) and they had significantly more 
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fractured ribs (p = .01). Following treatment, there were no differences in length of stay 
in the hospital, length of stay in the ICU, or duration of analgesia administration. The 
closest finding to significance was duration in the ICU: 4.4 ± 4.1 days in the epidural 
group vs. 2.5 ± 3.5 days in the IV group (p = .18). There were also no differences 
between the groups in incidence of cardiac, pulmonary, or neurological complications. 
No differences in mortality. There were no side effects associated with epidural 
treatment. Patients in the epidural group did experience superior pain reduction at all time 
points (every 8 hours up to hour 80). 
 
In 2012, Yeh and colleagues8 compared TEA (bupivicaine and fentanyl) to IV and 
oral narcotics (no methods provided) in patients with at least 3 fractured ribs. There were 
34 patients in the epidural group (73.9% male, 48.8 ± 18.4 yr, 5.0 ± 2.0 fractured ribs, 
ISS = 23.1 ± 9.3) and 153 in the non-epidural group (65.6% male, 69.6 ± 10.1 yr, 5.6 ± 
2.3 fractured ribs, ISS = 21.5 ± 9.3). The presence of flail segments and/or pulmonary 
contusions were not reported. Age (p < .001) and gender (p = .054) were different. The 
patients who received epidurals had longer stays in the hospital (median of 7 vs. 5 days; p 
< .001) and ICU (median of 1 vs. 0 days; p = .001). However, they also had more severe 
injuries. They fractured more total ribs (7.1 vs. 5.0; p < .001), had a higher incidence of 
bilateral rib fractures (32.4% vs. 15.0%; p = .026), and showed a trend of having more 
common upper rib fractures (47.1% vs. 30.1%; p = .070) and required more chest tube 
placements (55.9% vs. 37.9%; p = .082). The only variable that significantly predicted 
complication (when adjusted for age, injury severity, etc.) was the requirement for chest 
tube placement (OR 2.791 [95% confidence interval 1.205–6.462], p = .017). Those with 
chest tubes placed had complications 29.7% of the time compared to 11.8% in those 
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without chest tubes (p = .029). Three variables predicted longer hospital stay: increasing 
age (coefficient 0.106 [95% confidence interval 0.040–0.172], p = 0.002), increasing 
injury severity (coefficient 0.236 [95% CI 0.097–0.076], p = 0.001), and requiring chest 
tube placement (coefficient 3.263 [95% CI 0.948–5.579], p = 0.006). Chest tube 
placement associated with a median of 6 days compared to 5.5 days (p = .037). No 
variables predicted longer stay in the ICU. Older patients (≥ 55, n=123) experience more 
complications than those who are <55 (n=64) (26.6% vs. 12.2%; p = .023) despite having 
lower rates of organ injury (7.8% vs. 25.2%; p = .003) and chest tube placement (29.7% 
vs. 47.2%; p = .028). There was a trend for older patients to stay longer in the hospital as 
well (p = .067). Yeh and colleagues concluded that TEA did not improve outcomes in 
pulmonary complications or length of stay in the ICU or hospital relative to IV and oral 
narcotics. 
 
Compared to other regional techniques 
 
In a 2009 pilot study by Mohta and colleagues29, they compared TEA 
(bupivacaine) to thoracic paravertebral infusion (bupivacaine) in patients with at least 3 
fractured ribs. They randomized 15 patients to the epidural group (80% male, 38.9 ± 14.9 
yr, 4.9 ± 1.8 fractured ribs, 7% had a flail segment, ISS = 15.9 ± 7.1) and 15 patients to 
the paravertebral group (80% male, 40.4 ± 14.8 yr, 4.9 ± 1.4 fractured ribs, 27% had a 
flail segment, ISS = 13.6 ± 5.6). There was no difference in the duration of bupivacaine 
infusion between groups (thoracic epidural group = 129.1 hours, thoracic paravertebral 
group = 120.5 hours, p = .525) or the duration of hospital or ICU stays (10.1 and 6.3 days 
for thoracic epidural group; 11.7 and 6.8 days for thoracic paravertebral group). Both 
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groups experienced a significant reduction in pain (measured by visual analog scale) 
during rest and during coughing at every time point following administration of treatment 
but no intergroup differences were found (rest: p = .426; coughing: p = .721). Respiratory 
rate and peak expiratory flow rate significantly improved in both groups at all time points 
but no differences were found between groups (respiratory rate p = .092; peak expiratory 
flow rate p = .515). The ratio of arterial oxygen to inspired oxygen concentration showed 
little change but there was a difference between the two groups at 72 hours, with the 
thoracic epidural group having a better ratio (p = .018). There was no patient mortality. 
Pneumonia was developed by 1 patient in the thoracic epidural group and 2 patients in 
the thoracic paravertebral group. Fever was developed by 2 patients in the thoracic 
epidural group and 3 patients in the thoracic paravertebral group. Overall, pulmonary 
complications were not different between groups, but incidence of hypotension was 
higher with the thoracic epidural group (40%) than the paravertebral group (7%). A 
patient in the thoracic paravertebral group developed convulsions 68 hours after 
commencement of treatment (attributed to local anesthetic toxicity). 
 
In 1994, Shinohara and colleagues93 compared thoracic epidural block (lidocaine) 
and intrapleural block (lidocaine) in patients with multiple unilateral fractured ribs and 
hemopneumothorax.  All subjects received a chest drain for hemopneumothorax (average 
duration: 5 ± 1.7 days). Both intrapleural and thoracic blocks were installed in all 
patients. On the first day, when a patient complained of pain, that patient received 
treatment through one of the two blocks (randomly chosen). On the second day, when a 
patient complained of pain, the other block was used. The intervention group is 
considered to be those who received intraleural block prior to thoracic block and the 
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comparison group consisted of those who received thoracic block prior to intrapleural 
block. There were 8 patients randomized to the thoracic epidural block group and 9 
patients randomized to the intrapleural block group. Patient characteristics were only 
presented among the total sample (88.2% male, 50.3 ± 16.0 yr, 5.7 ± 1.4 fractured ribs). 
ISS and presence of flail segments were not reported. There were no significant 
differences in pain relief. 4 patients showed no hypesthesia with intrapleural block; 2 
patients showed no hypesthesia with thoracic epidural block. Blood pressure fell 
significantly with thoracic epidural block, but not with intrapleural block (data presented 
in unclear graphs). Heart rate fell significantly 10 minutes after intrapleural block and 5 
to 30 minutes after thoracic epidural block (data presented in unclear graphs). Respiratory 
rate fell significantly in both treatments (intrapleural: 20.6 to 17.7, thoracic epidural: 20.7 
to 16.9) but the difference between treatments was not significant. Blood gas values 
changed significantly in both groups but the difference between groups was not 
significant (PaO2 in thoracic epidural: 89.2 to 102.7, PaO2 in intrapleural group: 94.2 to 
103.9; PaCO2 in thoracic epidural: 43.4 to 38.9, PaCO2 in intrapleural group: 43.9 to 
39.9). No subject required additional analgesia during treatment. There was no mortality, 
no toxic reactions from lidocaine administration (e.g., no cardiovascular toxicity, etc.), 
and no pneumonia. No other side effects were seen in either group. 
 
Risks of TEA 
 
Treating with epidural analgesia is not without risks. It’s more technically 
complex than the administration of IV analgesia, which puts the patient at a higher risk of 
complications.38 Although infrequent, these include inadvertent dural puncture101,102 and 
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spinal cord injury (when done in the thoracic region)38,47, epidural infection30,56, 
hypotension30,47, hematoma (following puncture of epidural vessels during catheter 
placement)68, abscesses in the epidural space109,110, nausea, vomiting36,37, respiratory 
depression56, pruritis and urinary retention in the presence of an opioid38, and motor 
block compromising mobilization.47 
 
In 2011, Kim and colleagues97 reported on the complications that arose in 35 
patients (65.7% male, 51.4 ± 12.8 yr, 1,7 ± .7 fractured ribs) who underwent surgical 
reduction and fixation of fractured ribs, and were treated with thoracic epidural 
anesthesia and analgesia. 83% of patients were undergoing their first surgery (fixing 
malunions of fractured ribs). The remaining 17% underwent a second surgery (owing to 
incompletely fixed ribs during prior surgery under general anesthetic). ISS and the 
presence of flail segments were not noted. General anesthesia was administered to 1 
patient (out of 36). There were no adverse events (e.g., hypotension, arrhythmia, or 
respiratory failure by cardiopulmonary dysfunction). 3 patients experienced postoperative 
complications (a wound infection that was treated and 2 cases of extrapleural hematoma 
that resolved without treatment). No patient died. All patients resumed eating upon 
waking up and ambulation without limitation the day after surgery. 
 
Individual outcomes associated with TEA 
 
Mortality 
 
4 studies found epidural analgesia to associate with a lower mortality rate 
compared to an alternative treatment: Bulger et al., 2000 (compared to all other non-
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epidural patients)6, Dittmann et al., 1982 (compared to mechanical ventilation; 24.5% of 
ventilated patients died compared to 4.5% of patients receiving epidurals; this is never 
described as different and no p-value is provided)65, Flagel et al., 2005 (compared to all 
other treatments)10, and Wisner, 1990 (compared to IV/IM narcotics).82 
 
No study found epidural analgesia to associate with a higher mortality rate 
compared to an alternative treatment. 
 
8 studies found no difference in mortality rate when using epidural analgesia 
compared to an alternative treatment: Bulger et al., 2004 (compared to patient-controlled 
IV morphine, hydromorphone, and fentanyl)11, Dittmann et al., 1975 (compared to 
mechanical ventilation; 13.7% of ventilated patients died compared to 6.1% of patients 
receiving epidurals; this is never described as different and no p-value is provided)85, 
Gibbons et al., 1973 (compared to intercostal nerve block or parenteral narcotics; 2 
patients died, both in the comparison group; no p-value or other statistics are provided)66, 
Kieninger et al., 2005 (compared to IV narcotics; patients in the epidural group had more 
severe injuries)96, Mohta et al., 2009 (compared to thoracic paravertebral bupivacaine; no 
patient in either group died)29, Shinohara et al., 1994 (compared to intrapleural lidocaine; 
no patient in either group died)93, Waqar et al., 2013 (compared to IV opioids)9, and Wu 
et al., 1999 (compared to patient-controlled IV morphine; no patient in either group 
died).7 
 
Pain management 
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7 studies found epidural analgesia to associate with better pain management 
compared to an alternative treatment: Hashemzadeh et al., 2011 (compared to intercostal 
block with marcaine; the data are significant, but unclear)61, Luchette et al., 1994 
(compared to intrapleural bupivacaine)83, Moon et al., 1999 (compared to patient-
controlled IV morphine; only significant on days 1 and 3)78, Pierre et al., 2005 (compared 
to patient-controlled IV morphine; actual data aren’t provided)94, Waqar et al., 2013 
(compared to IV opioids; actual data aren’t provided)9, Wisner, 1990 (compared to IV/IM 
narcotics; based on number of patients who had to switch treatments)82, and Wu et al., 
1999 (compared to patient-controlled IV morphine).7 
 
No study found epidural analgesia to be inferior at reducing pain compared to an 
alternative treatment. 
 
3 studies found no difference in pain management when using epidural analgesia 
compared to an alternative treatment: Mackersie et al., 1991 (compared to IV 
administration of fentanyl; both groups experienced significant pain reductions; the 
epidural group experienced a trend, p = .08, toward greater reduction)36, Mohta et al., 
2009 (compared to thoracic paravertebral bupivacaine)29, and Shinohara et al., 1994 
(compared to intrapleural lidocaine).93 
 
Duration of stay in the ICU 
 
6 studies found epidural analgesia to associate with shorter stays in the ICU 
compared to an alternative treatment: Dittmann et al., 1978 (compared to mechanical 
ventilation)84; Dittmann et al., 1982 (compared to mechanical ventilation)65; 
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Hashemzadeh et al., 2011 (compared to intercostal block with marcaine)61; Pierre et al., 
2005 (compared to patient-controlled IV morphine)94; Ullman et al., 1989 (compared to 
IV morphine)89; Waqar et al., 2013 (compared to IV opioids).9 
 
2 studies found epidural analgesia to associate with longer stays in the ICU 
compared to an alternative treatment: Bulger et al., 2000 (compared to all other non-
epidural patients; patients in the epidural group were older and had more severe injuries)6 
and Yeh et al., 2012 (compared to patient-controlled oral and IV narcotics; patients in the 
epidural group had more severe injuries).8 
 
4 studies found no difference in ICU duration when using epidural analgesia 
compared to an alternative treatment: Bulger et al., 2004 (compared to patient-controlled 
IV morphine, hydromorphone, and fentanyl; epidural patients had more chest tubes 
placed, p = .03, and were 1.8 times more likely to have a flail segment, though not 
significant; p = .20)11, Mohta et al., 2009 (compared to thoracic paravertebral 
bupivacaine)29, Moon et al., 1999 (compared to patient-controlled IV morphine; epidural 
analgesia associated with 1.9 days longer stay, but it didn’t reach significance)78, and Wu 
et al., 1999 (compared to patient-controlled IV morphine; epidural analgesia associated 
with 1.9 days longer stay, but it didn’t reach significance).7 
 
Duration of stay in the hospital 
 
4 studies found epidural analgesia to associate with shorter stays in the hospital 
compared to an alternative treatment: Dittmann et al., 1982 (compared to mechanical 
ventilation)65, Pierre et al., 2005 (compared to patient-controlled IV morphine)94, Ullman 
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et al., 1989 (compared to IV morphine)89, and Waqar et al., 2013 (compared to IV 
opioids).9 
 
3 studies found epidural analgesia to associate with longer stays in the hospital 
compared to an alternative treatment: Bulger et al., 2000 (compared to all other non-
epidural patients; patients in the epidural group were older and had more severe 
injuries)6, Kieninger et al., 2005 (compared to IV narcotics; patients in the epidural group 
had more severe injuries)96, Yeh et al., 2012 (compared to patient-controlled oral and IV 
narcotics; patients in the epidural group had more severe injuries).8 
 
5 studies found no difference in hospital duration when using epidural analgesia 
compared to an alternative treatment: Bulger et al., 2004 (compared to patient-controlled 
IV morphine, hydromorphone, and fentanyl; epidural patients had more chest tubes 
placed, p = .03, and were 1.8 times more likely to have a flail segment, though not 
significant; p = .20)11, Mackersie et al., 1991 (compared to IV administration of 
fentanyl)36, Mohta et al., 2009 (compared to thoracic paravertebral bupivacaine)29, Moon 
et al., 1999 (compared to patient-controlled IV morphine)78, and Wu et al., 1999 
(compared to patient-controlled IV morphine).7 
 
Incidence of pneumonia  
 
2 studies found epidural analgesia to associate with a lower incidence of 
pneumonia compared to an alternative treatment: Bulger et al., 2004 (compared to 
patient-controlled IV morphine, hydromorphone, and fentanyl)11 and Wisner, 1990 
(compared to IV/IM narcotics; 8% vs. 19%, but no p-value was reported).82 
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1 study found epidural analgesia to associate with a higher incidence of 
pneumonia compare to alternative treatments: Bulger et al., 2000 (compared to all other 
non-epidural patients; patients in the epidural group were older and had more severe 
injuries).6 
 
6 studies found no difference in the incidence of pneumonia when using epidural 
analgesia compared to an alternative treatment: Flagel et al., 2005 (compared to all other 
treatments)10, Mackersie et al., 1991 (compared to IV administration of fentanyl; neither 
group experienced any cases of pneumonia)36, Mohta et al., 2009 (compared to thoracic 
paravertebral bupivacaine)29, Shinohara et al., 1994 (compared to intraleural lidocaine; 
neither group experienced any cases of pneumonia)93, Waqar et al., 2013 (compared to IV 
opioids; patients taking IV opioids had twice the incidence of pneumonia – 26% 
compared to 13% – but it wasn’t significant; p = .87)9, and Wu et al., 1999 (compared to 
patient-controlled IV morphine).7 
 
Cardiopulmonary outcomes 
 
6 studies have reported mixed findings when comparing the effects of epidural 
analgesia to an alternative treatment on cardiopulmonary outcomes: Hashemzadeh et al., 
2011 (compared to intercostal block with marcaine; epidural subjects improved more in 
arterial oxygen tension; intercostal block patients improved more in minute volume, tidal 
volume, and vital capacity; no differences were found in respiratory rate, heart rate, 
oxygen saturation, or mean arterial pressure)61, Luchette et al., 1994 (compared to 
intrapleural bupivacaine; patients receiving epidural analgesia improved more in tidal 
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volume and negative inspiratory force on day 3 of treatment; no differences were found 
in vital capacity, minute ventilation, or respiratory rate)83, Mackersie et al., 1991 
(compared to IV administration of fentanyl; patients receiving epidural analgesia 
improved more in maximum inspiratory pressure, arterial oxygen tension, and carbon 
dioxide tension; no differences were found in vital capacity, respiratory rate, tidal 
volume, or minute ventilation)36, Moon et al., 1999 (compared to patient-controlled IV 
morphine; patients receiving epidural analgesia exhibited better outcomes in maximal 
inspiratory force and tidal volume; no differences were found in forced expiratory 
volume)78, Shinohara et al., 1994 (compared to intrapleural lidocaine; blood pressure was 
adversely affected by epidural analgesia but not intrapleural block; no differences were 
found in respiratory rate or arterial oxygen tension)93, and Ullman et al., 1989 (compared 
to IV morphine; patients receiving epidural analgesia exhibited better outcomes in tidal 
volume; no differences were found in vital capacity).89 
 
DISCUSSION 
 
Discrepancies in findings 
 
The treatment for rib fracture pain has not been standardized; not just mode (e.g., 
oral, IV, epidural, etc.), but location (e.g., lumbar vs. thoracic epidural).7 This might be a 
consequence of discrepant findings in the literature, in which some studies do not find 
enhanced outcomes with TEA use. One explanation for the reduced success in many of 
the studies comparing TEA to other treatments is that the data often come from 
retrospective reviews in which patients were not randomly assigned treatments.   
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There are 10 studies that randomize patients to a treatment group: Abouhatem et 
al., 198425; Allen et al., 200998; Bulger et al., 200411; Hakim et al., 201228; Hashemzadeh 
et al., 201161; Luchette et al., 199483; Mackersie et al., 199136; Mohta et al., 200929; Moon 
et al., 199978; Shinohara et al., 1994.93 
 
There are 18 non-randomized, retrospective trials: Balci et al., 200491; Bulger et 
al., 20006; Dittmann et al., 197585; Dittmann et al., 197884; Dittmann et al., 198265; Doss 
et al., 199941; Flagel et al., 200510; Gibbons et al., 197366; Govindarajan et al., 200239; 
Johnston et al., 198099; Kieninger et al., 200596; Kim et al., 201197; Ullman et al., 198989; 
Waqar et al., 20139; Wisner, 199082; Worthley, 198530; Wu et al., 19997; Yeh et al., 
2012.8 
 
Pierre et al.’s 2005 poster presentation94 never mentions whether the study was 
prospective or retrospective or assignment based on patient-specific criteria. Studies not 
in the English language have been omitted from these lists. 
 
When treatment is not randomly assigned, the criteria for assignment is often 
based on injury severity (and sometimes age), with the more severe cases and older 
patients more commonly receiving epidural catheters.6,7 For example, Flagel et al.10 
found use of epidural analgesia to increase by 50% among patients who fracture 6 or 
more ribs (compared to patients who fracture 5 or fewer). Despite this, in Flagel et al.’s 
sample, the ISS of patients treated with epidural catheters was slightly lower (18.71 ± 
0.26) than that of patients who were not treated with epidurals (21.10 ± 0.06). In the 2012 
study by Yeh et al.8, the 34 patients who received TEA (73.9% male, 48.8 ± 18.4 yr, ISS 
= 23.1 ± 9.3) were older (p < .001) and had more severe injuries than those assigned 
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alternative treatments (65.6% male, 69.6 ± 10.1 yr, ISS = 21.5 ± 9.3). They fractured 
more total ribs (7.1 vs. 5.0; p < .001), had a higher incidence of bilateral rib fractures 
(32.4% vs. 15.0%; p = .026), and showed a trend of having more common upper rib 
fractures (47.1% vs. 30.1%; p = .070) and requiring more chest tube placements (55.9% 
vs. 37.9%; p=.082). Thus, when those with TEA require longer stays in the hospital 
(median of 7 vs. 5 days; p < .001) and ICU (median of 1 vs. 0 days; p = .001), it seems 
likely to be related more to injury severity than mode of treatment. Likewise, in the study 
by Waqar and colleagues (2013), patients who received TEA (75% male, 54 ± 17 yr, 6.4 
± 2.1 fractured ribs, 19% having a flail segment, ISS = 23.6 ± 10.3) were significantly 
older and had significantly more fractured ribs than patients in the IV group (76% male, 
45 ± 22 yr, 5.2 ± 2.5 fractured ribs, 13% having a flail segment, ISS = 21.0 ± 6.7). It was 
despite this severity that patients receiving thoracic epidurals had significantly shorter 
periods of time on analgesia (4.25 ± 1.2 days compared to 5.5 ± 3.2 days), and 
significantly shorter stays in the hospital (19 ± 3.1 days compared to 21 ± 4.1 days), and 
the ICU (12 ± 2.4 days compared to 14 ± 3.5 days). Similarly, in the 1999 study by Wu 
and colleagues7, patients assigned thoracic epidural treatment (52% male, 56 ± 17 yr, 5.6 
± 2.1 fractured ribs) were significantly older and had significantly more fractured ribs 
than the patients who were assigned IV treatment (51% male, 45 ± 22 yr, 4.4 ± 1.5 
fractured ribs). 
 
Additionally, the methods of catheterization are not always described, so one 
cannot know how differences in administration technique might impact outcomes. 
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There are 11 studies that describe the methods of catheterization thoroughly: 
Abouhatem et al., 198425; Dittmann et al., 197585; Govindarajan et al., 200239; Hakim et 
al., 201228; Luchette et al., 199483; Mohta et al., 200929; Moon et al., 199978; Shinohara et 
al., 199493; Ullman et al., 198989; Worthley, 198530; Wu et al., 1999.7 
 
There are 16 studies in which the methods of catheterization are either absent or 
incompletely described: Allen et al., 200998; Bulger et al., 20006; Bulger et al., 200411; 
Dittmann et al., 198265; Doss et al., 199941; Flagel et al., 200510; Gibbons et al., 197366; 
Hashemzadeh et al., 201161; Johnston et al., 198099; Kieninger et al., 200596; Kim et al., 
201197; Mackersie et al., 199136; Pierre et al., 200594; Waqar et al., 20139; Wisner et al., 
199082; Yeh et al., 2012.8 
 
Dittmann et al.’s 1978 study84 provides minimal detail concerning methods, but 
cite their 1975 paper85 (of which the present study is merely an expansion of that study’s 
dataset) for further methodological instruction. However, in the brief details they do 
provide (namely bupivacaine concentration), the methods between the two papers are 
incongruent. Balci et al.91 do not discuss catheterization methods, but they only discuss 
methods of analgesia briefly as a tertiary outcome. Studies not in the English language 
have been omitted from these lists. 
 
Lastly, confounding variables such as age are often, but not always accounted for 
(the effect of age is illustrated under the mortality heading on page 6). Among the studies 
evaluating TEA outcomes in English, 2 failed to report age41,66 and other researchers, 
such as Hashemzadeh and colleagues61, claim age to be insignificant despite large-scale 
differences (Hashemzadeh et al.’s groups had differences of 20 years; p = .19). 
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Summary of evidence 
 
To date, 16 studies have shown TEA to be effective at improving treatment 
outcomes in patients with rib fractures; 8 of these involved a comparison group. 
Opposing these findings, 10 studies have reported either poorer outcomes or comparable 
outcomes associated with TEA use; 2 of these were not designed to evaluate the efficacy 
of TEA. Thus, out of all studies with methods sufficient to answer this question, 8 have 
supported the use of TEA against alternative treatments and 8 have failed to show a 
benefit of TEA.  
 
Owing to the complexity of administration, TEA may put the patient at a slightly 
elevated risk of treatment-associated complications such as dural puncture, epidural 
infection, abscesses in the epidural space, and hematoma. Nausea, vomiting, and 
hypotension have also been seen. 
 
Limitations 
 
Much of the available literature either evaluates the NTDB or quantifies groups of 
patients from individual hospitals. Little of this work controls for influential variables 
such as injury severity; less of it randomizes the treatment options. In general, greater 
injury severity associates with more likely use of TEA. Groups are analyzed accordingly 
and described incompletely. 
 
Conclusions 
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Based on limited evidence, TEA may associate with benefits in mortality rate 
among patients with multiple fractured ribs. As a first step, more hospitals should 
quantify their data registries, controlling for injury severity (particularly number of 
fractured ribs, presence of flail segment, and injury severity score), and evaluate the 
effectiveness and safety of TEA among patients with rib fractures. 
 
Disclaimers 
 
This study is associated with no source of funding. It is a collaboration between 
the University of Connecticut, Sum Integral in Chicago, and St. Vincent Hospital in 
Indianapolis. 
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Chapter 3: The efficacy of thoracic epidural analgesia in the treatment 
of rib fractures 
 
ABSTRACT 
 
300,000 patients with rib fractures are admitted to U.S. trauma centers each year. The 
mortality rate among these patients may be as high as 10%, but risk varies depending on 
the age of the patient and severity of the injury. Pain management is crucial to successful 
treatment outcomes. Thoracic epidural analgesia (TEA) is one type of pain management. 
The purpose of this investigation was to assess the impact of TEA on treatment outcomes 
among rib fracture patients, and determine whether more frequent use may be indicated. 
Methods: We retrospectively analyzed the registry of an ACS-verified Level II trauma 
center. All patients admitted with ≥ 1 rib fracture (n=1,008) were evaluated; 195 of them 
received TEA. The primary outcome was mortality. Secondary outcomes were incidence 
of complications, the use of mechanical ventilation, and the length of stay (LOS) in the 
hospital and intensive care unit (ICU). Additional data include patient demographics and 
the mechanism and severity of injuries. Results: The overall mortality rate was 6.1%; the 
incidence of pneumonia was 12.2%; mechanical ventilation was required in 23.3% of 
patients for an average duration of 9.1 days; the average LOS in the hospital was 7.5 
nights; 51.2% of patients were admitted to the ICU with an average LOS of 6.7 nights. 
TEA was administered to 19.3% of all patients (~10 times the national average). The 
patients who received TEA had more severe injuries: 2.3 more fractured ribs (p<0.001), 
4.7 times the incidence of flail segments (p<0.001), 1.6 times the incidence of 
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pneumothoraces (p<0.001), 1.4 times the incidence of pulmonary contusions (p=0.016), 
and 1.4 times the incidence of bilateral fractures (p=0.042). Despite the differences in 
injury severity, patients who did not receive TEA were 7 times more likely to die 
(p<0.001). After eliminating patients who were not candidates for TEA, the use of TEA 
continued to improve mortality outcomes. Conclusion: TEA appears to reduce the risk of 
mortality in patients with rib fractures but it remains uncommonly used in most hospital 
settings. Better care of this population might be facilitated by the implementation of a 
dedicated anesthesia/pain service that permits greater reliance on TEA. 
 
 
INTRODUCTION 
 
Rib fractures are the most common injury in blunt thoracic trauma.1,2,49 Rib fractures are 
reported to be present in 7% to 10% of all patients admitted to U.S. trauma centers2,10,113 
but the true incidence might be even higher as some fractures likely go undetected at 
admission.5,49 In total, it is estimated that nearly 300,000 patients with rib fractures are 
admitted to U.S. hospitals each year.4 The most common cause of this injury is motor 
vehicle collisions while falls account for about 25% of the incidence.6,26,27,57 
 
Depending on the age of the patient and the severity of the injury, there is a high 
risk of morbidity and mortality. Among people who fracture 3 or more ribs, these risks 
increase as a consequence of pain-induced changes in breathing mechanics.11,35,36,38-40 
Painful breathing can impair a patient’s ability to clear airway secretions by coughing, 
resulting in the retention of sputum.11,37-39 In turn, this elevates the risk of atelectasis, 
pneumonia, and ultimately respiratory failure and the need for ventilatory support.38,41 In 
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many cases, the pain a patient experiences following an injury is more harmful than the 
injury itself.10,19,37 Thus, effective pain management is vital to the success of the 
treatment.41,46,47  
 
There are numerous modes of pain control. Patients who present with 1 or 2 
fractured ribs are usually treated with oral analgesic drugs (NSAIDs, acetaminophen, or 
hydrocodone)47 and have a low risk of complications and mortality.1,10 If pain relief is 
inadequate, other systemic modes of pain control may be administered, such as 
intravenous (IV) morphine or dilaudid.47 In the presence of 3 or more fractured ribs, 
however, systemic drugs might not be sufficient. As the number of fractures increases, so 
does the likelihood that regional modes of analgesia will become the primary 
treatment.10,47 Regional analgesia comes in a variety of forms, including intercostal nerve 
block, intrapleural nerve block, thoracic paravertebral block, and thoracic epidural 
analgesia (TEA).37,47  
 
The purposes of this study were 1) to describe the characteristics of patients 
admitted to a Level II trauma center with one or more fractured ribs, 2) to investigate the 
effectiveness of TEA in reducing mortality, incidence of pulmonary complications, use of 
mechanical ventilation, and duration of stay in the hospital and ICU, and 3) to examine 
the relationships between patient age, the number of fractured ribs, the presence of 
bilateral fractures, injury severity score (ISS), the incidence of associated injuries (flail 
segment, pulmonary contusion, pneumothorax, and hemothorax), and mortality to 
provide perspective on the complexities of managing patients with fractured ribs.    
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Setting, Care Structure, and Review of Literature 
 
St. Vincent Trauma Center 
 
Ascension Health is a non-profit network of Catholic health facilities operating in 
the United States. In addition to being the largest Catholic health system in the U.S., it is 
also the largest non-profit health system. With more than 70 hospitals in 23 states and an 
annual operating revenue exceeding $17 billion, it is more than twice the size of its 
runner up.157-159 St. Vincent Health is one of many members of Ascension Health, and 
currently operates 22 hospitals and health facilities in the state of Indiana.160 The flagship 
hospital of this group is St. Vincent Hospital in Indianapolis. 
 
Although St. Vincent Hospital was founded in 1881 (then known as the St. 
Vincent Infirmary), the trauma center was not complete until November 2010. Since 
then, it has been open 24 hours/day, every day of the year, with 16 beds and StatFlight 
and StatGround transportation support. It is currently a Level II trauma center, certified 
by the American College of Surgeons (ACS), treating patients in an urban-suburban 
setting. 
 
History of rib fracture care at St Vincent’s – The patients 
 
The first patient admitted to the St. Vincent Trauma Center (on November 5, 
2010) was a 44-year-old male who sustained 7 unilateral rib fractures with a flail segment 
in a fall. He had an injury severity score (ISS) of 17 and presented with a pulmonary 
contusion and pneumothorax. He received TEA, spent 4 nights in the intensive care unit 
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(ICU), and 7 in the hospital. He was never intubated and experienced no pulmonary 
complications. 
 
Since the successful discharge of that patient, St. Vincent Trauma Center has 
treated about 250 patients with rib fractures each year; a total of 1,008 since opening. The 
range of injury severity in these patients is broad. While many arrive with a single rib 
fractured, one patient, a 27-year-old male, fractured all 24 ribs in an automotive accident. 
He died before treatment could be administered. 
 
The administration of TEA at St. Vincent Trauma Center 
 
A unique feature of St. Vincent’s treatment model is Anesthesia Pain Service 
(APS). APS is a care team that includes dedicated anesthesiologists and nurses who are 
trained in pain management. Although the anesthesiologists are only available to place 
epidurals during the daytime hours, once installed, the nurses provide 24/7 patient 
coverage, monitoring pain levels and adjusting medication doses as necessary. If 
complications arise during the nighttime hours, the anesthesiologists are available for 
consultation by telephone. 
 
Although this model increases the likelihood of TEA administration, not all 
patients are candidates. The decision to request an APS consultation is complex. 
Characteristics that increase the likelihood are: a greater number of rib fractures, the 
presence of flail chest, bilateral fractures, and a subjective pain level that interferes with 
respiratory excursions and the patients’ ability to cough and clear secretions.  
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Among patients with less severe injuries, the initial treatment is typically IV 
narcotics or a combination of IV and oral narcotics. If that does not provide sufficient 
relief, an APS consultation will be requested. The time of day that a patient is admitted 
will also affect epidural placement, as APS is only in house during the day (and on the 
weekends, they may only be available in the mornings). Thus, if a patient is admitted in 
the morning, and is likely to benefit from an epidural, then TEA may be the first line of 
treatment. If the same patient were to be admitted in the evening, an alternative pain 
medication is often attempted first and pain levels are reevaluated the following morning. 
At that time, if pain control is inadequate, an APS consultation will be scheduled. 
 
Mortality and morbidity associated with rib fracture 
 
The mortality rate among patients with rib fractures is approximately 10%2,3,5,10 
although some smaller studies have reported more favorable odds of survival. In 2003, a 
Turkish hospital published a 2-year mortality rate of 5.7%.58 However, 31% of the 
patients in this sample were children and adolescents, age 5–17, and none of them died. 
Conversely, the mortality rate among adults was 8.2%. More recently, a 
“multidisciplinary clinical pathway” has been used as a highly aggressive approach to 
reduce mortality. Among patients age 45 years or older who sustain 4 or more fractured 
ribs, the default treatment involves physical therapy, respiratory therapy, nutrition 
services, and multiple modes of pain management (oral, IV, and TEA). In one study, this 
combination of treatments reduced mortality from 13% to 4%.59 This approach is both 
extensive and expensive. While it might be worth the cost, follow-up studies have yet to 
validate efficacy or assess the individual contribution of each therapeutic component. 
 119 
 
Pulmonary complications (e.g., pneumonia, aspiration pneumonia, empyema, pulmonary 
embolism, pneumothorax, and respiratory distress syndrome) can be expected to arise in 
nearly half of all patients who fracture at least 1 rib.10 With each additional rib fractured, 
these risks increase.6,10 Pneumonia is a commonly reported complication but incidence 
varies broadly depending on the patients’ age and injury characteristics.10,46 Bulger et al.6 
found pneumonia in 17% of younger patients and 31% of elderly patients.  
 
Previous reports suggest about 60% of rib fracture patients require mechanical 
ventilation for a mean duration of 13 days; the severity of injury predicts both need for 
ventilation and the duration of use.10 On average, rib fracture patients spend 7 to 16 
nights in the hospital and about 44% are admitted to the ICU, where they remain for 4 to 
8 nights; a greater number of fractures corresponds to a longer length of stay (LOS).2,5,10 
 
Research on the effectiveness of TEA 
 
I found 16 studies reporting epidural analgesia to be effective at treating patients 
with rib fractures.9,10,25,30,39,41,61,65,66,82-85,89,94,99 Five studies did not include a comparison 
group25,30,39,41,99, 3 compared epidural analgesia to mechanical ventilation65,84,85, 4 
compared epidural analgesia to IV treatments9,82,89,94, and the remaining 4 compared 
epidural analgesia to other regional techniques.10,61,66,83  
 
Conversely, 10 studies did not find epidural analgesia to be a superior treatment 
for patients with rib fractures. 6-8,11,29,36,78,91,93,96 Two of these were not designed to 
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evaluate the efficacy of epidural analgesia6,91, 6 compared epidural analgesia to IV 
treatments7,8,11,36,78,96, and 2 compared epidural analgesia to other regional techniques.29,93 
 
Among all 26 studies, 4 reported that epidural analgesia reduced mortality 
compared to an alternative treatment6,10,65,82, no study found epidural analgesia to 
increase the risk of mortality, and 8 studies reported no difference between epidural 
analgesia and an alternative treatment.7,9,11,29,66,85,93,96 The incidence of pneumonia was 
reported to be lower in patients treated with epidural analgesia in 2 studies11,82 and higher 
in 1.6 Six studies reported no difference in rates of pneumonia between patients receiving 
epidural analgesia and those receiving an alternative treatment.7,9,10,29,36,93 Six studies 
reported that epidural analgesia shortened the duration of care in an ICU when compared 
to an alternative treatment9,61,65,84,89,94, 2 reported longer stays for patients receiving 
epidural analgesia6,8, and 4 studies reported no differences.7,11,29,78 Four studies found 
epidural analgesia to shorten the length of hospitalization compared to an alternative 
treatment9,65,89,94, 3 studies found longer stays for patients receiving epidural 
analgesia6,8,96, and 5 studies found no differences.7,11,29,36,78 
 
 
METHODS 
 
The current study is a retrospective analysis of a trauma registry from an ACS-
verified Level II trauma center. It was approved by the hospital’s institutional review 
board (IRB) and by the IRB of a collaborating university.  
 
We examined all patients who were admitted with 1 or more rib fractures, 
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comparing the treatment outcomes of those who received TEA with those who did not 
receive TEA. 
 
Data acquisition and management 
 
All data were exported from the hospital’s trauma registry. The documented ICD9 
codes were compared with written descriptions of each patient’s injuries to determine 
which patients sustained rib fractures, how many ribs were fractured, whether the injuries 
were unilateral or bilateral, and the presence of associated injuries such as flail segments 
and pulmonary contusions. These data were compiled with demographic records, vital 
signs and cardiorespiratory markers, methods of treatment, and treatment outcomes into a 
single database. Where data only existed in written reports (e.g., mechanism of injury, 
which medications were used), entries were assigned nominal values. Where the timing 
of treatment was important (e.g., anticoagulation, intubation), data were extracted by 
comparing time stamps on the procedure codes. 
 
Outcomes 
 
The primary outcome was patient mortality. Secondary outcomes were incidence 
of pulmonary complications, the use of mechanical ventilation, and the duration of stay in 
the hospital and ICU. Additional data reported include patient demographics and the 
mechanism and severity of injuries sustained.  
 
Data are reported across the whole sample and across matched samples. 
 
Matching samples 
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To assess effectiveness, we 
eliminated patients who were not 
candidates for TEA. In doing so, we 
attempted to compare outcomes of 
patients who received TEA to those 
who could have been treated with 
TEA but were not.  
 
We combed the patient 
records to identify 3 groups: 1) 
patients who received TEA, 2) 
patients who were not candidates for 
TEA, and 3) patients who were 
candidates for TEA but received 
alternative treatments. We then 
compared groups 1 and 3. 
 
Criteria for TEA administration 
 
Contraindications for the use 
of TEA include anticoagulation prior 
to treatment and intubation upon 
arrival. 
 
Decision tree for TEA administration 
Patient is admitted to trauma center 
Presents with at least 2 fractured ribs 
Rib fractures are bilateral 
Presence of flail chest 
No contraindications to epidural (e.g., 
anticoagulated or already intubated) 
Clinical assessment: pain level, interference 
with respiratory excursion, ability to 
cough/clear secretions 
Possible failure of other methods of pain 
control 
Patient agrees to epidural catheter use 
APS consultation 
APS agrees placement is indicated and would 
be beneficial 
Epidural catheter is placed 
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Anticoagulation medications such as Coumadin and Plavix increase the risk of 
atrial fibrillation and the likelihood of bleeding into the epidural space, thus elevating the 
patients’ risk of spinal cord compression and paralysis. However, delivery of 
anticoagulation commonly follows TEA to reduce the risk of clotting, elevated by long 
hours spent lying in bed. 
 
Early intubation and ventilatory support are often administered in more severely 
injured patients, but those patients are not usually treated with TEA. Instead, their pain 
can be managed with high doses of narcotics. However, some patients who are intubated 
for a short time do receive epidurals immediately after extubation to optimize pain 
control and their ability to cough and breathe deeply. 
 
Finally, some patients succumbed to their injuries before treatment with TEA 
could be considered. To better match the characteristics of patients who received TEA 
with those who did not, these patients were also excluded from comparison. 
 
To summarize, when matching important characteristics of the patients treated 
with TEA to those who were candidates for TEA but treated with other forms of pain 
management, we eliminated the patient record if: 1) the patient died within 24 hours of 
arrival, 2) the patient was intubated upon arrival or within 12 hours of admission, or 3) 
the patient was on anticoagulation medication prior to treatment. 
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 During the 4-year study period, a total of 
10,242 patients were admitted to St. Vincent 
Trauma Center; 1,008 of these patients had rib 
fractures. After eliminating patients who met 
exclusionary criteria for the use of TEA, 721 
patients with rib fractures remained in the 
database. 
 
Data analyses 
 
Dichotomous data (e.g., mortality, 
presence of complications, use of mechanical 
ventilation) were analyzed with binary logistic 
regression. Discrete data (e.g., number of days in 
the ICU and hospital, days on mechanical 
ventilation, ISS) were analyzed with linear 
regression. Group means (TEA vs. non-TEA and 
survival vs. mortality) were compared with 
independent samples t-tests; wherever Levene’s 
test for equality of variances was significant, 
equal variances were not assumed. Categorical 
variables were compared with chi-square tests. 
All analyses were first conducted on the total 
samples. Patients who met the exclusionary 
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criteria were then eliminated and all analyses were repeated. 
 
All statistical tests were conducted using SPSS version 22 (IBM SPSS Statistics, 
IBM Corporation, Chicago, IL). 
 
 
RESULTS 
 
Patient characteristics across the total sample (n=1,008) 
 
Two-thirds of the patients were male, 92% were white, and their ages ranged 
across the lifespan, from 15 to 98 years. On average, patients were middle aged (55.3 ± 
20.3 yrs), but the distribution was broad (Figure 3.1). 
 
Figure 3.1: Patient ages by decade 
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The most common causes of injury were automotive accidents (37.6%), falls (32.9%), 
and motorcycle accidents (13.7%). The remaining 15.8% of patients were injured during 
a variety of activities – in order of most to least frequent: bicycle accidents, ATV 
accidents, firearm/bullet injuries, assault, struck by an object (e.g., baseball, jack stand), 
pedestrian struck by a car, animal-related injuries (e.g., fall, bite, kick, gore, trample), 
other motor vehicle accidents (e.g., golf carts, snowmobiles), heavy machinery accidents 
(e.g., mining, earth-drilling), and pedestrian struck by a train. There were no significant 
relationships between mode of injury and use of TEA (p=0.717) or survival (p=0.204).  
 
On average, across all modes of injury, patients fractured about 4 ribs, but the 
range was broad, from a single rib to all 24 (mode=1; median=3). The frequency of rib 
fracture counts is displayed in Figure 3.2. 
 
Figure 3.2: Frequency of rib fracture counts 
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Men and women differed in both age and number of ribs fractured. On average, 
men were younger (52.4 ± 18.5 vs. 60.9 ± 22.3 yrs; p<0.001) and fractured more ribs (4.0 
± 3.1 vs. 3.7 ± 2.5; p=0.049). Men also had a higher ISS (16.7 ± 10.3 vs. 15.1 ± 10.7; 
p=0.018) and a higher incidence of flail segments (7.5% vs. 4.1%; p=0.036). Despite 
being younger, men were more likely to experience pneumonia (14.0% vs. 8.8%; 
p=0.018), require mechanical ventilation (26.3% vs. 17.5%; p=0.002), and be intubated 
within 12 hours of admission (22.3% vs. 15.5%; p=0.011) owing to the extent of their 
injuries. More men were also admitted to the ICU (54.4% vs. 44.9%; p=0.004), although 
there was no difference in LOS between men and women who were admitted (6.9 ± 8.5 
vs. 6.2 ± 7.5 days; p=0.328).  
 
It’s possible that the differences in the severity of injury are at least partly related 
to differences in the mode of injury between men and women (p<0.001), as depicted in 
Figure 3.3. 
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Figure 3.3: Mode of injury among men versus women. 
 
The greater severity of injuries suffered by men may have resulted in a higher 
mortality rate (6.9% vs. 4.4%; p=0.116) although a larger sample is needed to confirm 
this observation. There were no differences between men in women in the proportion 
treated with TEA (19.5% vs. 19.1%; p=0.871). 
 
Overall, TEA was administered much more frequently at St Vincent compared to 
other hospitals. Based upon reports from the National Trauma Data Bank (NTDB), 
patients who presented with rib fractures at St. Vincent were almost 10 times more likely 
to receive TEA10 and patients with flail segments were 7 times more likely to receive 
TEA.26 Figure 3.4 compares St. Vincent’s use of TEA to published NTDB reports among 
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all patients who sustained rib fractures and among patients who presented with flail 
segments. 
 
Figure 3.4: Use of TEA among patients with rib fractures and those with flail segments 
 
At St. Vincent Trauma Center, nearly 20% of all patients admitted with rib 
fractures received TEA and more than half of all patients with flail segments received 
TEA.  
 
There were numerous differences in injury severity between those who received 
TEA and those who did not (Table 3.1). 
 
Table 3.1: Demographics and injury characteristics 
 Non-TEA TEA Total Sample Significance 
N 813 195 1008  
Sex 66.1% male 66.6% male 66.2% male p = 0.871 
Age (years) 54.9 ± 20.7 56.9 ± 18.4 55.3 ± 20.3 p = 0.197 
# Ribs Fractured 3.5 ± 2.8 5.8 ± 2.7 3.9 ± 2.9 p < 0.001 
Injury Severity Score 16.1 ± 10.9 16.5 ± 8.2 16.1 ± 10.4 p = 0.492 
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% Flail Segment 3.7% 17.4% 6.4% p < 0.001 
% Bilateral Fracture 13.3% 18.5% 14.7% p = 0.042 
% Pulmonary Contusion 18.5% 26.2% 20.0% p = 0.016 
% Pneumothorax 18.6% 30.3% 20.9% p < 0.001 
% Hemothorax 5.5% 5.6% 5.6% p = 0.957 
% Hemopneumothorax 5.2% 7.2% 5.6% p = 0.272 
Pulse (scene) 91.8 ± 23.6 92.5 ± 18.6 91.9 ± 22.8 p = 0.763 
Pulse (hospital) 89.4 ± 22.9 90.3 ± 19.8 89.5 ± 22.3 p = 0.602 
Respiratory rate (scene) 17.6 ± 6.0 19.6 ± 6.5 18.0 ± 6.2 p = 0.008 
Respiratory rate (hospital) 18.0 ± 6.0 19.1 ± 4.9 18.2 ± 5.8 p = 0.018 
SBP (scene) 132.1 ± 34.5 132.9 ± 28.5 132.2 ± 33.4 p = 0.825 
SBP (hospital) 129.8 ± 31.9 136.5 ± 25.6 131.1 ± 30.9 p = 0.007 
DBP (scene) 80.2 ± 17.3 80.9 ± 16.6 80.4 ± 17.1 p = 0.749 
DBP (hospital) 80.3 ± 17.1 82.1 ± 16.3 80.6 ± 17.0 p = 0.169 
Glasgow Coma Score (scene) 12.7 ± 4.2 14.3 ± 2.3 13.0 ± 4.0 p < 0.001 
Glasgow Coma Score (hospital) 12.8 ± 4.5 14.4 ± 2.3 13.1 ± 4.2 p < 0.001 
 
 
Patients receiving TEA presented with 2.3 more fractured ribs, had 4.7 times the 
incidence of flail segments, 1.6 times the incidence of pneumothorax, 1.4 times the 
incidence of pulmonary contusions, and 1.4 times the incidence of bilateral fractures.  
 
At the scene of the accident, TEA and non-TEA patients were similar in pulse, 
systolic blood pressure (SBP) and diastolic blood pressure (DBP), but patients receiving 
TEA presented with a higher respiratory rate and Glascow Coma Score (GCS). Upon 
arrival at the hospital, pulse and DBP remained similar, but SBP was higher in patients 
treated with TEA. Respiratory rate and GCS also remained higher in TEA patients. These 
differences however are small and unlikely of clinical importance.  
 
Treatment outcomes across the total sample (n=1,008) 
 
Despite similar complication rates between groups, patients who did not receive 
TEA were 7 times more likely to die than patients who were treated with TEA (Table 
3.2). 
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Table 3.2: Mortality, complications, and treatment outcomes 
 Non-TEA TEA Total Sample Significance 
Mortality 7.2% 1.0% 6.1% p = 0.001 
Pneumonia 11.4% 15.4% 12.2% p = 0.132 
Sepsis 0.9% 0.5% 0.8% p = 0.623 
Respiratory Distress 2.1% 1.5% 2.0% p = 0.619 
Respiratory Failure 1.8% 3.1% 2.1% p = 0.279 
LOS in the Hospital (days) 7.2 ± 8.7 8.7 ± 5.8 7.5 ± 8.2 p = 0.006 
% Admitted to ICU 48.2% 63.6% 51.2% p < 0.001 
LOS in the ICU (days) 7.0 ± 8.6 5.8 ± 6.7 6.7 ± 8.2 p = 0.110 
% Needing Ventilation 24.4% 18.5% 23.3% p = 0.075 
Ventilation duration (days) 9.0 ± 9.0 9.6 ± 8.1 9.1 ± 8.8 p = 0.689 
 
 
There were no differences between patients who received TEA and those who did 
not in complication rates. There was a trend that patients who did not receive TEA were 
32% more likely to need mechanical ventilation, possibly owing to failure of the 
treatment. Conversely, the patients receiving TEA were 32% more likely to be admitted 
to the ICU, possibly owing to the increased severity of their injuries. Despite more 
frequent admissions to the ICU, among those admitted, there was no significant 
difference in LOS between patients who received TEA (5.8 days) and those who did not 
(7.0 days). Patients receiving TEA did spend an additional 1.5 days in the hospital, 
however. 
 
Relationships with mortality across the total sample (n=1,008) 
 
Differences in demographics, injury characteristics, and treatment outcomes 
between the patients who survived and the patients who died are characterized in Tables 
3.3 and 3.4. 
 
Table 3.3: Demographics, injury characteristics, and treatment outcomes of survivors 
and non-survivors 
 Survivors Non-Survivors Total Sample Significance 
N 947 61 1008  
Sex 65.6% male 75.4% male 66.2% male p = 0.116 
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Age (years) 55.0 ± 20.1 59.4 ± 22.3 55.3 ± 20.3 p = 0.102 
# Ribs Fractured 3.8 ± 2.8 6.0 ± 4.4 3.9 ± 2.9 p < 0.001 
Injury Severity Score 15.3 ± 9.5 28.6 ± 15.8 16.1 ± 10.4 p < 0.001 
% Flail Segment 5.9% 13.1% 6.4% p = 0.026 
% Bilateral Fracture 13.3% 29.5% 14.7% p = 0.001 
% Pulmonary Contusion 19.0% 34.4% 20.0% p = 0.004 
% Pneumothorax 21.0% 18.0% 20.9% p = 0.576 
% Hemothorax 4.4% 23.0% 5.6% p < 0.001 
% Hemopneumothorax 5.5% 6.6% 5.6% p = 0.726 
Pulse (scene) 92.0 ± 20.9 91.3 ± 38.4 91.9 ± 22.8 p = 0.910 
Pulse (hospital) 90.0 ± 20.6 81.5 ± 40.4 89.5 ± 22.3 p = 0.120 
Respiratory rate (scene) 18.3 ± 5.3 14.3 ± 11.9 18.0 ± 6.2 p = 0.052 
Respiratory rate (hospital) 18.5 ± 5.4 13.7 ± 9.5 18.2 ± 5.8 p = 0.001 
SBP (scene) 134.3 ± 29.0 106.8 ±61.8 132.2 ± 33.4 p = 0.010 
SBP (hospital) 133.3 ± 27.8 96.2 ± 50.5 131.1 ± 30.9 p < 0.001 
DBP (scene) 80.0 ± 16.9 87.3 ± 19.9 80.4 ± 17.1 p = 0.081 
DBP (hospital) 81.3 ± 16.5 67.7 ± 20.0 80.6 ± 17.0 p < 0.001 
Glasgow Coma Score (scene) 13.6 ± 3.3 7.3 ± 5.6 13.0 ± 4.0 p < 0.001 
Glasgow Coma Score (hospital) 13.6 ± 3.6 6.0 ± 4.9 13.1 ± 4.2 p < 0.001 
Pneumonia 12.1% 13.1% 12.2% p = 0.825 
Sepsis 0.7% 1.6% 0.8% p = 0.443 
Respiratory Distress 1.9% 3.3% 2.0% p = 0.454 
Respiratory Failure 1.6% 9.8% 2.1% p < 0.001 
LOS in the Hospital (days) 7.7 ± 8.3 4.4 ± 6.3 7.5 ± 8.2 p = 0.003 
% Admitted to ICU 50.3% 65.6% 51.2% p = 0.020 
LOS in the ICU (days) 6.8 ± 8.4 5.1 ± 5.6 6.7 ± 8.2 p = 0.079 
% Needing Ventilation 20.4% 67.2% 23.3% p < 0.001 
Ventilation duration (days) 10.1 ± 9.1 4.1 ± 4.9 9.1 ± 8.8 p < 0.001 
 
On average, patients who died fractured 2.2 more ribs, were 2.2 times more likely 
to experience bilateral fractures, and 2.2 times more likely to present with a flail segment. 
They also had a greater incidence of both pulmonary contusions (34.4% vs. 19.0%) and 
hemothorax (23.0% vs. 4.4%), their ISS was 13.3 points higher, and they had less stable 
vital signs at the scene of the accident and at the hospital.  
 
Patients who died had a higher risk of respiratory failure (9.8% vs. 1.8%) but 
otherwise did not exhibit a greater risk of complications. Survivors were less likely to 
require mechanical ventilation (20.4% vs. 67.2%) but if ventilated, the duration was 6.0 
days longer. The survivors also stayed 3.3 additional days in the hospital, and if admitted 
to the ICU, showed a trend of staying an additional 1.7 days. 
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Table 3.4: Demographics, injury characteristics, and treatment outcomes of survivors 
and non-survivors who did and did not receive TEA 
 TEA Mort. TEA Survived No TEA Mort. No TEA Survived 
N 2 193 59 754 
Sex 100% male 66.3% male 74.6% male 65.4% male 
Age (years) 83.0 ± 4.2 56.7 ± 18.3 58.6 ± 22.3 54.6 ± 20.5 
# Ribs Fractured 7.0 ± 0 5.8 ± 2.7 6.0 ± 4.5 3.3 ± 2.5 
Injury Severity Score 13.5 ± 5.0 16.6 ± 8.2 29.1 ± 15.8 15.0 ± 9.8 
% Flail Segment 0% 17.6% 13.6% 2.9% 
% Bilateral Fracture 0% 18.7% 30.5% 11.9% 
% Pulmonary Contusion 0% 26.4% 35.6% 17.1% 
% Pneumothorax 0% 30.6% 18.6% 18.6% 
% Hemothorax 0% 5.7% 23.7% 4.1% 
% Hemopneumothorax 0% 7.3% 6.8% 5.0% 
Pulse (scene) No data 92.5 ± 18.9 91.2 ± 38.4 91.8 ± 21.4 
Pulse (hospital) 65.0 ± 1.4 90.6 ± 19.8 82.1 ± 41.0 89.9 ± 20.8 
Respiratory rate (scene) No data 19.6 ± 6.5 14.3 ± 11.9 17.9 ± 4.9 
Respiratory rate (hospital) 22.5 ± 9.2 19.1 ± 4.9 13.4 ± 9.4 18.4 ± 5.6 
SBP (scene) No data 132.9 ± 28.5 106.8 ± 61.8 134.7 ± 29.1 
SBP (hospital) 134.0 ± 1.4 136.5 ± 25.8 94.8 ± 50.8 132.5 ± 28.2 
DBP (scene) No data 80.9 ± 16.6 87.3 ± 19.9 79.7 ± 17.0 
DBP (hospital) 68.5 ± 5.0 82.3 ± 16.3 67.7 ± 20.5 81.0 ± 16.6 
Glasgow Coma Score (scene) No data 14.3 ± 2.3 7.3 ± 5.6 13.4 ± 3.5 
Glasgow Coma Score (hospital) 9.0 ± 0.0 14.4 ± 2.2 6.0 ± 5.0 13.3 ± 3.9 
% Pneumonia 100% 14.5% 10.1% 11.5% 
% Sepsis 50% 0% 0% 0.9% 
% Respiratory Distress 50% 1.0% 1.7% 2.1% 
% Respiratory Failure 50% 2.6% 8.5% 1.3% 
LOS in Hospital (days) 12.5 ± 16.3 8.6 ± 5.7 4.1 ± 5.9 7.5 ± 8.9 
% Admitted to ICU 100% 63.2% 64.4% 46.9% 
LOS in ICU (days) 12.0 ± 15.6 5.7 ± 6.5 4.7 ± 4.9 7.2 ± 8.9 
% Needing Ventilation 50% 18.1% 67.8% 21.0% 
Vent duration (days) 15 ± 0.0 9.5 ± 8.1 3.9 ± 4.7 10.3 ± 9.3 
 
 
Patients who received TEA and survived (n=193) were the same age (p=0.508) 
and fractured the same number of ribs (p=0.749) as the patients who did not receive TEA 
and died (n=59). However, the ISS of survivors who received TEA was 12.5 points lower 
than the ISS of those who did not receive TEA and died (p<0.001). Although there was 
no difference in the incidence of flail segments (p=0.464), there was a trend for survivors 
who received TEA to present with fewer bilateral fractures (p=0.070). Survivors who 
received TEA also exhibited a trend for more frequent pneumothorax (p=0.073) while the 
patients who did not receive TEA and died had a greater incidence of hemothorax 
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(p<0.001). 
 
At the scene of the accident, the respiratory rate of survivors who received TEA 
was higher (p<0.001) and this difference was preserved upon arrival at the hospital 
(p<0.001). There were no differences in pulse at the site of the injury (p=0.850) or upon 
arrival at the hospital (p=0.145). SBP of survivors who received TEA was higher at the 
scene of the accident (p=0.016) and this difference was exacerbated upon arrival at the 
hospital (p<0.001). Although there was no difference in DBP at the scene of the accident 
(p=0.150), upon arrival at the hospital, survivors who received TEA had much higher 
values than patients who did not receive TEA and died (p<0.001). The GCS of survivors 
who received TEA was also higher at the scene of the accident (p<0.001) and this 
difference was exacerbated upon arrival at the hospital (p<0.001). 
 
Patients who did not receive TEA and died experienced more acute respiratory 
failure (p=0.043) than survivors who received TEA. There were no other significant 
differences in complication rates. The patients who did not receive TEA and died were 
3.7 times more likely to require mechanical ventilation (p<0.001) than the survivors who 
received TEA, although if ventilated, the survivors receiving TEA remained on it for an 
additional 5.6 days (p=0.001). There were no differences in the percentage of patients 
who were admitted to the ICU (p=0.868) or ICU LOS (p=0.404), but survivors who 
received TEA stayed in the hospital 4.5 days longer (p<0.001) than patients who did not 
receive TEA and died. 
 
Predictors of mortality across the total sample (n=1,008) 
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Unilateral vs. bilateral rib fractures: If a patient sustained bilateral fractures, the 
odds of mortality were 2.9:1 (95% CI of odds ratio: 1.6–5.1; p=0.001).  
 
Presence of a flail segment: If a patient presented with a flail segment, the odds of 
mortality were 2.4:1 (95% CI of odds ratio: 1.088–5.291; p=0.026).  
 
Number of ribs fractured: For each additional rib fractured, the odds of mortality 
were 20% greater (95% CI of odds ratio: 1.1–1.3; p<0.001). Much of this relationship 
was driven by an inflexion point at 6 fractured ribs. If a patient fractured 5 or fewer ribs, 
the risk of mortality was 3.6%; if a patient fractured 6 or more ribs, the risk of mortality 
was 12.4% (p<0.001). This inflexion point is illustrated in Figure 3.5. 
 
Figure 3.5: Mortality rate based on number of ribs fractured 
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Among patients who did not receive TEA, at 4 fractured ribs, the mortality rate 
was 3.1%, at 5 fractures, it was 8.0%, and at 6 fractures, it was 18.8%. Among patients 
who received TEA, no patient who fractured fewer than 7 ribs died and among patients 
who fractured 7 or more ribs, the mortality rate was 2.7%. By comparison, the mortality 
rate of patients who fractured a single rib and did not receive TEA was 3.4%. 
 
The number of fractured ribs remained a significant predictor of mortality in the 
presence of additional variables in the equation; however, bilateral injury status and the 
presence of a flail segment did not maintain significance in the presence of additional 
predictors.  
 
Incidence of pulmonary contusion: If a patient presented with a pulmonary 
contusion, the odds of mortality were 2.2 times greater (95% CI of odds ratio: 1.286–
3.882; p=0.004).  
 
When the number of ribs fractured and the presence of a pulmonary contusion 
were both included in the model, having a pulmonary contusion increased odds of 
mortality by about 74% (95% CI of odds ratio: .957–3.168; p=0.069) and each additional 
rib fractured increased the odds of mortality by about 18% (95% CI of odds ratio: 1.098–
1.270; p<0.001). 
 
Incidence of pneumothorax and/or hemothorax: Having a pneumothorax did not 
predict risk of mortality, but having a hemothorax did. However, with hemothorax in the 
model, pulmonary contusion is no longer a significant predictor of mortality. With 
hemothorax and number of fractured ribs in the model, both are significant (p<0.001), the 
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model accurately predicts 94.3% of deaths, and it accounts for 9.4% of the variance in 
mortality. In this model, if a patient presented with a hemothorax, the odds of mortality 
were 3.8 times greater (95% CI of odds ratio: 1.805–8.160).  
 
Injury severity score: By itself, ISS accounts for 17.2% of the variance in 
mortality (p<0.001). Each additional point of injury severity (scores range from 1 to 75) 
increased the odds of mortality by 8% (95% CI of odds ratio: 1.062–1.105). With all 3 
variables in the equation (number of fractured ribs, hemothorax, and ISS), the model 
accounts for about 22% of the variance in mortality. In this model, ISS is significant 
(p<0.001), hemothorax is significant (p=0.005), and the number of fractured ribs is 
trending (p=0.066). 
 
Vital signs: Pulse, respiratory rate, SBP, and DBP have varying levels of 
predictive power, generally sharing inverse relationships with mortality (as pulse, 
respiratory rate, and blood pressure decrease, the odds of mortality increase). 
Unfortunately, none of these variables met assumptions of normally distributed data. The 
variances are much larger than the means, the skewness and kurtosis are concerning, box-
and-whiskers plots show numerous data points far outside of the interquartile range, and 
the Kolmogorov-Smirnov test of normality (used for larger samples) is highly significant. 
In short, there is no pulse, no respiratory rate, and no blood pressure in a deceased 
patient; the correlations with survival were driven by these zeroes. 
 
Glascow Coma Scale: The GCS has three components (eye, verbal, and motor) 
that give a composite score rating a patient’s degree of consciousness. Scores range from 
3 (comatose) to 15 (normally conscious and functional). Similar to vital signs, when the 
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GCS was used to predict mortality, the strength of the relationship was in the outliers. 
 
The use of mechanical ventilation: If mechanical ventilation (dichotomous 
variable: y/n) is included in the model with ISS, number of fractured ribs, and incidence 
of hemothorax, each individual predictor is significant (p<0.05), the overall model is 
significant (p<0.001), and it accounts for 26.6% of the variance in mortality. In this 
model, if a patient received mechanical ventilation as a component of treatment, the odds 
of mortality were 4.2 times greater (95% CI of odds ratio: 2.150–8.300).  
 
Evaluating the number of days spent on mechanical ventilation is useful on its 
own, but not as a part of the predictive equation, as it reduces the sample to 230 cases 
while sharing predictive power with other variables. However, it is worth noting that, 
when evaluating ISS and duration of mechanical ventilation together, each additional day 
on mechanical ventilation reduced the odds of survival by 14% (p<0.001). Moreover, the 
two variables shared little predictive power, so this finding was not strictly a product of 
injury severity. 
 
Use of TEA: By itself, TEA explains about 4% of the variance in mortality 
(p=0.005). The administration of TEA reduced the odds of mortality by about 87% (95% 
CI of odds ratio: 0.032–0.547). This relationship may have been stronger, but the more 
ribs a patient fractured (and thus the greater odds of mortality), the greater the likelihood 
of TEA administration (Figure 3.6). 
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Figure 3.6: Use of TEA based on number of ribs fractured 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Among patients who presented with a single rib fracture, 1.9% of them received 
TEA; among patients who fractured 8 ribs, 50.0% received TEA. Many patients who 
fractured 9 or more ribs still received TEA, but an increasing number were not 
candidates, owing to conditions such as early intubation. 
 
Although there wasn’t as clear of an inflexion point with the number of fractured 
ribs and the use of TEA, there is a clear difference in administration of TEA above and 
below the inflexion point for mortality (Figure 3.7). 
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Figure 3.7: Use of TEA above and below the inflexion point of rib fractures and mortality 
 
 
 
Among patients who fracture 6 or more ribs (12.4% mortality rate), 39.0% 
received TEA; among patients who fractured 5 or fewer ribs (3.6% mortality rate), 13.2% 
received TEA (p<0.001). 
 
Age: When tested by itself, age is not a significant predictor of mortality as a 
continuous variable (p=0.101) or as a categorical variable, categorized by decade 
(p=0.122). The mortality rate across age groups is displayed in Figure 3.8. 
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Figure 3.8: Mortality rates among individual age groups 
 
There was an inflexion point at 80 years whereby patients above that age had 
more than twice the risk of mortality compared to patients age 79 and below (p=0.002). 
This inflexion point is illustrated in Figure 3.9. 
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Figure 3.9: Mortality rates above and below inflexion point of age 
 
When tested by itself, if a patient was age 80 or older, the odds of mortality were 
2.5 times greater (95% CI of odds ratio: 1.374–4.374; p=0.002).  
 
Binary logistic regression: Prediction equation for mortality across the total sample 
(n=1,008) 
 
Variables in the equation: Use of TEA, number of fractured ribs, ISS, presence of 
hemothorax, use of mechanical ventilation, and inflexion point of age. 
 
986 subjects (97.8%) had sufficient data to be included in this analysis. All 
variables maintain significance when tested individually (Table 3.6). 
 
Table 3.6: Analysis of variables when tested individually (not in the equation) 
Variable Score Degrees of Freedom Significance 
Use of TEA 9.918 1 p=0.002 
Number of fractured ribs 30.981 1 p<0.001 
Injury Severity Score 99.251 1 p<0.001 
Presence of hemothorax 23.057 1 p<0.001 
Use of mechanical ventilation 74.240 1 p<0.001 
Inflexion point of age 12.121 1 p<0.001 
Overall Statistics 168.530 6 p<0.001 
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This model elicits a Nagelkerke R2 value (a surrogate R2 for binary logistic 
regressions) of 0.375, indicating that about 38% of the variance in mortality can be 
explained by this collection of predictors. The overall model is significant (Table 3.7) and 
all predictors are significant when tested in the model (Table 3.8). 
 
 Table 3.7: Variables in the equation 
 β S.E. Wald D.F. Sig. Odds Ratio 
Constant -2.791 0.136 418.361 1 p<0.001 0.061 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
Table 3.8: Variables in the equation 
Variable β S.E. Wald D.F. Sig. Odds Ratio 
Use of TEA -2.257 0.766 8.675 1 p=0.003 0.105 
Number of fractured ribs 0.116 0.044 7.024 1 p=0.008 1.123 
Injury Severity Score 0.056 0.013 16.981 1 p<0.001 1.057 
Presence of hemothorax 1.343 0.438 9.422 1 p=0.002 3.831 
Use of mechanical ventilation 1.892 0.396 22.806 1 p<0.001 6.630 
Inflexion point of age 2.195 0.408 28.979 1 p<0.001 8.976 
Constant -5.843 0.482 146.899 1 p<0.001 0.003 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
 
In this model, use of TEA reduced the odds of mortality by almost 90% (95% CI 
of odds ratio: 0.023–0.470), each additional fractured rib increased the odds of mortality 
by 12% (95% CI of odds ratio: 1.031–1.224), each additional point of severity in the ISS 
increased the odds of mortality by 6% (95% CI of odds ratio: 1.030–1.085), the presence 
of a hemothorax increased the odds of mortality by 383% (95% CI of odds ratio: 1.625–
9.032), needing mechanical ventilation increased the odds of mortality by 663% (95% CI 
of odds ratio: 3.050–14.411), and being ≥80 years of age increased the odds of mortality 
by 898% (95% CI of odds ratio: 4.037–19.957). 
 
If age (continuous variable) is used in the place of its inflexion point 
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(dichotomous variable), it is not significant when tested on its own, but is significant in 
the full model (p=0.001). The overall model is weaker (Nagelkerke R2 is reduced from 
0.375 to 0.297), but for each additional year of age, the odds of mortality increased by 
2.6% (95% CI of odds ratio: 1.010–1.043). 
 
The presence of a flail segment is generally considered to be an important 
predictor of mortality, but it was not significant in our patient population. A probable 
explanation is its association with TEA. At St. Vincent, patients with flail segments were 
much more likely to receive TEA. Among patients who did not receive TEA, 3.7% 
presented with flail segments; among patients who received TEA, 17.4% had flail 
segments (p<0.001). In short, having a flail segment associated with increased use of 
TEA and increased use of TEA associated with better odds of survival. 
 
Matched samples: Characteristics of eliminated patients 
 
Patients were eliminated if they died within 24 hours of arrival, if they were 
intubated within 12 hours of admission, or if they were on anticoagulation medication 
prior to treatment.  
 
29 patients died within 24 hours of arrival. One of them – an 80-year-old male 
who broke 7 ribs in a fall – received TEA, but died shortly after the epidural was placed. 
The other 28 did not receive TEA. The demographic data and injury characteristics these 
patients are displayed in Table 3.9.  
 
Table 3.9: Demographics and injury characteristics of patients who died within 24 hours 
 Died within 24h Survived 24h Significance 
N 29 979  
Sex 79.3% male 65.8% male p = 0.129 
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Age (years) 50.6 ± 23.0 55.4 ± 20.2 p = 0.270 
# Ribs Fractured 6.8 ± 5.1 3.9 ± 2.8 p = 0.007 
Injury Severity Score 31.1 ± 15.8  15.7 ± 9.9 p < 0.001 
% Flail Segment 24.1% 5.8% p < 0.001 
% Bilateral Fracture 48.1% 13.7% p < 0.001 
% Pulmonary Contusion 44.8% 19.2% p = 0.001 
% Pneumothorax 20.7% 20.9% p = 0.982 
% Hemothorax 34.5% 4.7% p < 0.001 
% Hemopneumothorax 10.3% 5.4% p = 0.254 
 
 
202 patients (20.0%) were intubated within 12 hours of admission. The majority 
of these patients were not candidates for TEA; only 23 (11.4%) were administered TEA 
either before or after intubation. Moreover, patients who were intubated within 12 hours 
of admission were much more likely to die (22.3%) than patients who were not intubated 
within the first 12 hours (2.0%; p < 0.001). The demographic data and injury 
characteristics of these patients are displayed in Table 3.10.  
 
Table 3.10: Demographics and injury characteristics of patients intubated within 12 
hours 
 Intubated within 12h Not intubated during first 12h Significance 
N 202 806  
Sex 73.8% male 64.3% male p = 0.011 
Age (years) 48.7 ± 18.3 56.9 ± 20.4 p < 0.001 
# Ribs Fractured 5.0 ± 4.1 3.7 ± 2.5 p < 0.001 
Injury Severity Score 20.7 ± 13.5 13.4 ± 7.4 p < 0.001 
% Mortality 22.3% 2.0% p < 0.001 
% Flail Segment 11.9% 5.0% p < 0.001 
% Bilateral Fracture 28.9% 11.0% p < 0.001 
% Pulmonary Contusion 40.6% 14.8% p < 0.001 
% Pneumothorax 26.7% 19.4% p = 0.021 
% Hemothorax 11.9% 4.0% p < 0.001 
% Hemopneumothorax 12.8% 3.7% p < 0.001 
 
 
91 patients (9.0%) were on anticoagulation upon arrival at the hospital. On 
average, these patients were 20 years older (p<0.001), had an ISS nearly 4 points lower (p 
<0.001), and lower incidences of pulmonary contusions (p=0.002) and pneumothorax 
(p=0.001). Despite contraindications, 10 of these patients (11.0%) still received TEA; to 
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be consistent, these patients were removed from the database as well. The demographic 
data and injury characteristics are displayed in Table 3.11. 
 
Table 3.11: Demographics and injury characteristics of patients on anticoagulation upon 
arrival 
 Anticoagulation on arrival No anticoagulation on arrival Significance 
N 91 917  
Sex 61.5% male 66.6% male p = 0.327 
Age (years) 73.2 ± 13.3 53.5 ± 20.0 p < 0.001 
# Ribs Fractured 3.9 ± 3.1  3.9 ± 2.9 p = 0.915 
Injury Severity Score 12.7 ± 7.3 16.5 ± 10.7 p < 0.001 
% Mortality 2.2% 6.4% p = 0.106 
% Flail Segment 8.8% 6.1% p = 0.318 
% Bilateral Fracture 15.6% 14.6% p = 0.799 
% Pulmonary Contusion 7.7% 21.2% p = 0.002 
% Pneumothorax 7.7% 22.2% p = 0.001 
% Hemothorax 6.6% 5.5% p = 0.652 
% Hemopneumothorax 6.6% 5.5% p = 0.652 
 
 
Patient characteristics across matched samples (n=721) 
 
287 patients met criteria for exclusion. After eliminating them from analyses, the 
difference in injury severity between patients who received TEA and those who did not 
receive TEA was enlarged (Table 3.12). 
 
Table 3.12: Demographics and injury characteristics (matched samples) 
 Non-TEA TEA Total Sample Significance 
N 558 163 721  
Sex 64.7% male 65.0% male 64.8% male p = 0.937 
Age (years) 54.5 ± 20.6  56.9 ± 8.6  55.0 ± 20.2  p = 0.188 
# Ribs Fractured 3.1 ± 2.1  5.5 ± 2.4  3.6 ± 2.4 p < 0.001 
Injury Severity Score 13.0 ± 7.2  15.7 ± 7.5  13.6 ± 7.4 p < 0.001 
% Flail Segment 2.0% 12.9% 4.4% p < 0.001 
% Bilateral Fracture 9.0% 16.4% 10.6% p = 0.008 
% Pulmonary Contusion 12.9% 23.9% 15.4% p = 0.001 
% Pneumothorax 19.0% 27.6% 20.9% p = 0.018 
% Hemothorax 3.1% 5.5% 3.6% p = 0.137 
% Hemopneumothorax 2.3% 6.7% 3.3% p = 0.006 
Pulse (scene) 88.8 ± 19.3  90.5 ± 18.0  89.2 ± 19.0 p = 0.471 
Pulse (hospital) 88.6 ± 19.5 89.8 ± 19.3 88.9 ± 19.5  p = 0.482 
Respiratory rate (scene) 18.2 ± 3.9 19.5 ± 4.6 18.5 ± 4.1  p = 0.019 
Respiratory rate (hospital) 18.7 ± 4.8 19.0 ± 3.9  18.8 ± 4.6 p = 0.420 
SBP (scene) 137.2 ± 25.6 132.8 ± 29.3 136.2 ± 26.5  p = 0.192 
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SBP (hospital) 135.1 ± 25.6 137.1 ± 25.5  135.6 ± 25.5 p = 0.387 
DBP (scene) 80.7 ± 15.0 80.5 ± 15.4 80.7 ± 15.1 p = 0.921 
DBP (hospital) 81.6 ± 15.4 82.3 ± 15.9 81.7 ± 15.5 p = 0.609 
Glasgow Coma Score (scene) 14.5 ± 1.8  14.5 ± 1.5  14.5 ± 1.7 p = 0.728 
Glasgow Coma Score (hospital) 14.7 ± 1.5 14.7 ± 1.0  14.7 ± 1.4 p = 0.432 
 
 
Compared to patients who did not receive TEA, those who were treated with TEA 
fractured 2.4 more ribs, were 1.8 times more likely to present with bilateral fractures, had 
6.5 times the incidence of flail segments, 1.9 times the incidence of pulmonary 
contusions, and 1.5 times the incidence of pneumothorax. The ISS of patients who 
received TEA was 2.7 points higher. 
 
Treatment outcomes across matched samples (n=721) 
 
After eliminating patients who met exclusionary criteria, the overall mortality rate 
fell from 6.1% to 1.7%. Despite TEA patients having more severe injuries, there was no 
difference in mortality between treatment groups (Table 13). 
 
Table 3.13: Mortality, complications, and treatment outcomes (matched samples) 
 Non-TEA TEA Total Sample Significance 
Mortality 2.0% 0.6% 1.7% p = 0.233 
Pneumonia 5.4% 11.0% 6.7% p = 0.011 
Sepsis 0.5% 0.6% 0.6% p = 0.909 
Respiratory Distress 0.5% 1.8% 0.8% p = 0.107 
Respiratory Failure 0.9% 2.5% 1.2% p = 0.115 
LOS in the Hospital (days) 5.0 ± 5.0 7.9 ± 5.1 5.6 ± 5.2 p < 0.001 
% Admitted to ICU 37.1% 58.2% 41.9% p < 0.001 
LOS in the ICU (days) 3.5 ± 3.8 4.9 ± 5.9 4.0 ± 4.6 p = 0.047 
% Needing Ventilation 5.6% 9.8% 6.6% p = 0.056 
Ventilation duration (days) 6.8 ± 5.1 11.5 ± 7.4 8.4 ± 6.3 p = 0.013 
 
 
The patients receiving TEA had 1.8 times the risk of pneumonia, but they did not 
experience increased risk of other complications. There was a trend for more TEA 
patients to require ventilation. Among those who received ventilation, patients given 
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TEA were intubated for an additional 4.7 days. They also spent an additional 2.9 days in 
the hospital and were 1.6 times more likely to be admitted to the ICU, likely owing to the 
increased severity of their injuries. Among patients admitted to the ICU, the LOS of those 
receiving TEA was 1.4 days longer. 
 
Relationships with mortality across matched samples (n=721) 
 
Differences in demographics, injury characteristics, and treatment outcomes 
between the patients who survived and the patients who died are characterized in Tables 
3.15 and 3.16. 
 
Table 3.15: Demographics, injury characteristics, and treatment outcomes of survivors 
and non-survivors (matched samples) 
 Survivors Mortalities Total Sample Significance 
N 709 12 721  
Sex 64.7% male 66.7% male 64.8% male p = 0.890 
Age (years) 54.7 ± 20.1 72.1 ± 22.0 55.0 ± 20.2  p = 0.003 
# Ribs Fractured 3.6 ± 2.4 4.4 ± 2.5 3.6 ± 2.4 p = 0.254 
Injury Severity Score 13.6 ± 7.3 14.3 ± 6.5 13.6 ± 7.4 p = 0.719 
% Flail Segment 4.5% 0% 4.4% p = 0.451 
% Bilateral Fracture 10.8% 0% 10.6% p = 0.248 
% Pulmonary Contusion 15.7% 0% 15.4% p = 0.136 
% Pneumothorax 21.0% 16.7% 20.9% p = 0.712 
% Hemothorax 3.4% 16.7% 3.6% p = 0.015 
% Hemopneumothorax 3.4% 0% 3.3% p = 0.517 
Pulse (scene) 89.0 ± 18.8 97.5 ± 29.4 89.2 ± 19.0 p = 0.281 
Pulse (hospital) 88.8 ± 19.4 94.1 ± 24.8 88.9 ± 19.5  p = 0.369 
Respiratory rate (scene) 18.5 ± 4.1 18.7 ± 3.9 18.5 ± 4.1  p = 0.941 
Respiratory rate (hospital) 18.8 ± 4.6 18.5 ± 3.1 18.8 ± 4.6 p = 0.856 
SBP (scene) 136.2 ± 26.5 134.2 ± 33.6 136.2 ± 26.5  p = 0.850 
SBP (hospital) 135.6 ± 25.5 133.2 ± 27.9 135.6 ± 25.5 p = 0.755 
DBP (scene) 80.7 ± 15.0 80.4 ± 20.0 80.7 ± 15.1 p = 0.968 
DBP (hospital) 81.9 ± 15.5 72.3 ± 13.6 81.7 ± 15.5 p = 0.042 
Glasgow Coma Score (scene) 14.5 ± 1.6 12.8 ± 4.8 14.5 ± 1.7 p = 0.438 
Glasgow Coma Score (hospital) 14.8 ± 1.2 11.2 ± 5.3 14.7 ± 1.4 p = 0.051 
Pneumonia 6.2% 33.3% 6.7% p < 0.001 
Sepsis 0.4% 8.3% 0.6% p < 0.001 
Respiratory Distress 0.7% 8.3% 0.8% p = 0.004 
Respiratory Failure 0.8% 25% 1.2% p < 0.001 
LOS in the Hospital (days) 5.6 ± 5.1 9.3 ± 8.3 5.6 ± 5.2 p = 0.144 
% Admitted to ICU 91.7% 41.0% 41.9% p < 0.001 
LOS in the ICU (days) 3.8 ± 4.5 8.4 ± 6.7 4.0 ± 4.6 p = 0.048 
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% Needing Ventilation 5.5% 66.7% 6.6% p < 0.001 
Ventilation duration (days) 8.4 ± 6.6 8.5 ± 5.1 8.4 ± 6.3 p = 0.955 
 
 
On average, the patients who died were 17.4 years older than those who survived. 
Injury severity was similar between groups. The only differences were a higher incidence 
of hemothorax among patients who died and a higher GCS upon arrival at the hospital 
(not on scene) among patients who survived. 
 
Despite similar injury severity, the patients who died were 5.4 times more likely 
to acquire pneumonia, 20.8 times more likely to become septic, 11.9 times more likely to 
develop respiratory distress syndrome, and 31.3 times more likely to experience acute 
respiratory failure compared to the patients who survived. The patients who died were 
also 12.1 times more likely to receive mechanical ventilation. The duration of ventilation 
was similar between groups. Lastly, the patients who died were 2.2 times more likely to 
be admitted to the ICU and among those admitted, the patients who ultimately died 
stayed an additional 4.6 days. 
 
Table 3.16: Demographics, injury characteristics, and treatment outcomes of survivors 
and non-survivors who did and did not receive TEA (matched samples) 
  TEA Mort. TEA Survived No TEA Mort. No TEA Survived 
N 1 162 11 547 
Sex Male 64.8% male 63.6% male 64.7% male 
Age (years) 86 56.7 ± 18.5 70.8 ± 22.6 54.2 ± 20.5 
# Ribs Fractured 7 5.5 ± 2.4 4.2 ± 2.5 3.1 ± 2.1 
Injury Severity Score 17 15.7 ± 7.5 14.1 ± 6.7 12.9 ± 7.2 
% Flail Segment No 13.0% 0% 2.0% 
% Bilateral Fracture No 16.5% 0% 9.1% 
% Pulmonary Contusion No 24.1% 0% 13.2% 
% Pneumothorax No 27.8% 18.2% 19.0% 
% Hemothorax No 5.5% 18.2% 2.7% 
% Hemopneumothorax No 6.8% 0% 2.4% 
Pulse (scene) No data 90.5 ± 18.0 97.5 ± 29.4 88.6 ± 19.1 
Pulse (hospital) 66 90.0 ± 12.3 96.1 ± 24.2 88.4 ± 19.4 
Respiratory rate (scene) No data 19.5 ± 4.6 18.7 ± 3.9 18.2 ± 3.9 
Respiratory rate (hospital) 16 19.1 ± 3.9 18.8 ± 3.1 18.7 ± 4.8 
SBP (scene) No data 132.8 ± 29.3 134.2 ± 33.6 137.3 ± 25.5 
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SBP (hospital) 135 137.1 ± 25.6 133.0 ± 29.4 135.2 ± 25.5 
DBP (scene) No data 80.5 ± 15.4 80.4 ± 20.0 80.7 ± 14.9 
DBP (hospital) 72 82.4 ± 16.0 72.3 ± 14.3 81.7 ± 15.4 
Glasgow Coma Score (scene) No data 14.5 ± 1.5 12.8 ± 4.8 14.5 ± 1.6 
Glasgow Coma Score (hospital) 9 14.8 ± 0.9 11.4 ± 5.6 14.7 ± 1.3 
% Pneumonia Yes 10.5% 27.3% 4.9% 
% Sepsis Yes 0% 0% 0.5% 
% Respiratory Distress Yes 1.2% 0% 0.5% 
% Respiratory Failure Yes 1.9% 18.2% 0.5% 
LOS in Hospital (days) 24 7.8 ± 5.0 8.0 ± 7.2 4.9 ± 4.9 
% Admitted to ICU Yes 58.0% 90.9% 36.0% 
LOS in ICU (days) 23 4.7 ± 5.7 6.9 ± 4.9 3.4 ± 3.7 
% Needing Ventilation Yes 9.3% 63.6% 4.4% 
Vent duration (days) 15 11.3 ± 7.6 7.6 ± 4.7 6.5 ± 5.3 
 
 
Among patients who did not receive TEA, the survivors were 16.6 years younger 
than those who died (p=0.008). Furthermore, the patients who died had a higher 
incidence of hemothoraces (p=0.003) and exhibited trends for more fractured ribs 
(p=0.077), a lower DBP at the hospital (p=0.056), and a lower GCS at the hospital 
(p=0.091). Patients who died were more likely to develop pneumonia (p=0.001) and 
acute respiratory failure (p<0.001), and ultimately require mechanical ventilation 
(p<0.001). Patients who died were 14.5 times more likely to be admitted to the ICU 
(p<0.001) and their average LOS was an additional 3.5 days (p=0.004). 
 
Among patients who were treated with TEA, only one patient died: an 86-year-
old man who fractured 7 ribs in a fall, was mechanically ventilated for 15 days and stayed 
in the ICU for 23 days. The remaining 162 patients survived. 
 
When comparing survivors who received TEA to patients who did not receive 
TEA and died, survivors who received TEA were 14.1 years younger (p=0.017). There 
were trends for survivors who received TEA to have more fractured ribs (p=0.079), more 
pulmonary contusions (p=0.064), and a higher DBP at the hospital (p=0.054). Despite 
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trends for increased severity, survivors who received TEA had fewer instances of acute 
respiratory failure (p=0.002) and were less likely to need mechanical ventilation 
(p<0.001). If ventilated, they remained intubated for an additional 3.7 days, though owing 
to a small sample of patients (n=22), this difference was not significant (p=0.251). 
Survivors who received TEA were also admitted to the ICU less frequently (p=0.031) 
and, if admitted, were discharged 2.2 days sooner, although this, too, was statistically 
insignificant (p=0.233) and would need a larger sample to confirm. There were no other 
differences between groups. 
 
Predictors of mortality across matched samples (n=721) 
 
Variables that predict mortality when tested independently are the use of 
mechanical ventilation (p<0.001), the presence of a hemothorax (p=0.011), and age 
(p=0.003). When tested with other variables, the use of TEA is a trending predictor 
(p=0.071). 
 
Use of mechanical ventilation: If a patient received mechanical ventilation as a 
component of treatment, the odds of mortality were 34.2 times greater (95% CI of odds 
ratio: 9.855–118.366; p<0.001). The duration a patient spent on ventilation was not a 
significant predictor (p=0.954). 
 
Presence of a hemothorax: If a patient had a hemothorax, the odds of mortality 
were 5.7 times greater (95% CI of odds ratio: 1.805–8.160; p=0.030). The presence of a 
hemothorax lost its predictive power when paired with other explanatory variables.  
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Age: When tested by itself, age predicts mortality as a continuous variable 
(p=0.005) or as a categorical variable, categorized by decade of life (p=0.009). For each 
additional year of age, the risk of mortality increased by 4.7% (95% CI of odds ratio: 
1.014–1.081). The mortality rates across age groups are displayed in Figure 3.10. 
 
Figure 3.10: Mortality rates among individual age group (matched samples) 
 
The inflexion point at 80 years was even more exaggerated after samples were 
matched (Figure 3.11). 
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Figure 3.11: Mortality rates above and below inflexion point of age (matched samples) 
 
Patients above the age of 80 were approximately 8 times more likely to die than 
patients below the age of 80 (95% CI of odds ratio: 2.509–25.849; p<0.001).  
 
Among matched samples, the only patient who received TEA and died was 86 
years old. If patients above the age of 80 (n=112) were to be eliminated from the 
database, mortality would become an all-or-none phenomenon in which every patient 
who received TEA survived while 1.1% of patients who did not receive TEA died. 
 
Use of TEA: On its own, the use of TEA did not significantly predict mortality 
(p=0.230), but when tested with other variables, it became a trending predictor. For 
example, with age, use of mechanical ventilation, and the administration of TEA in the 
model, the use of TEA reduced the odds of mortality by about 87% (p=0.071).  
 
Binary logistic regression: Prediction equation for mortality across matched samples 
(n=721) 
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Variables included in the prediction equation: Age, the use of TEA, and the use 
of mechanical ventilation. 
 
Table 3.17: Analysis of variables when tested individually (not in the equation) 
Variable Score Degrees of Freedom Significance 
Age 8.843 1 p=0.003 
Use of TEA 1.441 1 p=0.230 
Use of mechanical ventilation 71.993 1 p<0.001 
Overall Statistics 82.808 3 p<0.001 
 
 
717 subjects (99.4%) had sufficient data to be included in this analysis. The 
model elicits a Nagelkerke R2 value of 0.390, indicating that about 39% of the variance in 
mortality can be explained by this collection of predictors. 
 
 Table 3.18: Variables in the equation 
 β S.E. Wald D.F. Sig. Odds Ratio 
Constant -4.073 0.291 195.768 1 p<0.001 0.017 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
 
Table 3.19: Variables in the equation 
Variable β S.E. Wald D.F. Sig. Odds Ratio 
Age 0.063 0.022 8.500 1 p=0.004 1.065 
Use of TEA -2.031 1.123 3.270 1 p=0.071 0.131 
Use of mechanical ventilation 4.052 0.723 31.450 1 p<0.001 57.531 
Constant -9.130 1.752 27.145 1 p<0.001 0.000 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
 
In this model, each additional year of age increased the odds of mortality by about 
7% (95% CI of odds ratio: 0.021–1.112; p=0.004), the use of TEA reduced the odds of 
mortality by about 87% (95% CI of odds ratio: 0.015–1.186; p=0.071), and patients who 
needed mechanical ventilation were about 58 times more likely to die (95% CI of odds 
ratio: 13.958–237.126; p<0.001). 
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If age is analyzed by its inflexion point, the use of TEA no longer exhibits a trend 
in prediction (p=0.101). Removing TEA, and only including the predictors that were 
significant both by themselves and in the model, the ideal equation to predict mortality 
among matched samples includes only age and the use of mechanical ventilation. If age is 
a continuous variable, this model explains about 35% of the variance in mortality, each 
additional year of age increases the risk of mortality by about 6% (95% CI of odds ratio: 
1.018–1.106; p=0.005), and the patients who required mechanical ventilation were about 
41 times more likely to die (95% CI of odds ratio: 10.919–154.667; p<0.001). If age is 
analyzed by its inflexion point, this model explains about 39% of the variance in 
mortality, patients who were above the inflexion point of age were about 14 times more 
likely to die (95% CI of odds ratio: 3.395–56.166; p<0.001), and the patients who 
required mechanical ventilation were about 52 times more likely to die (95% CI of odds 
ratio: 12.553–213.117; p<0.001). This model is displayed in Tables 3.20 and 3.21. 
 
Table 3.20: Variables in the equation 
 β S.E. Wald D.F. Sig. Odds Ratio 
Constant -4.073 0.291 195.768 1 p<0.001 0.017 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
 
Table 21: Variables in the equation 
Variable β S.E. Wald D.F. Sig. Odds Ratio 
Age (inflexion point) 2.625 0.716 13.451 1 p<0.001 13.809 
Use of mechanical ventilation 3.946 0.722 29.834 1 p<0.001 51.724 
Constant -6.189 0.714 75.201 1 p<0.001 0.002 
β = coefficient for the constant; S.E. = standard error around the coefficient for the constant; Wald = Wald 
chi-square test; D.F. = degrees of freedom for the Wald chi-square test; Sig. = significance. 
 
 
DISCUSSION 
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Rib fracture injuries normally account for 7–10% of all trauma center 
admissions.2,113 At St. Vincent’s trauma center, during the 4-year study period, 9.8% of 
all admissions were patients with rib fractures. These patients were typical of other 
patient populations admitted to trauma centers with rib fractures. Two-thirds were male, 
they had an average age of 55 years, presented with an average of 4 fractured ribs, and 
the rates of associated injuries (e.g., flail chest, pulmonary contusion) were comparable to 
the rates reported in other studies. 
 
Among all patients admitted to trauma centers with ≥ 1 fractured rib, a mortality 
rate of about 10% can be expected2,3,5,10 and the risk of pneumonia ranges between 17 
and 31%.6 About 60% of rib fracture patients will likely require mechanical ventilation 
for a mean duration of 13 days; the severity of injury predicts both the need for 
ventilation and the duration of its use.10 The typical LOS in the hospital is 7 to 16 nights 
and among patients admitted to the ICU (generally > 40%) they can be expected to stay 
for 4 to 8 nights, with a greater number of fractures predicting longer stays.2,5,10  
 
In our patients, the overall mortality rate was 6.1% and the incidence of 
pneumonia was 12.2%. Mechanical ventilation was required in 23.3% of patients for an 
average duration of 9.1 days. They spent 7.5 nights in the hospital, 51.2% were admitted 
to the ICU, and those patients remained there for 6.7 nights.  
 
Given our normal patient profile, the relatively low rates of mortality and 
pulmonary complications may be partly explained by the mode of treatment. A unique 
feature of our treatment model is the APS care team. This team involves dedicated 
anesthesiologists with expertise and interest in acute pain techniques and nurses who are 
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trained in pain management. The anesthesiologists are assigned to the trauma patients for 
a week at a time and their duties are limited to those patients. They do not work in the 
operating room during the week they are covering, they round all 7 days, assume all pain 
management responsibilities for their patients, and they’re available for nurses to page 
them 24 hours a day with questions about pain control, adjustments of dosage, and side 
effects. This service facilitates much higher reliance on TEA to manage rib fracture pain. 
 
In published reports evaluating the NTDB, about 2% of all rib fracture patients 
and nearly 8% of patients with flail segments received TEA.10,26 At St. Vincent, nearly 
20% of all rib fracture patients and more than 50% of patients with flail segments 
received TEA. Moreover, as the severity of injury increased, so did the likelihood that 
TEA would be administered. For example, among patients who fractured a single rib, 
1.9% received TEA; among patients who fractured 8 ribs, 50.0% received TEA. Many 
patients who fractured 9 or more ribs still received TEA (38.0%), but an increasing 
number were not candidates.  
 
Although evaluations of the total population showed TEA was used in more 
severely injured patients, and it elicited remarkable improvements in treatment outcomes, 
most notably reducing mortality by a factor of 7, many patients with the most severe 
injuries were not eligible to receive TEA. Thus, to better understand the effect TEA had 
on mortality, morbidity, use of mechanical ventilation, and LOS in the hospital and ICU, 
we attempted to match patient samples. Patients who died within 24 hours or were 
intubated within 12 hours of admission may have missed the opportunity to receive TEA. 
Patients who were on anticoagulation medication upon arrival were contraindicated for 
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its use. After eliminating 287 patients who met these 3 criteria, we reevaluated our 
treatment outcomes. 
 
The overall mortality rate fell from 6.1% to 1.7%. The variables that predicted 
mortality before matching the samples were age, the number of fractured ribs, the 
presence of a hemothorax, the use of ventilation, and the administration of TEA. Patients 
who received TEA had lower odds of mortality, whereas increasing age, fracturing more 
ribs, having a higher ISS, sustaining a hemothorax, and receiving mechanical ventilation 
all associated with greater odds of mortality. After matching samples, the predictors of 
mortality were narrowed to age (above or below the inflexion point of 80 years) and use 
of mechanical ventilation. Being ≥ 80 years of age increased the odds of mortality by a 
factor of 14 while use of mechanical ventilation increased the odds of mortality by a 
factor of 52. 
 
After matching samples, there were 3 important differences between the patients 
who died and those who survived. On average, patients who died were 17.4 years older, 
they were 4.9 times more likely to present with a hemothorax, and they scored 3.6 points 
lower on the GCS upon arrival at the hospital. Despite otherwise comparable injury 
severity (e.g., number of fractured ribs, incidence of bilateral fractures, presence of flail 
segments and pulmonary contusions), the patients who died were 5.4 times more likely to 
contract pneumonia, 11.9 times more likely to develop respiratory distress syndrome, and 
31.3 times more likely to experience acute respiratory failure. The patients who died were 
also 12.1 times more likely to require mechanical ventilation, 2.2 times more likely to be 
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admitted to the ICU, and, among those admitted, the patients who died stayed 4.6 
additional days. 
 
In attempt to avoid ventilation and minimize the risk of mortality and pulmonary 
complications, TEA was a mainstay in treating the patients with more severe injuries. 
Compared to the eligible candidates who did not receive TEA, those who were treated 
with TEA fractured 2.4 more ribs, were 1.8 times more likely to present with bilateral 
fractures, scored 2.7 points higher on the ISS, had 6.5 times the incidence of flail 
segments, 1.9 times the incidence of pulmonary contusions, and 1.5 times the incidence 
of pneumothoraces. In short, patients who received TEA had much more severe injuries. 
Despite this, there was no difference in mortality between patients who received TEA 
(0.6%) and those who did not (2.0%). Notably, the only patient who received TEA and 
died was an 86-year-old man who fractured 7 ribs in a fall. He was above the inflexion 
points for both age and the number of ribs fractured. The remaining 162 patients who 
received TEA survived.  In contrast, the patients who did not receive TEA and died were 
about 15 years younger and fractured about 3 fewer ribs. 
 
Comparisons can be drawn between the survivors who received TEA and the 
patients who did not receive TEA and died. The survivors who received TEA were 14.1 
years younger, but displayed a trend of more fractured ribs and nearly a quarter of them 
had pulmonary contusions (compared to none among patients who did not receive TEA 
and died). There were also no bilateral injuries or cases of flail segments among the 
patients who did not receive TEA and died (compared to 13.0% and 16.5% respectively 
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among patients who received TEA and survived). Despite these being all-or-none 
phenomena, the sample size was not sufficient to elicit significance with these injuries. 
 
In response to the treatments, despite trends for increased injury severity, 
survivors who received TEA had fewer instances of acute respiratory failure and were 
less likely to require mechanical ventilation.  
 
At the very minimum, the use of TEA appears to have blunted the rise in 
mortality associated with increased injury severity. However, it did not seem to influence 
other treatment outcomes. There was a trend that patients who were treated with TEA had 
nearly twice the risk of acquiring pneumonia compared to patients who did not receive 
TEA. Among patients who were ventilated, those receiving TEA were intubated for 
nearly 5 more days. They stayed about 3 additional days in the hospital, were 57% more 
likely to be admitted to the ICU, and stayed in the ICU for an additional 1.4 days. 
 
Limitations 
 
In the present study, after matching samples, a single patient who received TEA 
died and there were 11 mortalities among patients not receiving TEA. Given these small 
samples, we may have missed important relationships and drawn meaningful conclusions 
where there were none. While our findings are an important step in outlining best 
practices for the treatment of patients with rib fractures, larger samples will be needed to 
confirm our observations. 
 
Conclusions 
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 Based on limited evidence, TEA appears to improve treatment outcomes for 
patients with rib fractures, most notably attenuating the rise in mortality that typically 
accompanies more severe injuries. Much of our success seems to be attributable to the 
presence of a dedicated anesthesiologist and the consequent ease with which TEA is 
administered and adjusted. This APS model for rib fracture care may be considered as a 
roadmap for other programs to implement. As a first step, more hospitals should quantify 
their data registries, controlling for injury severity, and evaluate the effectiveness, and 
safety of TEA among patients with rib fractures. 
 
Disclaimers 
 
This study is associated with no source of funding. It is a collaboration between 
the St. Vincent Hospital in Indianapolis, the University of Connecticut, and Sum Integral. 
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Chapter 4: The cost-effectiveness of thoracic epidural analgesia in rib 
fracture care 
 
 
ABSTRACT 
 
Rib fractures are the most common injury in blunt thoracic trauma; they are 
present in nearly 300,000 patients admitted to U.S. trauma centers each year. Patients 
who only fracture 1 or 2 ribs are typically treated with oral analgesic drugs and are 
discharged with few complications. The cost of those treatments generally reflects the 
brevity of the care. When a patient fractures 3 or more ribs, there is an increased risk of 
complication and mortality. To achieve successful outcomes, the extent of treatment is 
broadened and the duration prolonged. Hospital costs and patient expenses accumulate 
accordingly. While health, function, and survival have been widely explored, cost 
effectiveness has not. When a patient is admitted with rib fractures, there is a host of 
treatment options; thoracic epidural analgesia (TEA) is one of them. The purpose of this 
investigation was to assess the cost effectiveness of TEA as a treatment for patients with 
rib fractures. Methods: We analyzed the registry of a Level II trauma center. All patients 
who fractured at least 1 rib (n=1,008) were evaluated; 195 of them received TEA. The 
primary outcomes were hospital costs and patient billing. We also report patient 
demographics, the mechanism and severity of injuries, and the predictors of expense 
(e.g., duration of treatment). Results: The variables that predicted patient charges were 
age, injury severity, length of stay in the hospital and intensive care unit (ICU), the use of 
TEA, and the incidence of respiratory distress syndrome. The average patient bill was 
about $55k and the use of TEA could be expected to reduce it by more than $12k 
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(p<0.001). The variables that predicted hospital expense were age, injury severity, length 
of stay in the hospital and ICU, and the use of TEA. The average cost per patient was 
about $6,700 and the use of TEA could be expected to reduce it by more than $2,500 
(p<0.001). Conclusion: TEA significantly reduced both hospital costs and patient 
charges. From an administrative and insurance perspective, more frequent reliance on 
TEA may be indicated. 
 
 
INTRODUCTION 
 
Each year, about 10-15% of all patients admitted to U.S. trauma centers have 
sustained blunt thoracic trauma.161 Chest wall injuries are common with most involving 
rib fractures.1,2,49 Nearly 300,000 patients are admitted to U.S. trauma centers each year 
with rib fractures4 (about 7% to 10% of all trauma patients).2,10,113 The true incidence 
may be even higher as some fractures may go undetected at admission.5,49 Many of these 
patients – especially older patients and those with more severe injuries – undergo 
extensive treatment.59  
 
Patients who present with 1 or 2 fractured ribs are typically treated with oral 
analgesic drugs (e.g., NSAIDs)47, scarcely die, and experience few complications.1,10 If 
pain relief is not sufficient, other systemic analgesics (e.g., intravenous morphine) may be 
attempted.47 Patients who present with 3 or more rib fractures have an elevated risk of 
complication.1 Much of this risk is a consequence of pain-induced changes in ventilatory 
mechanics.35,36 Patients who experience pain with coughing and deep breathing tend to 
avoid those behaviors, which limits the clearance of airway secretions. Retention of those 
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secretions increases the risk of pulmonary complications (e.g., pneumonia). These 
complications precipitate respiratory failure; respiratory failure often necessitates 
ventilatory support; and ventilatory support elevates the risk of mortality.10,11,19,35-41 In 
short, pain can initiate a deleterious cascade that ends in poorer treatment outcomes. In 
turn, poorer treatment outcomes result in higher treatment costs.162-164 Effective pain 
management is thus vital to a treatment’s therapeutic success and its cost-
effectiveness.41,46,47 Thoracic epidural analgesia (TEA) is one mode of pain control. 
While TEA has been shown to reduce morbidity11,82 and mortality6,10,65,82 among patients 
with multiple rib fractures, we were unable to find any studies that reported its effect on 
treatment cost. 
 
The purpose of this study is to evaluate the cost-effectiveness of TEA and 
determine which variables predict medical expenses in rib fracture patients. To our 
knowledge, this is the first publication of its kind. 
 
Expected treatment outcomes and relationships with treatment cost 
 
Among patients with ≥ 1 rib fracture, a mortality rate of about 10% can be 
expected2,5,10 and pulmonary complications can arise in nearly half.10 With each 
additional fracture, these risks increase.6,10 Rates of pneumonia vary depending on the 
patients’ age and injury severity, but an incidence of 17–31% can be expected.6,10,46 
Mechanical ventilation is required in about 60% of rib fracture patients and these patients 
remain ventilated for an average of 13 days; increased injury severity predicts the need 
for ventilation and the duration of its use.10 Among all rib fracture patients, an average 
hospital stay of 7–16 nights can be expected, about 44% will be admitted to the intensive 
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care unit (ICU), and will likely remain there for 4–8 nights; the severity of injury predicts 
the length of stay (LOS).2,5,10  
 
Some hospitals have achieved better outcomes in these domains by implementing 
more aggressive approaches, such as the “multidisciplinary clinical pathway”. Here, 
among older patients with more severe injuries, the default treatment includes physical 
therapy, respiratory therapy, nutrition services, and several modes of pain control. In one 
study, use of these services reduced the rate of mortality from 13% to 4% and the rates of 
complications similarly.59 However, the cost of this treatment – both to the hospital and 
to the patient – was not reported. Few authors disclose the cost of medical care for 
patients with rib fractures. An analysis in 1993 found fewer than 2% of anesthesia 
publications included cost analyses.165 Although others may exist, we were only able to 
identify 5 relevant studies: 
 
In 1991, Mackersie and colleagues36 reported on 32 patients admitted to a U.S. 
hospital with rib fractures: 17 were treated with IV opioids and 15 were treated with 
TEA. The total hospital charges among patients who received TEA was $21k ± $10k 
whereas the total charges among patients who received IV opioids was $15k ± $16k. 
Other than listing these figures, the only mention of financial outcomes in the paper was a 
clarification that “Although hospital charges and LOS were slightly higher for the 
epidural group, the ISS was also increased, resulting in a similar charge/ISS/day.” 
 
In 2002, Tanaka and colleagues164 reported on 37 patients who were admitted to a 
Japanese hospital with flail chest; 18 underwent surgical fixation and 19 were managed 
conservatively (internal pneumatic stabilization). Medical costs were obtained through 
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public health insurance records and yen were converted to dollars. These records showed 
total cost of the surgical group was $13,455 ± $5,840 while the conservative group cost 
$23,423 ± $1,380 (p<0.05). Most of this was related to duration of mechanical ventilation 
and LOS in the ICU, in which conservative treatments lasted 7.5 days longer (p<0.05) 
and 10.3 days longer (p<0.05) respectively. 
 
In 2012, Bhatnagar and colleagues162 evaluated Medicare reimbursement records 
of American patients with flail chest. Although very little detail was documented in the 
methods, they found surgical fixation to be more cost effective than non-operative care. 
While the operations themselves added to treatment costs, they reduced the rates of 
complications and shortened durations of ventilator use and hospital stay (by unreported 
amounts). The authors reported financial data relative to quality of life (measured by “an 
arbitrary quality of life improvement factor”). The incremental cost per quality of life unit 
was $17,162 for the surgical option and $22,537 for the non-surgical option. 
 
In 2012, Menditto and colleagues166 evaluated 240 patients admitted to an Italian 
hospital’s emergency department with blunt thoracic trauma. These patients were 
analyzed in two separate groups: those treated in 2006 and those treated in 2007. There 
were 110 patients in the first group and 130 in the second. They fractured an average of 
2.1 and 2.7 ribs respectively. Treatment costs were gathered from the hospital’s finance 
department and were reported in euros. Cost-effectiveness was calculated by dividing the 
mean cost per patient by the success rate (the success rate was defined as the number of 
patients who were not readmitted to the emergency department divided by the total 
number of patients who were treated in the emergency department). The median cost per 
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patient was € 430 for the first group and € 588 for the second. The cost-effectiveness was 
€ 487 for the first group and € 616 for the second. 
 
In 2013, Marasco and colleagues163 reported on 46 patients who were admitted to 
an Australian hospital with traumatic flail injuries; 23 were randomized to operative 
fixation and 23 were randomized to non-operative management. On average, patients in 
the non-operative group remained in the ICU for 5 extra days, which cost an additional 
$21,243 per patient. This difference was offset by the costs of the surgical procedure, 
which averaged $6,800 per patient. The estimated savings of having the operation were 
$14,443 per patient. 
 
In other studies, topics such as “cost-effectiveness” were mentioned in the 
abstract, but no financial records were reported in the paper.167 
 
Effect of TEA on treatment outcomes and implications on treatment cost 
 
We found 16 studies reporting TEA to be an effective mode of treatment for 
patients with rib fracture injuries9,10,25,30,39,41,61,65,66,82-85,89,94,99 and 10 studies that failed to 
find superior outcomes with TEA.6-8,11,29,36,78,91,93,96 None of these studies reported any 
data related to treatment cost. 
 
 
METHODS 
 
We retrospectively analyzed the registry of an ACS-verified Level II trauma 
center. All patients who were admitted with rib fractures between November 2010 and 
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December 2014 were included in our analyses. We evaluated the cost-effectiveness of 
treatments, comparing those who received TEA to those who did not receive TEA. 
 
This study was approved by the hospital’s institutional review board (IRB) and by 
the IRB of a collaborating university. 
 
Data acquisition and management 
 
All data were exported from the trauma registry of St. Vincent Hospital in 
Indianapolis, Indiana. We compared ICD9 codes of each patient with the written reports 
of their injuries to determine the presence, number, and location of rib fractures as well as 
the incidence of associated injuries (e.g., flail segments). The characteristics of injury 
were compiled with demographic records, modes of treatment, and treatment outcomes. 
Where data only existed as written reports (e.g., mechanism of injury), we quantified 
those variables numerically. Wherever the timing of treatment was important (e.g., timing 
of intubation), we compared the time stamps of the relevant procedure codes with the 
time of admission. 
 
Outcomes 
 
The primary outcome was treatment cost, both to the patient and to the hospital. 
In investigating the predictors of cost, we analyzed interrelationships between patient 
demographics, injury severity, and the mode of treatment, particularly the administration 
of TEA. We also assessed the effects of mortality, pulmonary complications, mechanical 
ventilation, and LOS in the hospital and ICU on patient expenses and hospital costs. 
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Matching patient samples 
 
Despite the seeming effectiveness of TEA when tested across the whole 
population, many patients were not candidates for its use. We identified 3 exclusionary 
criteria: 
 
1) Patients who died within 24 hours of arrival. Patients who do not survive 24 
hours often have the most severe injuries and many are unlikely to respond to any 
treatment. Moreover, depending on the day and time of admission, some of these patients 
do not survive long enough to be seen by an anesthesiologist; thus they miss the 
opportunity to have an epidural placed. 
 
2) Patients who were intubated upon arrival or within 12 hours of admission. 
Many of the most severely injured patients develop respiratory failure quickly and are 
intubated before being seen by an anesthesiologist. A major goal of administering TEA is 
to avoid the need for intubation. Once intubated, patients generally have pain managed 
with higher doses of narcotics, are deeply sedated, and are no longer candidates for 
epidurals.  
 
3) Patients who were on an anticoagulants prior to treatment. Anticoagulation 
medications elevate a patient’s risk of bleeding into the epidural space; this can cause 
spinal cord compression and paralysis. Thus TEA is typically contraindicated in these 
patients. 
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In our attempt to match patients who 
received TEA with those who did not receive TEA, 
every patient who met any of the above criteria was 
eliminated from analyses. 
 
Data analyses 
 
Discrete data (e.g., total cost of treatment) 
were analyzed with linear regressions. Predictor 
variables were eliminated if they had tolerance 
values ≤0.10 or variance inflation factors ≥10. If any 
data were missing, cases were excluded pairwise. 
Normal probability plots were assessed to ensure 
minimal deviance from line of best fit. Scatter plots 
were used to ensure well-distributed means and 
identify outliers. Group means (e.g., TEA vs. non-
TEA) were compared with independent samples t-
tests. Categorical data (e.g., inflexion points) were 
compared with chi-square tests. Analyses were 
conducted on the total population as well as 
matched samples. All statistical tests were 
conducted using SPSS version 22 (IBM SPSS 
Statistics, IBM Corporation, Chicago, IL). 
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RESULTS 
 
Population 
 
On average, patients were 55 years old, but age ranged across the lifespan, from 15 to 98 
years (Figure 4.1). 
 
Figure 4.1: Patient ages by decade (total sample) 
 
Two-thirds of our patients were male, 92% were white, and the most common 
mode of injury was automotive accidents (Figure 4.2). 
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Figure 4.2: Mechanism of injury (total sample) 
 
“Other” is a mode of injury encompassing a variety of activities. In order of most 
to least common: bicycle accidents, ATV accidents, firearm/bullet injuries, assault, struck 
by an object, pedestrian struck by a car, animal-related injuries, other motor vehicle 
accidents (e.g., golf carts, snowmobiles), heavy machinery accidents, and pedestrian 
struck by a train. 
 
Across all mechanisms of injury, our patients presented with an average of 4 
fractured ribs (Figure 4.3). 
 
 
 
 
 
 173 
Figure 4.3: Frequency of rib fracture counts (total sample) 
 
Patients who fractured more ribs were more likely to receive TEA. Patient 
demographics, injury characteristics, and treatment outcomes are displayed in Table 4.1. 
 
Table 4.1: Patient demographics, injury characteristics, and treatment outcomes (total 
sample) 
 Non-TEA TEA Total Sample Significance 
N 813 195 1008  
Sex 66.1% male 66.6% male 66.2% male p = 0.871 
Age (years) 54.9 ± 20.7 56.9 ± 18.4 55.3 ± 20.3 p = 0.197 
# Ribs Fractured 3.5 ± 2.8 5.8 ± 2.7 3.9 ± 2.9 p < 0.001 
Injury Severity Score 16.1 ± 10.9 16.5 ± 8.2 16.1 ± 10.4 p = 0.492 
% Flail Segment 3.7% 17.4% 6.4% p < 0.001 
% Bilateral Fracture 13.3% 18.5% 14.7% p = 0.042 
% Pulmonary Contusion 18.5% 26.2% 20.0% p = 0.016 
% Pneumothorax 18.6% 30.3% 20.9% p < 0.001 
% Hemothorax 5.5% 5.6% 5.6% p = 0.957 
Glasgow Coma Score (scene) 12.7 ± 4.2 14.3 ± 2.3 13.0 ± 4.0 p < 0.001 
Glasgow Coma Score (hospital) 12.8 ± 4.5 14.4 ± 2.3 13.1 ± 4.2 p < 0.001 
Mortality 7.2% 1.0% 6.1% p = 0.001 
Pneumonia 11.4% 15.4% 12.2% p = 0.132 
Sepsis 0.9% 0.5% 0.8% p = 0.623 
Respiratory Distress 2.1% 1.5% 2.0% p = 0.619 
Respiratory Failure 1.8% 3.1% 2.1% p = 0.279 
LOS in the Hospital (days) 7.2 ± 8.7 8.7 ± 5.8 7.5 ± 8.2 p = 0.006 
% Admitted to ICU 48.2% 63.6% 51.2% p < 0.001 
LOS in the ICU (days) 7.0 ± 8.6 5.8 ± 6.7 6.7 ± 8.2 p = 0.110 
% Needing Ventilation 24.4% 18.5% 23.3% p = 0.075 
Ventilation duration (days) 9.0 ± 9.0 9.6 ± 8.1 9.1 ± 8.8 p = 0.689 
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There were several differences in injury severity but no differences in 
complication rates between patients who received TEA and those who did not. Patients 
who received TEA had one-seventh the risk of mortality but they stayed an extra day and 
a half in the hospital and were more commonly admitted to the ICU.  
 
Among all patients admitted with rib fractures, the average bill for treatment was 
about $85k. The range was broad: from $2,448 to $985,979. The amount a patient was 
charged was proportionate to the length of stay (LOS) in the hospital; on average, 
patients were billed $11,727 per day. 
 
Because patients treated with TEA stayed an additional day and a half, their bills 
were expected to be $17,590 higher. However, their average charges ($82,725) were 
comparable to patients who did not receive TEA ($85,425; p=0.707). This can be 
explained by the per-night charge of patients receiving TEA being about $3,500 less 
(p<0.001). In turn, part of this discrepancy can be explained by the fees associated with 
mortality. The average per-night charge to patients who die is 2.5 times greater than the 
amount survivors are charged (p<0.001). All financial data are displayed in Table 4.2. 
 
Table 4.2: Financial data among TEA, non-TEA, survivors, and mortalities (total 
sample)  
 Survivors Mortalities Non-TEA TEA Total Sample 
N      
Total Charge to Patient $85,599.69 $74,086.54 $85,425.09 $82,725.18 $84,902.27 
Standard Deviation $112,556.40 $72,125.19 $116,522.84 $81,205.83 $110,537.58 
Direct Cost to Hospital $11,121.78 $9,053.78 $11,169.15 $10,277.63 $10,996.51 
Standard Deviation $17,678.06 $10,747.69 $18,438.53 $11,721.28 $17,340.63 
Charge:Cost Ratio 10.2:1 11.0:1 10.6:1 8.9:1 10.3:1 
Standard Deviation 4.3:1 5.6:1 4.8:1 2.0:1 4.5:1 
Per Night Charge $10,824.00 $27,107.99 $12,428.13 $8,860.55 $11,726.84 
Standard Deviation $6,265.87 $18,308.10 $8,968.10 $3,668.20 $8,321.50 
 
 
 175 
Although the patients who died were charged about 2.5 times more per night, 
survival added about $11,500 to the total charges; this is mostly a consequence of 
hospital LOS lasting 3.3 days longer in patients who survived.  
 
The actual cost of care was about $11k per patient, but ranged from $143 to 
$148,594. Furthermore, although the direct cost to the hospital was similar between 
patients who did and did not receive TEA, the charge-to-cost ratio was lower in patients 
receiving TEA (p<0.001), resulting in a lower profit margin among patients treated with 
TEA. 
 
Group differences between patients who received TEA and survived, patients who 
received TEA and died, patients who did not receive TEA and survived, and patients who 
did not receive TEA and died are displayed in Table 4.3. 
 
Table 4.3: Financial data among TEA survivors, TEA mortalities, non-TEA survivors, 
and non-TEA mortalities (total sample) 
 TEA Mortality TEA Survivors noTEA Mortality noTEA Survivors 
N 2 193 59 754 
Age (years) 83.0 ± 4.2 56.7 ± 18.3 58.6 ± 22.3 54.6 ± 20.5 
# Ribs Fractured 7.0 ± 0 5.8 ± 2.7 6.0 ± 4.5 3.3 ± 2.5 
Injury Severity Score 13.5 ± 5.0 16.6 ± 8.2 29.1 ± 15.8 15.0 ± 9.8 
LOS in Hospital (days) 12.5 ± 16.3 8.6 ± 5.7 4.1 ± 5.9 7.5 ± 8.9 
% Admitted to ICU 100% 63.2% 64.4% 46.9% 
LOS in ICU (days) 12.0 ± 15.6 5.7 ± 6.5 4.7 ± 4.9 7.2 ± 8.9 
% Needing Ventilation 50% 18.1% 67.8% 21.0% 
Vent duration (days) 15 ± 0.0 9.5 ± 8.1 3.9 ± 4.7 10.3 ± 9.3 
Total Charge to Patient $117,936.16 $82,360.30 $72,600.11 $86,429.97 
SD $144,507.69 $80,878.10 $70,376.35 $119,360.46 
Direct Cost to Hospital $16,516.83 $10,212.98 $8,800.79 $11,354.72 
SD $20,492.81 $11,671.45 $10,500.94 $18,912.26 
Charge:Cost Ratio 7.4:1 8.9:1 11.2:1 10.6:1 
SD 0.5:1 2.0:1 5.9:1 4.7:1 
Per Night Charge $12,462.70 $8,823.22 $27,660.64 $11,343.02 
SD $4,654.31 $3,653.28 $18,414.70 $6,685.89 
 
 
Patients who received TEA and survived had higher injury severity scores (ISS) 
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than patients who did not receive TEA and died (p<0.001). Age and number of fractured 
ribs were similar. Patients who were not treated with TEA and died were 3.7 times more 
likely to need mechanical ventilation (p<0.001) than the survivors who were treated with 
TEA (p<0.001). However, if ventilated, survivors who were treated with TEA remained 
on ventilation for an additional 5.6 days (p=0.001). Survivors who received TEA also 
stayed in the hospital for an additional 4.5 days (p<0.001) than those who did not receive 
TEA and died. 
 
If the average nightly charge of $11,726.84 were multiplied by the 4.5 additional 
days, the excess fees accumulated by the survivors who received TEA would be 
$52,770.78. However, the average bill for these survivors only exceeded that of the 
patients who did not receive TEA and died by $9,760.19. The difference was not 
significant (p=0.404). This is partly explained by discrepancies in nightly charges: 
survivors who received TEA were charged $18,837.42 less per day LOS than the patients 
who did not receive TEA and died (p<0.001). Much of this is accounted for by the 
charge-to-cost ratio. Patients who did not receive TEA and died had a charge-to-cost ratio 
that was about 26% higher than patients who received TEA and survived (p<0.001). 
Although it cost the hospital about $1,400 more to deliver care to the TEA patients who 
survived, the difference was not significant (p=0.406), the hospital billed those patients 
nearly $10,000 more (also insignificant: p=0.404), and the patients lived to pay the bills. 
The hospital collected 38% of the bill from TEA survivors and 32% from patients who 
did not receive TEA and died. 
 
Variables that predict the price and cost of treatment across the total sample 
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Variables that predict total charges to the patient: 
 
When tested individually, the variables that predict charges to the patient are: age 
(r = -0.145; p<0.001), number of fractured ribs (r = 0.202; p<0.001), presence of bilateral 
fractures (r = 0.231; p<0.001), presence of a flail segment (r = 0.105; p=0.001), presence 
of a pulmonary contusion (r = 0.230; p<0.001), presence of a pneumothorax (r = 0.121; 
p<0.001), presence of a hemothorax (r = 0.067; p=0.034), ISS (r = 0.532; p<0.001), use 
of mechanical ventilation (r = 0.604; p<0.001), duration of ventilation (r = 0.782; 
p<0.001), hospital LOS (r = 0.907; p<0.001), ICU LOS (r = 0.843; p<0.001), incidence 
of pneumonia (r = 0.463; p<0.001), incidence of respiratory distress syndrome (r = 0.261; 
p<0.001), acute respiratory failure (r = 0.203; p<0.001), and sepsis (r = 0.167; p<0.001).  
 
Sex (p=0.329) and use of TEA (p=0.760) were not significant predictors on their 
own, but emerged as significant when tested in a prediction equation. At the same time, 
many other variables lost their significance, owing to shared explanatory power. For 
example, the number of fractured ribs was closely correlated with the presence of 
bilateral fractures (r = 0.427; p<0.001), the presence of a flail segment (r = 0.369; 
p<0.001), and ISS (r = 0.379; p<0.001). In turn, ISS was closely correlated with the 
presence of bilateral fractures (r = 0.239; p<0.001), hospital LOS (r = 0.442; p<0.001), 
and the use of mechanical ventilation (r= 0.507; p<0.001). When tested in the full 
equation, the only variables that maintained significance were: 
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Age: β = -319.27 (standardized: -0.059); p<0.001 
Sex: β = 5,135.87 (standardized: 0.022); p=0.065 
ISS: β = 1,162.66 (standardized: 0.110); p<0.001 
Hospital LOS: β = 9,277.65 (standardized: 0.692); p<0.001 
ICU LOS: β = 3,240.35 (standardized: 0.198); p<0.001 
Use of ventilation: β = 13,271.76 (standardized: 0.051); p=0.002 
Use of TEA: β = -15,358.74 (standardized: -0.055); p<0.001 
Acute respiratory failure: β = 16,773.66 (standardized: 0.022); p=0.069 
Pneumonia: β = -21,143.51 (standardized: -0.063); p<0.001 
 
 
 
All tolerance values were >0.20 and variance inflation factors <5. In this model, if 
all other variables were held constant, each additional year of age predicts a $319 
reduction in patient charges. Some of this relationship can be attributed to the decreasing 
medical expenses among patients above the age of 70. In turn, some of that relationship 
was related to increasing mortality, as there was an inflexion point at age 80. Among 
patients ≥ 80 years, the mortality rate was 11.5%; among patients ≤ 79 years, the 
mortality rate was 5.1% (p=0.002). Age also reflected injury severity. Patients who were 
< 70 years had an ISS that was 4.7 points higher than patients who were ≥ 70 years 
(p<0.001). Patient billing as it relates to age is illustrated in Figure 4.4. 
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Figure 4.4: Average patient fees based on decade of age (total sample) 
 
 
There was a trend for men to be billed more than women. Sex was related to both 
age and injury severity. On average, men were younger than women (52.4 ± 18.5 vs. 60.9 
± 22.3 yrs; p<0.001), fractured more ribs (4.0 ± 3.1 vs. 3.7 ± 2.5; p=0.049), had a higher 
ISS (16.7 ± 10.3 vs. 15.1 ± 10.7; p=0.018), a higher incidence of flail segments (7.5% vs. 
4.1%; p=0.036), were more likely to require mechanical ventilation (26.3% vs. 17.5%; 
p=0.002), and were more likely to acquire pneumonia (14.0% vs. 8.8%; p=0.018). 
 
Among all assessments of injury severity, ISS was the strongest predictor of 
patient billing. When tested on its own, the number of ribs fractured was a relatively 
strong predictor (r = 0.202; p<0.001) and there was an inflexion point at 6 ribs (Figure 
4.5). 
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Figure 4.5: Average patient charges based on number of ribs fractured (total sample) 
 
This same inflexion point (6 ribs) predicted patient mortality (Figure 4.6). 
 
Figure 4.6: Mortality rate based on number of ribs fractured (total sample) 
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If patients were below the inflexion point of 6 ribs, there was a significant 
reduction in the amount of money billed to the patient (p<0.001) as well as the cost to the 
hospital of delivering that care (p<0.001). Figure 4.7 illustrates these differences. 
 
Figure 4.7: Average price and cost of treatment based on number of ribs fractured (total 
sample) 
 
In the full model, the number of ribs fractured and ISS shared predictive power. 
Only ISS remained significant. With all other variables held constant, each additional 
point of severity (scores range from 1 to 75) predicts a $1,163 increase in the patient’s 
bill. 
 
The number of days a patient spent both in the hospital and the ICU predicted 
patient billing as well. In the hospital, with all other variables held constant, each 
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additional day added $9,278 while each additional day in the ICU added $3,240. The use 
of mechanical ventilation increased the predicted bill by $13,272 while the use of TEA 
decreased the bill by $15,359. There was a trend (p=0.069) for the incidence of acute 
respiratory failure to predict a $16,774 increase in the patient’s bill. On average, patients 
who developed pneumonia were charged $222,124.51 while patients who did not develop 
pneumonia were charged $65,809.13 (p<0.001). However, in the model, if all other 
variables are held constant, incidence of pneumonia predicted a $21,144 decrease in the 
patient’s bill. The diagnosis of pneumonia was related to a number of other variables, 
including sex, number of fractured ribs, incidence of bilateral fractures, presence of flail 
segments and pulmonary contusions, ISS, the use of mechanical ventilation, LOS in both 
the hospital and ICU, respiratory distress syndrome, acute respiratory failure, and sepsis. 
Among unmatched samples, it’s difficult to understand the complexity of the relationship 
between pneumonia and patient billing. 
 
Variables that predict total cost to the hospital: 
 
When tested individually, the variables that predict treatment cost to the hospital 
are: age (r = -0.139; p<0.001), number of fractured ribs (r = 0.169; p<0.001), presence of 
bilateral fractures (r  = 0.248; p<0.001), presence of a flail segment (r = 0.092; p=0.003), 
presence of pulmonary contusions (r = 0.195; p<0.001), presence of a pnumothorax (r = 
0.135; p<0.001), presence of a hemothorax (r = 0.063; p = 0.047), ISS (r = 0.498; 
p<0.001), use of mechanical ventilation (r = 0.567; p<0.001), duration of ventilation (r = 
0.710; p<0.001), hospital LOS (r = 0.866; p<0.001), ICU LOS (r = 0.826; p<0.001), 
incidence of pneumonia (r = 0.447; p<0.001), incidence of respiratory distress syndrome 
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(r = 0.230; p<0.001), acute respiratory failure (r = 0.197; p<0.001), and sepsis (r = 0.148; 
p<0.001) 
 
The use of TEA (p=0.519) was not a significant predictor on its own, but emerged 
as significant when tested in the full model. Other variables lost significance when tested 
in combination with other predictors. The only variables that maintained significance 
were: 
 
Age: β = -40.15 (standardized: -0.047); p=0.002 
Number of fractured ribs: β = -430.60 (standardized: -0.072); p<0.001 
ISS: β = 192.49 (standardized: 0.116); p<0.001 
Bilateral fractures: β = 3,749.13 (standardized: 0.076); p<0.001 
Pulmonary contusion: β = -1,405.69 (standardized: -0.032); p=0.036 
Pneumothorax: β = 1,639.04 (standardized: 0.038); p=0.009 
Hospital LOS: β = 1,255.92 (standardized: 0.597); p<0.001 
ICU LOS: β = 738.47 (standardized: 0.288); p<0.001 
Use of TEA: β = -2,114.01 (standardized: -0.048); p=0.002 
Acute respiratory failure: β = 3,247.63 (standardized: 0.027); p=0.068 
Pneumonia: β = -2,931.41 (standardized: -0.055); p=0.002 
 
All tolerance values were >0.20 and variance inflation factors <5. In this model, 
holding all other variables constant, the use of TEA predicted a reduction of hospital 
expenses by $2,114. 
 
Matched samples: Characteristics of eliminated patients 
 
The criteria for exclusion were: 1) mortality within 24 hours of admission, 2) 
intubation within 12 hours of admission, and 3) use of anticoagulation medication prior to 
treatment. All patients who met one or more of those criteria were eliminated form the 
database. 
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29 patients died within 24 hours of arrival. The characteristics of these patients 
are displayed in Table 4.4.  
 
Table 4.4: Characteristics of patients who died within 24 hours of admission 
 Died within 24h Survived 24h Significance 
N 29 979  
Sex 79.3% male 65.8% male p = 0.129 
Age (years) 50.6 ± 23.0 55.4 ± 20.2 p = 0.270 
# Ribs Fractured 6.8 ± 5.1 3.9 ± 2.8 p = 0.007 
Injury Severity Score 31.1 ± 15.8  15.7 ± 9.9 p < 0.001 
% Flail Segment 24.1% 5.8% p < 0.001 
% Bilateral Fracture 48.1% 13.7% p < 0.001 
% Pulmonary Contusion 44.8% 19.2% p = 0.001 
% Pneumothorax 20.7% 20.9% p = 0.982 
% Hemothorax 34.5% 4.7% p < 0.001 
Total Charge to Patient $28,694.13  $86,568.97 p < 0.001 
SD $19,386.86 $111,686.65  
Direct Cost to Hospital $2,890.83 $11,236.86 p < 0.001 
SD $3,311.86 $17,529.99  
Charge:Cost Ratio 13.0:1 10.2:1 p = 0.059 
SD 7.5:1 4.3:1  
Per Night Charge $30,448.85 $11,294.12 p < 0.001 
SD $20,061.56 $7,289.93  
 
 
202 patients were intubated within 12 hours of admission. The characteristics of 
these patients are displayed in Table 4.5.  
 
Table 4.5: Characteristics of patients who were intubated within 12 hours of admission 
 Intubated within 12h Not intubated during first 12h Significance 
N 202 806  
Sex 73.8% male 64.3% male p = 0.011 
Age (years) 48.7 ± 18.3 56.9 ± 20.4 p < 0.001 
# Ribs Fractured 5.0 ± 4.1 3.7 ± 2.5 p < 0.001 
Injury Severity Score 20.7 ± 13.5 13.4 ± 7.4 p < 0.001 
% Mortality 22.3% 2.0% p < 0.001 
% Flail Segment 11.9% 5.0% p < 0.001 
% Bilateral Fracture 28.9% 11.0% p < 0.001 
% Pulmonary Contusion 40.6% 14.8% p < 0.001 
% Pneumothorax 26.7% 19.4% p = 0.021 
% Hemothorax 11.9% 4.0% p < 0.001 
Total Charge to Patient $203,806.10 $55,065.53 p < 0.001 
SD $172,367.43 $58,457.75  
Direct Cost to Hospital $28,181.02  $6,684.37 p < 0.001 
SD $27,706.01 $9,567.03   
Charge:Cost Ratio 8.9:1 10.6:1 p < 0.001 
SD 3.8:1 4.5:1   
Per Night Charge $16,817.30 $10,494.54 p < 0.001 
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SD $11,582.12 $6,748.00   
 
 
91 patients were on an anticoagulation medication upon arrival at the hospital. 
The characteristics of these patients are displayed in Table 6.  
 
Table 4.6: Characteristics of patients who were on anticoagulation medication upon 
arrival at the hospital 
 Anticoagulation on arrival No anticoagulation on arrival Significance 
N 91 917  
Sex 61.5% male 66.6% male p = 0.327 
Age (years) 73.2 ± 13.3 53.5 ± 20.0 p < 0.001 
# Ribs Fractured 3.9 ± 3.1  3.9 ± 2.9 p = 0.915 
Injury Severity Score 12.7 ± 7.3 16.5 ± 10.7 p < 0.001 
% Mortality 2.2% 6.4% p = 0.106 
% Flail Segment 8.8% 6.1% p = 0.318 
% Bilateral Fracture 15.6% 14.6% p = 0.799 
% Pulmonary Contusion 7.7% 21.2% p = 0.002 
% Pneumothorax 7.7% 22.2% p = 0.001 
% Hemothorax 6.6% 5.5% p = 0.652 
Total Charge to Patient $78,596.59 $85,528.71 p = 0.569 
SD $104,814.03 $111,125.16  
Direct Cost to Hospital $9,539.27 $11,141.28 p = 0.401 
SD $14,367.70 $17,608.69  
Charge:Cost Ratio 10.1:1 10.3:1 p = 0.683 
SD 3.7:1 4.5:1  
Per Night Charge $10,744.37 $11,838.00 p = 0.234 
SD $8,791.09 $8,267.10  
 
 
Patient characteristics across matched samples (n=721) 
 
287 patients met criteria for exclusion and were eliminated from the database. 
Among the remaining patients, the average age was still 55 years, and still spanned 15 to 
98 years (Figure 4.8). 
 
 
 
 
 
 
 
 
 186 
Figure 4.8: Patient ages by decade (matched sample) 
 
 
 
On average, patients fractured 3.6 ribs (compared to 3.9 prior to exclusion). The 
distribution of rib fracture counts is displayed in Figure 4.9. 
 
Figure 4.9: Frequency of rib fracture counts (matched sample) 
 
 
 
 
 
 
 
 
 187 
After eliminating patients who met exclusionary criteria, the mean ISS was 0.4 
points lower, the overall mortality rate fell from 6.1% to 1.7%, the rate of pneumonia fell 
from 12.2% to 6.7%, and the average patient charges were decreased by $29,691 (Table 
4.7). 
 
Table 4.7: Demographics, injury characteristics, treatment outcomes, and financial data 
(matched samples) 
 Non-TEA TEA Total Sample Significance 
N 558 163 721  
Sex 64.7% male 65.0% male 64.8% male p = 0.937 
Age (years) 54.5 ± 20.6  56.9 ± 8.6  55.0 ± 20.2  p = 0.188 
# Ribs Fractured 3.1 ± 2.1  5.5 ± 2.4  3.6 ± 2.4 p < 0.001 
Injury Severity Score 13.0 ± 7.2  15.7 ± 7.5  13.6 ± 7.4 p < 0.001 
% Flail Segment 2.0% 12.9% 4.4% p < 0.001 
% Bilateral Fracture 9.0% 16.4% 10.6% p = 0.008 
% Pulmonary Contusion 12.9% 23.9% 15.4% p = 0.001 
% Pneumothorax 19.0% 27.6% 20.9% p = 0.018 
% Hemothorax 3.1% 5.5% 3.6% p = 0.137 
Glasgow Coma Score (scene) 14.5 ± 1.8  14.5 ± 1.5  14.5 ± 1.7 p = 0.728 
Glasgow Coma Score (hospital) 14.7 ± 1.5 14.7 ± 1.0  14.7 ± 1.4 p = 0.432 
Mortality 2.0% 0.6% 1.7% p = 0.233 
Pneumonia 5.4% 11.0% 6.7% p = 0.011 
Sepsis 0.5% 0.6% 0.6% p = 0.909 
Respiratory Distress 0.5% 1.8% 0.8% p = 0.107 
Respiratory Failure 0.9% 2.5% 1.2% p = 0.115 
LOS in the Hospital (days) 5.0 ± 5.0 7.9 ± 5.1 5.6 ± 5.2 p < 0.001 
% Admitted to ICU 37.1% 58.2% 41.9% p < 0.001 
LOS in the ICU (days) 3.5 ± 3.8 4.9 ± 5.9 4.0 ± 4.6 p = 0.047 
% Needing Ventilation 5.6% 9.8% 6.6% p = 0.056 
Ventilation duration (days) 6.8 ± 5.1 11.5 ± 7.4 8.4 ± 6.3 p = 0.013 
Total Charge to Patient $51,017.77 $69,543.28 $55,211.74 p < 0.001 
Standard Deviation $57,148.23 $62,645.14 $58,906.15  
Direct Cost to Hospital $6,259.20 $8,374.47 $6,738.07 p = 0.015 
Standard Deviation $10,062.93 $8,652.35 $9,795.83  
Charge:Cost Ratio 11.2:1 9.0:1 10.7:1 p < 0.001 
Standard Deviation 5.0:1 1.9:1 4.6:1  
Per Night Charge $11,210.34 $8,308.50 $10,546.01 p < 0.001 
Standard Deviation $7,206.33 $3,203.64 $6,622.14  
 
 
Patients who received TEA had more severe injuries than those who did not. The 
TEA patients fractured 2.4 more ribs, were 6.5 times more likely to present with a flail 
segment, had nearly double the rates of bilateral fractures and pulmonary contusions, 
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were 1.5 times more likely to present with a pneumothorax, and had a mean ISS that was 
2.7 points higher. The TEA patients were also 1.6 times more likely to be admitted to the 
ICU and 1.8 times more likely to require mechanical ventilation. Among all patients who 
received ventilation, the TEA group remained on it for an additional 4.7 days. They also 
remained in the ICU an additional 1.4 days and in the hospital for an additional 2.9 days. 
Patients receiving TEA had 1.8 times the incidence of pneumonia, but there were no 
other differences in complication rates. Despite large differences in injury severity, there 
were no significant differences in mortality.  
 
Patients were billed about $55,000 for treatment, ranging from $3,792 to 
$496,315. Billing was proportionate to hospital LOS; on average, patients were billed 
$10,546 per day. The actual cost of care was $6,738 per patient, but ranged from $143 to 
$124,522 (Table 4.8). 
 
Table 4.8: Treatment cost among survivors and mortalities (matched samples) 
 Survivors Mortalities Total Sample Significance 
N 709 12 721  
Total Charge to Patient $54,101.34 $120,725.74 $55,211.74 p = 0.018 
Standard Deviation $57,850.53 $83,339.22 $58,906.15  
Direct Cost to Hospital $6,576.26 $16,284.82 $6,738.07 p = 0.016 
Standard Deviation $9,687.85 $11,781.33 $9,795.83  
Charge:Cost Ratio 10.7:1 8.2:1 10.7:1 p = 0.056 
Standard Deviation 4.6:1 1.9:1 4.6:1  
Per Night Charge $10,449.08 $16,200.74 $10,546.01 p = 0.063 
Standard Deviation $6,526.31 $9,613.73 $6,622.14  
 
 
Overall, the patients who died were charged 2.2 times more than those who 
survived and their treatment cost the hospital 2.5 times more. Treatment of patients who 
received TEA cost the hospital an additional $2,115, but they were charged $18,526 
more. Despite these differences, the charge-to-cost ratio among patients not treated with 
TEA was 24% higher. 
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Group differences between patients who received TEA and survived, patients who 
received TEA and died, patients who did not receive TEA and survived, and patients who 
did not receive TEA and died are displayed in Table 4.9. 
 
Table 4.9: Patient characteristics and financial data among TEA survivors, TEA 
mortalities, non-TEA survivors, and non-TEA mortalities (matched samples) 
 TEA Mortality TEA Survivors noTEA Mortality noTEA Survivors 
N 1 162 11 547 
Age (years) 86 56.7 ± 18.5 70.8 ± 22.6 54.2 ± 20.5 
# Ribs Fractured 7 5.5 ± 2.4 4.2 ± 2.5 3.1 ± 2.1 
Injury Severity Score 17 15.7 ± 7.5 14.1 ± 6.7 12.9 ± 7.2 
% Flail Segment No 13.0% 0% 2.0% 
% Bilateral Fracture No 16.5% 0% 9.1% 
% Pulmonary Contusion No 24.1% 0% 13.2% 
LOS in Hospital (days) 24 7.8 ± 5.0 8.0 ± 7.2 4.9 ± 4.9 
% Admitted to ICU Yes 58.0% 90.9% 36.0% 
LOS in ICU (days) 23 4.7 ± 5.7 6.9 ± 4.9 3.4 ± 3.7 
% Needing Ventilation Yes 9.3% 63.6% 4.4% 
Vent duration (days) 15 11.3 ± 7.6 7.6 ± 4.7 6.5 ± 5.3 
Total Charge to Patient $220,118.52 $68,613.81 $111,690.03 $49,795.44 
SD NA $61,701.65 $81,007.83 $55,996.73 
Direct Cost to Hospital $31,007.43 $8,234.76 $14,946.40 $6,084.18 
SD NA $8,492.75 $11,359.30 $9,969.20 
Charge:Cost Ratio 7.1:1 9.0:1 8.3:1 11.2:1 
SD NA  1.9:1 1.9:1 5.1:1 
Per Night Charge $9,171.61 $8,303.17 $16,839.75 $11,095.24 
SD NA $3,212.85 $9,812.04 $7,109.12 
 
 
Among patients who did not receive TEA, those who died had larger bills 
(p=0.030) and were more expensive to treat (p=0.004). Although they had a lower 
charge-to-cost ratio (p=0.053), their charges per day were much higher (p=0.009). Only 1 
patient who received TEA died. Patients who received TEA and survived can be 
compared to those who did not receive TEA and died. 
 
Compared to patients who were not treated with TEA and died, the survivors who 
received TEA were 14 years younger (p=0.017) but exhibited trends of more severe 
injuries: they fractured 1.3 more ribs (p=0.079) and nearly a quarter presented with 
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pulmonary contusions, compared to none (p=0.064). Despite differences in injury 
severity, survivors who received TEA were less likely to be admitted to the ICU 
(p=0.031) and less likely to require mechanical ventilation (p<0.001). Owing to small 
samples, differences in ICU LOS (p=0.233) and duration of ventilation (p=0.251) were 
not significant.  
 
Compared to survivors who were treated with TEA, patients who did not receive 
TEA and died were charged 63% more ($43,076; p=0.112) and cost the hospital 82% 
more ($6,712; p=0.081). Larger samples would be needed to confirm these trends. The 
daily charge to patients who receive TEA and survive is half that of patients who do not 
receive TEA and die (p=0.016). 
 
Variables that predict the price and cost of treatment across matched samples (n=721) 
 
Variables that predict total charges to the patient: 
 
When tested individually, the variables that predict patient billing are: Number of 
fractured ribs (r = 0.220; p<0.001), presence of bilateral fractures (r = 0.227; p<0.001), 
presence of a flail segment (r = 0.086; p=0.021), presence of a pulmonary contusion (r = 
0.163; p<0.001), ISS (r = 0.449; p<0.001), use of TEA (r = 0.132; p<0.001), use of 
mechanical ventilation (r = 0.600; p<0.001), duration of ventilation (r = 0.752; p<0.001), 
hospital LOS (r = 0.853; p<0.001), ICU LOS (r = 0.799; p<0.001), incidence of 
pneumonia (r = 0.411; p<0.001), incidence of respiratory distress syndrome (r = 0.339; 
p<0.001), acute respiratory failure (r = 0.148; p<0.001), sepsis (r = 0.238; p<0.001), and 
mortality (r = 0.145; p<0.001). 
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Age (r = -0.024; p=0.526) was not a significant predictor on its own, but emerged 
as significant when tested in combination with other variables. When tested in the full 
equation, the only variables that maintained significance were: 
 
Age: β = -191.02 (standardized: -0.066); p<0.001 
ISS: β = 869.56 (standardized: 0.109); p<0.001 
Bilateral fractures: β = 11,220.99 (standardized: 0.059); p=0.001 
Hospital LOS: 6,747.57 (standardized: 0.593); p<0.001 
ICU LOS: β = 4,771.47 (standardized: 0.289); p<0.001 
Use of TEA: β = -12,072.81 (standardized: -0.086); p<0.001 
Respiratory distress syndrome: β = 26,391.65 (standardized: 0.041); 
p=0.025 
 
 
 
All tolerance values were >0.30 or variance inflation factors <3. In this model, 
with all other variables held constant, each additional year of age predicts a $191 
reduction in the patient’s bill (95% CI: -291.83 to -90.22). Patient charges per decade of 
life are displayed in Figure 4.10. 
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Figure 4.10: Average patient fees based on decade of age (matched sample) 
 
 
Although this relationship appears to be driven by the relatively low charges to 
the eldest patients, if all patients ≥ 90 years of age are eliminated from the analysis, the 
predictive power of age maintains its strength (β = -198.21; standardized β = -0.062; 
p<0.001). Some of the relationship with age is a reflection of injury severity. Relative to 
patients ≥ 70 years of age, those younger than 70 have an ISS that is 3.0 points higher 
(p<0.001), are twice as likely to present with pulmonary contusions (p=0.002), and 1.7 
times more likely to experience bilateral fractures (p=0.028). 
 
Injury severity is a major predictor of patient billing. When tested by itself, the 
number of fractured ribs is strongly correlated with patient charges (r = 0.220; p<0.001). 
The average patient billing per rib fractured is displayed in Figure 4.11. 
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Figure 11: Average patient charges based on number of ribs fractured (matched sample) 
 
There is an inflexion point at 6 ribs: patients who fractured 6 or more ribs were 
charged 1.7 times more than patients who fractured 5 or fewer ribs (p<0.001). This 
inflexion point is illustrated in Figure 4.12. 
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Figure 4.12: Average patient charges based on inflexion point of ribs fractured (matched 
sample) 
 
 
 
In the full model, the number of ribs fractured and ISS shared predictive power, 
and only ISS remained as a predictor. With all other variables held constant, each 
additional point in a patient’s ISS predicted an increase of $870 in the patient’s bill (95% 
CI: 566.36 to 1,172.77). The presence of bilateral fractures also remained a predictor in 
the full model. A patient admitted with bilateral rib fractures would predict a $11,221 
increase in the patient’s bill (95% CI: 4,705.81 to 17,736.18). 
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Length of stay in the hospital and ICU were both strong predictors. Each 
additional day spent in the hospital predicted an increase in patient charges of $6,748 
(95% CI: 6,127.26 to 7,367.89) while each additional day in the ICU predicted an 
increase of $4,771 (95% CI: 3,864.96 to 5,677.98). The use of TEA predicted lower 
patient charges by $12,073 (95% CI: -16,939.89 to -7,213.73). Incidence of respiratory 
distress syndrome predicted an increase in patient billing by $26,392 (95% CI: 3,312.26 
to 49,471.03). 
 
Variables that predict total cost to the hospital: 
 
When tested individually, the variables that predict treatment cost to the hospital 
are: number of fractured ribs (r = 0.184; p<0.001), presence of bilateral fractures (r  = 
0.247; p<0.001), presence of a flail segment (r = 0.077; p=0.039), presence of pulmonary 
contusions (r = 0.117; p=0.002), ISS (r = 0.388; p<0.001), use of TEA (r = 0.090; 
p=0.015), use of mechanical ventilation (r = 0.555; p<0.001), duration of ventilation (r = 
0.637; p<0.001), hospital LOS (r = 0.775; p<0.001), ICU LOS (r = 0.745; p<0.001), 
incidence of pneumonia (r = 0.393; p<0.001), incidence of respiratory distress syndrome 
(r = 0.286; p<0.001), acute respiratory failure (r = 0.118; p=0.001), sepsis (r = 0.212; 
p<0.001), and mortality (r = 0.127; p=0.001). 
 
Age (r = -0.003; p=0.944) was not a significant predictor on its own, but emerged 
as significant when tested in the prediction equation. When tested in the full equation, the 
only variables that maintained significance were: 
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Age: β = -20.40 (standardized: -0.042); p=0.061 
ISS: β = 92.24 (standardized: 0.069); p=0.005 
Bilateral fractures: β = 3,133.40 (standardized: 0.099); p<0.001 
Hospital LOS: β = 977.23 (standardized: 0.517); p<0.001 
ICU LOS: β = 876.04 (standardized: 0.319); p<0.001 
Use of TEA: β = -2,583.96 (standardized: -0.110); p<0.001 
 
 
 
 
All tolerance values were >0.30 or variance inflation factors <3. Excepting only 
the duration of treatment, the predictor that accounted for the most variance in hospital 
expenses per patient was the use of TEA. In the full model, with all other variables held 
constant, the use of TEA predicted a reduction in patient expenses of $2,584 (95% CI: -
3,613.98 to -1,553.94). 
 
 
DISCUSSION 
 
Rib fractures are common injuries. In U.S. trauma centers, 7–10% of all patients 
admitted have at least 1 fractured rib2,113 At our trauma center, during the 4-year study 
period, 9.8% of all patients presented with rib fractures. The demographics and injury 
characteristics of these patients were typical of other patient populations. While age 
ranged across the lifespan and the severity of injury was broad, on average, our patients 
were 55 years old and presented with 4 fractured ribs. The rates of associated injuries 
such as flail chest were similar to the rates reported at other hospitals. 
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The primary goal in treating these patients is to minimize the risk of mortality and 
pulmonary complications. Historically, when a patient with ≥ 1 fractured rib is treated, 
the risk of mortality is about 10%, the risk of pneumonia ranges between 17 and 31%, 
and the expected hospital LOS is 7 to 16 nights.2,5,6,10 At our hospital, the mortality rate 
was 6.1%, the incidence of pneumonia was 12.2%, and the average hospital LOS was 7.5 
nights. 
 
Our approach to rib fracture care differs from most hospitals. According to 
analyses of the National Trauma Data Bank, 2.0% of all rib fracture patients receive 
TEA7 and 7.6% of patients with flail segments.26 At out hospital, 19.3% of all rib fracture 
patients receive TEA and 53.1% of patients with flail segments. We have achieved these 
rates by using a care team that includes dedicated anesthesiologists and nurses trained in 
pain management. The anesthesiologists are assigned to the trauma patients exclusively 
for a week at a time. They round all 7 days, assume all pain management responsibilities 
for those patients, and do not work in the operating room during the week. Although 
they’re not typically onsite during the nighttime hours, they are available all hours for the 
nurses to page them with questions about pain management. In turn, the nurses are 
responsible for treatment variations, such as adjustments of dosage. Through this service, 
we have been able to administer TEA to a higher percentage of patients than most 
hospitals. 
 
Other authors have found similar improvements in treatment outcomes using 
alternative strategies, such as the “multidisciplinary clinical pathway”. This is an 
aggressive approach to treating patients who are ≥ 45 years of age and present with ≥ 4 
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fractured ribs. The treatment involves several pain management techniques (oral, IV, and 
epidural), respiratory therapy (e.g., aerosolized pharmocoligic therapies and EzPAP 
positive airway pressure), physical therapy (e.g., range of motion and balance exercises), 
and nutrition services (dietary monitoring and supplement administration). When using 
this entire combination of treatments, one hospital reported its mortality rate declining 
from 13% to 4%, the incidence of pneumonia declining from 18% to 5%, and the hospital 
LOS shortening from 14.3 to 11.7 days (not statistically significant).59 
 
Although effective in terms of outcomes, costs to the hospital and charges to the 
patient were not reported in the multidisciplinary clinical pathway. Without access to any 
financial data, it is difficult to know the cost-effectiveness of this treatment. Its extensive 
nature is likely to be expensive to the hospital as well as to the patient. It is possible that 
some of the services (e.g., nutrition services) are adding more cost than value and it 
would be helpful to know the individual contribution of each therapeutic component to 
the treatment outcomes. 
 
Few authors have reported on the financial costs of treating patients with rib 
fractures. Although the available data are very limited, the most common finding is that, 
while additional treatments bear extra costs, if they can eliminate complications, reduce 
the need for mechanical ventilation and the duration of its use, and facilitate an earlier 
discharge from the hospital, the total treatment costs are likely to be decreased.162-164 In 
our population, the hospital’s treatment structure enabled greater reliance on TEA, which 
in turn reduced both hospital costs and patient bills. 
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After eliminating patients from the database who were not candidates for TEA, 
and only comparing patients who received TEA to eligible candidates who did not 
receive it, the variables that predicted patient charges were: age, ISS, presence of bilateral 
fractures, hospital LOS, ICU LOS, the use of TEA, and incidence of respiratory distress 
syndrome. The average patient bill was $55,212 and the combination of those predictors 
explained 80% of the variance in billing. The strongest predictors were hospital LOS and 
ICU LOS. In the full model, if all other variables were held constant, the use of TEA 
could be expected to reduce patient charges by $12,073 (p<0.001).  
 
Regarding hospital expenses, the average cost per patient was $6,738 and all of 
the same variables predicted expense except incidence of respiratory distress syndrome. 
The model explained 68% of the variance in hospital costs and the two largest predictors 
were still hospital LOS and ICU LOS. The next most important predictor was the use of 
TEA. In this prediction model, if all other variables were held constant, the use of TEA 
could be expected to reduce the cost to the hospital by $2,584 (p<0.001). 
 
Limitations 
 
After eliminating patients who were not candidates to receive TEA, there remained only 
1 patient who received TEA and died and 11 patients who did not receive TEA and died. 
These small samples may have resulted in a failure to identify important relationships 
that might have emerged with larger samples. Likewise, we may have assumed 
meaningful relationships owing to sampling errors. Additional studies with larger 
samples will be useful in confirming our observations. 
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Conclusions 
 
As the first known study to report on the cost effectiveness of TEA in patients with rib 
fracture injuries, its use appears to significantly reduce both hospital costs and patient 
charges. From an administrative and insurance perspective, more frequent reliance on 
TEA may be indicated. As a first step, other hospitals should report the cost-effectiveness 
of their care models among patients with rib fractures. 
 
Disclaimers 
 
This study is associated with no source of funding. It is a collaboration between the St. 
Vincent Hospital in Indianapolis, the University of Connecticut, and Sum Integral. 
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Chapter 5: Conclusion 
 
Rib fractures are a commonly treated injury in U.S. trauma centers. About 10–
15% of all admissions are the result of blunt thoracic trauma, which frequently results in 
chest wall injuries.2 The most common of these injuries, present in approximately 50% of 
patients who sustain blunt thoracic trauma, is rib fractues.1-3,31 In total, rib fractures are 
detected in nearly 300,000 patients admitted to U.S. trauma centers each year4 and many 
more fractures go undetected at admission.2,3,5 Among all patients who present with at 
least 1 fractured rib, a mortality rate of about 10% can be expected.2,3,5,10 With better 
treatments, hospitals seem capable of achieving better patient outcomes.59 Given the 
annual mortality rate attributable to rib fracture injuries, furthering our understanding of 
ideal care strategies is likely to save many lives. 
 
In the previous chapters, I reported my findings from analyses of a sample of rib 
fracture patients. This sample was derived from a trauma registry, obtained from St. 
Vincent Hospital in Indianapolis, Indiana. This hospital operates an ACS-verified Level 
II trauma center that began accepting patients in November 2010. The data I analyzed 
were exported in December 2014; thus it comprised 4 years of patient records. During 
those 4 years, there were 10,242 total patients treated; 1,008 of them (9.8%) had 
sustained rib fractures. This percentage is consistent with other trauma centers, which 
report between 7–10% of admitted patients to present with at least 1 fractured rib.2,19,113 
 
In treating these patients, age and injury severity affect the likelihood of 
success.6,8,10,82 Regarding age, the mean age of survivors tends to be at least 5 years 
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younger than the mean age of patients who die5,10 and when patients are separated into 
young (18–64 years) and old (≥ 65 years) populations, the mortality rate among the older 
group tends to be at least double that of the younger group.3,6 Regarding injury severity, 
among patients who only fracture 1–2 ribs, a mortality rate of 5–6% can be expected.2,10 
In the presence of 8 or more fractures, the mortality may surpass 30%.10 If both flail 
segments and pulmonary contusions are present, the mortality rate may exceed 40%.34 
Similar relationships exist with complication rates (e.g., pneumonia) and various 
treatment variables such as the use of mechanical ventilation and the length of stay (LOS) 
in the hospital and intensive care unit (ICU).2,5,6,10 
 
While the degree of structural damage that occurs in rib fracture injuries can be 
profound, it is often the pain itself that precipitates the high rates of morbidity and 
mortality.10,19,37 When a patient presents with multiple fractured ribs, normal ventilatory 
behaviors such as coughing and deep breathing are likely to exacerbate symptoms of 
pain. In response, patients alter pulmonary mechanics: they begin splinting in attempt to 
minimize pain.35,36 As their breathing becomes shallow and coughing infrequent, the 
normal mobilization of airway secretions gets impaired, resulting in the buildup of 
sputum.11,37-39,78,82,83,115 In combination with muscle spasms and progressively 
diminishing lung compliance, this elevates the risk of secondary complications, such as 
pneumonia, and increases the likelihood that patients will experience respiratory failure 
and require ventilatory support.37,38,40,41 In turn, the likelihood that a patient will die is 
drastically elevated.42-45 Thus, effectively managing each patient’s pain level is critical to 
successful treatment outcomes.41,46,47 
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There are multiple ways of controlling pain. Very fundamentally, patients can be treated 
with either systemic analgesic drugs (oral or intravenous) or regional modes of 
delivery.10,37,47 Among the regional modes, thoracic epidural analgesia (TEA) may be the 
most commonly evaluated.37,46,47,168 In the previous chapters, I focused on the use of TEA 
in patients with multiple fractured ribs, evaluating its relationships with mortality, risk of 
complications, treatment variables such as duration and the use of mechanical ventilation, 
and its affect on the cost, both to the patient and to the hospital. In this chapter, I will 
summarize the findings of those chapters. The topics discussed are: 
 
1) How the demographics and injury characteristics of St. Vincent’s patients 
compare to those of other reports. 
2) How the use of TEA at St. Vincent compares to the use of TEA at other trauma 
centers. 
3) How the treatment outcomes (mortality, incidence of pulmonary complications, 
use of mechanical ventilation, and LOS in the hospital and ICU) of St. Vincent’s 
patients compare to those of other reports. 
4) How the treatment outcomes of St. Vincent patients treated with TEA compare to 
those not treated with TEA. 
5) How TEA affected the cost of treatment, both to the patient and to the hospital. 
6) How St. Vincent’s care structure for the treatment of patients with rib fractures 
may be an ideal model for other hospitals to employ in their own trauma centers. 
 
Patient demographics and injury characteristics at baseline: How St. Vincent’s 
patients compare to those treated at other trauma centers 
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At St. Vincent, patients were aged across the lifespan, from 15 to 98 years, and 
the breadth of injury severity was vast. The number of fractured ribs among individual 
patients ranged from a single rib to all 24 ribs and the injury severity scores (ISS) ranged 
from 1 (lowest possible score) to 75 (maximum possible score). However, the mean 
values of all demographic data and injury characteristics were similar to the values 
reported in other studies. 
 
Sex. At most trauma centers, the majority of patients who are admitted with rib 
fractures are men. I only found 2 studies that reported the majority of patients to be 
women.82,96 I found 2 more studies that reported men to just barely outnumber women7,98 
and an additional 2 in which men totaled less than two-thirds of the population.28,78 
Opposite that, several studies reported men to compose about 90% of the patient 
population.61,93,169 In most reports, however, men represented about two-thirds to three-
fourths of the patient population.6,8,9,11,29,30,41,89,91,97,170 At St. Vincent, 66.2% of all 
patients were men. 
 
Age. Some studies tested younger patients78,91 and others tested older patients82,98, 
but the mean patient age reported in most studies was 40–55 years.7,9,11,25,28-30,36,61,83,89,92-
94,97,169-172 At St. Vincent, the mean age was 55.3 ± 20.3 years. 
 
Number of fractured ribs. Although some patients fractured fewer97 and some 
fractured more11,89,170, the mean number of fractures is typically about 4–6 ribs.6-
9,25,29,36,92-94,169,172 At St. Vincent, the mean number of fractured ribs was 3.9 ± 2.9. 
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ISS. Some studies report a relatively low mean ISS29,82,96 and others report a 
relatively high ISS11,78, but most report values between 17–22.6-10,36,83,89,91,94 At St. 
Vincent, the mean ISS was 16.1 ± 10.4. 
 
Incidence of flail segment. Some authors have found flail segments to be present 
in fewer than 4% of rib fracture cases26,28 while others have reported incidences over 
20%.11,27 Typically, among patients who present with at least 1 fractured rib, the 
incidence of flail chest falls in between those amounts, but remains diverse.3,6,9,29,30 At St. 
Vincent, 6.4% of patients presented with a flail segment. 
 
Incidence of pulmonary contusion. The incidence of pulmonary contusions in rib 
fracture studies is broad. The range of rates reported include 10%30,  16–17%25,29, 25–
30%3,6,7, 40–50%9,11,28, and as high as 58%83. At St. Vincent, 20.0% of patients presented 
with a pulmonary contusion. 
 
Overall, patients at St. Vincent Trauma Center were similar to patients admitted to 
other trauma centers in the U.S. 
 
TEA: How use at St. Vincent compares to use at other trauma centers 
 
TEA was administered more frequently to St Vincent patients than it was to 
patients at other trauma centers. According to analyses of the National Trauma Data Bank 
(NTDB), 2.0% of patients who were admitted with 1 or more rib fractures received 
TEA.10 At St. Vincent, 19.3% of all rib fracture patients received TEA. According to 
another NTDB report, 7.6% of patients admitted with a flail segment received TEA.26 At 
St. Vincent, 53.1% of patients with a flail segment received TEA. 
 206 
 
Although TEA is only used in about 2% of all rib fracture cases nationally, reliance is 
related to the severity of injury: it increases with each additional rib fractured (R2 = 0.96) 
and there is an inflexion point at 6 ribs, above which, the use of epidural catheters 
increases by 50% (figure 1).10 At St. Vincent, this relationship is less significant; 
although use does increase with each rib fractured (R2 = 0.097; p<0.001), there was no 
clear inflexion point (Figure 5.1). 
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Figure 5.1. Percentage of patients who received TEA at St. Vincent Trauma Center 
compared to the NTDB, as reported by Flagel et al., 2005. 
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Treatment outcomes: How St. Vincent’s patients compare to those treated at other 
trauma centers 
 
 Among all blunt thoracic trauma patients who present with rib fractures, the 
expected mortality rate is about 10%.2,3,5,10 Pulmonary complications develop in a third to 
half of all patients who fracture at least 1 rib.2,10 The incidence of pneumonia varies 
depending on the patients’ age and injury characteristics10,46, but Bulger et al.6 found it to 
arise in 17% of younger patients and 31% of elderly patients. On average, patients with 
rib fractures spend 7 to 16 nights in the hospital and 40–50% are admitted to the ICU, 
where they stay 4 to 8 nights.2,5,10 About 60% of patients with rib fractures receive 
mechanical ventilation for an average duration of 13 days.10 
 
By comparison, the mortality rate among patients treated for rib fractures at St. 
Vincent Trauma Center was 6.1%. We don’t have reports on all pulmonary complications 
but the incidence of pneumonia was 12.2%. Despite the lower rates of mortality and 
pneumonia, the percentage of patients admitted to the ICU (51.2%) was somewhat high. 
The average hospital LOS (7.5 days) and ICU LOS (6.7 days) were normal. Relatively 
few patients at St. Vincent received mechanical ventilation (23.3%) and the duration of 
use was relatively brief (9.1 days). 
 
Treatment outcomes: How St. Vincent patients treated with TEA compare to those 
not treated with TEA 
 
To evaluate the efficacy of TEA among St. Vincent patients, I eliminated the 
records of all patients who were not candidates for its use. This enabled comparisons to 
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be made between patients who received TEA and those who were eligible to receive it, 
but did not. Criteria for exclusion were: 1) the patient died within 24 hours of admission, 
2) the patient was intubated within 12 hours of admission, or 3) the patient was on an 
anticoagulation medication prior to treatment. 
 
After eliminating those who were not candidates for TEA, there remained 721 
patients in the database. Only 1 patient receiving TEA died (0.6%): an 86-year-old man 
who sustained 7 fractures in a fall. By comparison, 2.0% of patients not receiving TEA 
died; controlling for no other variables, this difference was not significant (p=0.233). 
Patients receiving TEA were 1.8 times more likely to develop pneumonia (p=0.011) but 
the risk of other complications was similar. TEA patients also spent an extra 2.9 days in 
the hospital (p<0.001), were 57% more likely to be admitted to the ICU (p<0.001), and 
among those admitted, they remained in the ICU 1.4 days longer (p=0.047). TEA patients 
required mechanical ventilation 75% more often (p=0.056) and among those intubated, 
they continued to receive ventilatory assistance for an additional 4.7 days (p=0.013). 
 
Much of this can be explained by differences in injury severity. Patients who 
received TEA had an ISS that was 2.7 points higher (p<0.001), fractured 2.4 more ribs 
(p<0.001), were 82% more likely to present with bilateral fractures (p=0.008), 85% more 
likely to have a pulmonary contusion (p=0.001), 6.5 times more likely to have a flail 
segment (p<0.001), and 45% more likely to present with a pneumothorax.  
 
Among these patients, the best predictors of mortality were age (p=0.004), the use 
of TEA (p=0.071), and the use of mechanical ventilation (p<0.001). The model is 
significant (p<0.001), includes 717 patients, and explains about 39% of the variance in 
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mortality. Regarding age, each additional year increased the odds of mortality by about 
7% (95% CI of odds ratio: 0.021–1.112), patients who received mechanical ventilation 
were about 58 times more likely to die (95% CI of odds ratio: 13.958–237.126), and the 
use of TEA decreased the odds of mortality by about 87% (95% CI of odds ratio: 0.015–
1.186). 
 
Cost of treatment: How TEA affected patient billing and hospital expenses 
 
Across the total population (n=1,008), the average patient bill was about $85k, but 
it ranged from $2,448 to $985,979 and was proportionate to LOS. The average amount 
patients were billed per day was $11,727. The average cost to the hospital was about 
$11k and ranged from $143 to $148,594. 
 
To compare the effect of TEA on a patient’s bill and hospital expenses, the same 
exclusionary criteria were employed (early mortality, early intubation, and pre-treatment 
anticoagulation). After eliminating the records of all patients who were never candidates 
for TEA, the remaining patients (n=721) were billed an average of $55k for treatment, 
ranging from $3,792 to $496,315 and the per-day charge was $10,546. The hospital 
expense for delivering care was $6,738 per patient, ranging from $143 to $124,522. 
 
Compared to patients who did not receive TEA, those who were treated with TEA 
cost the hospital $2,115 more (p=0.015) but were billed $18,526 more (p<0.001). On 
average, patients who did not receive TEA were billed $2,902 more per day. 
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The predictors of patient billing were age (p<0.001), ISS (p<0.001), presence of 
bilateral fractures (p=0.001), hospital LOS (p<0.001), ICU LOS (p<0.001), incidence of 
respiratory distress syndrome (p=0.041), and the administration of TEA (p<0.001). This 
collection of predictors explained about 80% of the variance in billing (p<0.001). The 
strongest predictors were hospital LOS and ICU LOS. Holding all other variables 
constant, each additional day in the hospital predicted an increase of $6,748 (95% CI: 
6,127.26 to 7,367.89) while each additional day in the ICU increased charges by $4,771 
(95% CI: 3,864.96 to 5,677.98). Conversely, treating patients with TEA predicted a 
$12,073 reduction in patient charges (95% CI: -16,939.89 to -7,213.73). 
 
The predictors of hospital expense were age (p=0.061), ISS (p=0.005), presence 
of bilateral fractures (p<0.001), hospital LOS (p<0.001), ICU LOS (p<0.001), and the 
administration of TEA (p<0.001). This collection of predictors explained about 68% of 
the variance in hospital expenses. After duration of treatment (hospital and ICU LOS), 
the next most significant predictor was the use of TEA. With all other variables held 
constant, delivering TEA to a patient predicted a $2,584 reduction in hospital expenses 
(95% CI: -3,613.98 to -1,553.94). 
 
St. Vincent’s care structure: How Anesthesia Pain Services (APS) can be 
incorporated into other trauma centers 
 
At St. Vincent, the treatment of patients admitted with rib fractures has elicited 
better outcomes compared to reports by other hospitals. Much of this success appears to 
be consequent of the increased reliance on TEA, while the ease of TEA administration is 
facilitated by the APS care model employed at St. Vincent.  
 212 
 
APS is a care team that includes dedicated anesthesiologists with expertise in 
acute pain control and nurses who are trained to manage those patients. The 
anesthesiologists work for a week at a time, they round all 7 days, and their duties are 
limited to the trauma center patients. Although they are only onsite and available to 
install epidural catheters during the daytime hours, they’re available to be paged by the 
nurses 24 hours a day with questions about patient management (e.g., dosage 
adjustments). Through this structure, the hospital has been able to drastically increase the 
administration of TEA.  
 
Conclusion 
 
When a patient is admitted with multiple fractured ribs, more severe injuries 
typically associate with poorer treatment outcomes, most notably elevating the risk of 
mortality. Administering TEA to these patients appears to attenuate this rise in mortality, 
resulting in better odds of survival. Furthermore, the use of TEA appears to reduce both 
the cost of delivering care and the amount the patient is billed. Despite these encouraging 
results, TEA continues to be an uncommon treatment, used in about 2% of rib fracture 
patients. 
 
More research still needs to be done to accurately compare the cost-effectiveness 
of TEA to other treatment options. As a first step, other trauma centers should analyze 
their data registries and report the efficacy and safety of different treatment options as 
well as the cost and charges associated with their delivery. If our findings are confirmed – 
that TEA improves patient outcomes while reducing the overall cost of care – then our 
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APS model for rib fracture care may be considered as a roadmap for other programs to 
implement.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 214 
References 
1. Lee R, Bass S, Morris JJ, MacKenzie E. Three or more rib fractures as an 
indicator for transfer to a level I trauma center: a population-based study. Journal 
of Trauma. 1990;30:689-694. 
2. Ziegler D, Agarwal N. The morbidity and mortality of rib fractures. Journal of 
Trauma. 1994;37:975-979. 
3. Sharma O, Oswanski M, Jolly S, Lauer S, Dressel R, Stombaugh H. Perils of rib 
fractures. Am Surg. 2008;74:310-314. 
4. Shuaib W, Vijayasarathi A, Tiwana M, Johnson J-O, Maddu K, Khosa F. The 
diagnostic utility of rib series in assessing rib fractures. Emerg Radiol. 
2013;21(2):159-164. 
5. Cameron P, Dziukas L, Hadj A, Clark P, Hooper S. Rib fractures in major trauma. 
Aust N Z J Surg. 1996;66(8):530-534. 
6. Bulger E, Arneson M, Mock C, Jurkovich G. Rib fractures in the elderly. Journal 
of Trauma. 2000;48:1040-1047. 
7. Wu C, Jani N, Perkins F, Barquist E. Thoracic epidural analgesia versus 
intravenous patient-controlled analgesia for the treatment of rib fracture pain after 
motor vehicle crash. Journal of Trauma. 1999;47(3):564-567. 
8. Yeh D, Kutcher M, Knudson M, Tang J. Epidural analgesia for blunt thoracic 
injury—Which patients benefit most? . Injury, Int. J. Care Injured. 2012;43:1667-
1671. 
9. Waqar S, Nasir K, Zahid M. Thoracic epidural analgesia versus intravenous 
opioid analgesia for the treatment of rib fracture pain. International Journal of 
Collaborative Research on Internal Medicine & Public Health 2013;5(2):112-
119. 
10. Flagel B, Luchette F, Reed L, et al. Half-a-dozen ribs: the breakpoint for 
mortality. Surgery. 2005;138(4):717-723. 
11. Bulger E, Edwards T, Klotz P, Jurkovich G. Epidural analgesia improves outcome 
after multiple rib fractures. Surgery. 2004;136:426-430. 
12. Sattler S, Maier R. Pulmonary Contusion. In: Karmy-Jones R, Nathens A, Stern 
E, eds. Thoracic Trauma and Critical Care. Berlin: Springer; 2002:159-160, 235-
243. 
13. Ullman E, Donley L, Brady W. Pulmonary trauma emergency department 
evaluation and management. Emergency Medicine Clinics of North 
America 2003;21(2):291-313. 
14. Allen G, Coates N. Pulmonary contusion: A collective review. The American 
Surgeon. 1996;62(11):895-900. 
15. Cohn S. Pulmonary contusion: Review of the clinical entity. Journal of 
Trauma 1997;42(5):973–979. 
16. Gavelli G, Canini R, Bertaccini P, Battista G, Bnà C, Fattori R. Traumatic 
injuries: imaging of thoracic injuries. European Radiology 2002;12(6):1273–
1294. 
17. Keough V, Pudelek B. Blunt chest trauma: Review of selected pulmonary injuries 
focusing on pulmonary contusion. AACN Clinical Issues 2001;12(2):270–281. 
 215 
18. Karmy-Jones R, Jurkovich G. Blunt Chest Trauma. Curr Probl Surg. 
2004;41:223-380. 
19. Mayberry J, Trunkey D. The fractured rib in chest wall trauma. Chest Surg Clin N 
Am. 1997;7:239-261. 
20. Nirula R, JC M. Rib Fracture Fixation: Contraversies and Technical Challenges. 
The American Surgeon. 2010;76(8):793-802. 
21. Haraguchi S, Hioki M, Hisayoshi T, et al. Resection of sternal tumors and 
reconstruction of the thorax: a review of 15 patients. Surgery Today. 
2006;36(3):225-229. 
22. Winge R, Berg J, Albret R, Krag C. VAC® for external fixation of flail chest. 
Clinics and Practice. 2012;28(2):e65. 
23. Chung C, Chin S, Chin M, Tellides G, Narayan D. Pectoralis major hemiosseous 
flap for paradoxical respiration. Plastic and Reconstructive Surgery. 
2006;117(6):2102-2103. 
24. Trinkle J, Richardson J, Franz J, Grover F, Arom K, Holmstrom F. Management 
of flail chest without mechanical ventilation. Ann Thoracac Surg. 1975;19:355-
362. 
25. Abouhatem R, Hendrickx P, Titeca M. Thoracic epidural analgesia in the 
treatment of rib fractures. Acta Anaesthesiologica Belgica. 1984;35(suppl):271-
275. 
26. Dehghan N, de Mestral C, McKee M, Schemitsc hE, Nathens A. Flail chest 
injuries: a review of outcomes and treatment practices from the National Trauma 
Data Bank. Journal of Trauma Acute Care Surg. 2014;76(2):462-468. 
27. Veysi V, Nikolaou V, Paliobeis C, Efstathopoulos N, Giannoudis P. Prevalence of 
chest trauma, associated injuries and mortality: a level I trauma centre experience. 
International Orghopaedics. 2009;33(5):1425-1433. 
28. Hakim S, Latif F. Comparison between lumbar and thoracic epidural morphine 
for severe isolated blunt chest wall trauma: a randomized open-label trial. J 
Anesthesia. 2012;26:836-844. 
29. Mohta M, Verma P, Saxena A, Sethi A, Tyagi A, Girotra G. Prospective, 
Randomized Comparison of Continuous Thoracic Epidural and Thoracic 
Paravertebral Infusion in Patients With Unilateral Multiple Fractured Ribs—A 
Pilot Study. Journal of Trauma. 2009;66:1096-1101. 
30. Worthley L. Thoracic epidural in the management of chest trauma: a study of 161 
cases. Intensive Care Med. 1985;11:312-315. 
31. Kaewlai R, Avery L, Asrani A, Novelline R. Multidetector CT of Blunt Thoracic 
Trauma. Radiographics. 2008;28(6):1555-1571. 
32. Light R, Lee Y. Pneumothorax, chylothorax, hemothorax, and fibrothorax. In: 
Mason R, Broaddus C, Martin T, King TJ, Schraufnagel D, eds. Murray & 
Nadel's Textbook of Respiratory Medicine. 5 ed. Philadelphia, PA: Saunders 
Elsevier; 2010. 
33. Segers P, Van Schil P, Jorens P, Van Den Brande F. Thoracic trauma: an analysis 
of 187 patients. Acta Chirurgica Belgica. 2001;101(6):277-282. 
34. Clark G, Schecter W, Trunkey D. Variables affecting outcome in blunt chest 
trauma: Flail chest vs pulmonary contusion. Journal of Trauma. 1988;28:298-304. 
 216 
35. Cicala R, Voclier G, Fox T, Fabian T, Kudsk K, Mangiante E. Epidural analgesia 
in thoracic trauma: effects of lumbar morphine and thoracic bupivacaine on 
pulmonary function. Crit Care Med. 1990;18:229-231. 
36. Mackersie R, Karagianes T, Hoyt D, Davis J. Prospective evaluation of epidural 
and intravenous administration of fentanyl for pain control and restoration of 
ventilatory function following multiple rib fractures. Journal of Trauma. 
1991;31(4):443-451. 
37. Karmakar M, Ho A. Acute pain management of patients with multiple fractured 
ribs. Journal of Trauma. 2003;54:615-625. 
38. De Buck F, Devroe S, Missant C, Van de Velde M. Regional anesthesia outside 
the operating room: indications and techniques. Current Opinion in 
Anesthesiology. 2012;25(4):501-507. 
39. Govindarajan R, Bakalova T, Michael R, Abadir A. Epidural buprenorphine in 
management of pain in multiple rib fractures. Acta Anaesthesiol Scand. 
2002;46:660–665. 
40. Kaiser A, Zollinger A, De Lorenzi D, Largiader F, Weder W. Prospective, 
randomized comparison of extrapleural versus epidural analgesia for 
postthoracotomy pain. Ann Thorac Surg. 1998;66:367-372. 
41. Doss N, Veliyaniparambil I, Krishnan R, Gintautas J, Abadir A. Continuous 
thoracic epidural ropivacaine drips for multiple rib fractures. Proceedings of the 
Western Pharmacology Society. 1999;42:99-100. 
42. Ferguson M, Luchette F. Management of Blunt Chest Injury. Respiratory Care 
Clinics of North America. 1996;2(3):449-467. 
43. Shackford S, Smith D, Zarins C, Rice C, Virgilio R. The management of flail 
chest: A comparison of ventilator and nonventilatory treatment. Am J Surg. 
1976;132:759-762. 
44. Shackford S, Virgilio R, Peters R. Selective use of ventilator therapy in flail chest 
injury. J Thorac Cardiovasc Surg. 1981;81:194-201. 
45. Linton D, Potgieter P. Conservative management of blunt chest trauma. S Afr Med 
J. 1982;61:917-919. 
46. Carrier F, Turgeon A, Nicole P, et al. Effect of epidural analgesia in patients with 
traumatic rib fractures: a systematic review and meta-analysis of randomized 
controlled trials. J Can Anesth. 2009;56:230-242. 
47. Ho A, Karmakar M, Critchley L. Acute pain management of patients with 
multiple fractured ribs: a focus on regional techniques. Curr Opin Crit Care. 
2011;17(4):323-327. 
48. Manion S, Brennan T. Thoracic epidural analgesia and acute pain management. 
Anesthesiology. 2011;115(1):181-188. 
49. Kara M, Dikmen E, Erdal H, Simsir I, Kara S. Disclosure of unnoticed rib 
fractures with the use of ultrasonography in minor blunt chest trauma. European 
Journal of Cardio-Thoracic Surgery. 2003;24(4):608-613. 
50. Khan M, Bilal A. A prospective study of penetrating chest trauma and evaluation 
of role of thoracotomy. JPMI. 2004;18(1):33-39. 
51. Wagner R, Slivko B. Highlights of the history of nonpenetrating chest trauma. 
Surg Clin North Am. 1989;69:1-14. 
 217 
52. Avery, Morch E, Benson D. Critically crushed chests. J Thoracic Surg. 
1956;32:291-311. 
53. Bollinger C, Van Eeden S. Treatment of multiple rib fractures: Randomized 
controlled trial comparing ventilatory with nonventilatory management. Chest. 
1990;97:943-948. 
54. Webb W. Thoracic trauma. Surg Clin North Am. 1974;54:1179-1192. 
55. Richardson J, Adams L, Flint L. Selective management of flail chest and 
pulmonary contusion. Ann Surg. 1982;196:481-487. 
56. Rankin A, Comber R. Management of fifty cases of chest injury with a regimin of 
epidural bupivacaine and morphine. Anesth Intensive Care. 1984;12:311-314. 
57. Truitt M, Murry J, Amos J, et al. Continuous Intercostal Nerve Blockade for Rib 
Fractures: Ready for Primetime? . Journal of Trauma. 2011;71:1548-1552. 
58. Sirmali M, Turut H, Topcu S, et al. A comprehensive analysis of traumatic rib 
fractures: morbidity, mortality and management. Eur J Cardiothorac Surg. 
2003;24:133-138. 
59. Todd S, McNally M, Holcomb J, et al. A multidisciplinary clinical pathway 
decreases rib fracture-associated infectious morbidity and mortality in high-risk 
trauma patients. American Journal of Surgery. 2006;192:806-811. 
60. Barnea Y, Kashtan H, Shornick Y, Werbin N. Isolated rib fractures in elderly 
patients: mortality and morbidity. Can J Surg. 2002;45:43-46. 
61. Hashemzadeh S, Hashemzadeh K, Hosseinzadeh H, Maleki R, Golzari S. 
Comparison Thoracic Epidural and Intercostal Block to Improve Ventilation 
Parameters and Reduce Pain in Patients with Multiple Rib Fractures. Journal of 
Cardiovascular and Thoracic Research. 2011;3(3):87-91. 
62. Gann D, Lilly M. The neuroendocrine response to multiple trauma. World J Surg. 
1983;7:101-118. 
63. Wu C. Acute postoperative pain. In: RD M, ed. Miller’s Anesthesia. 6 ed. 
Philadelphia, PA: Churchill Livingstone; 2005:2742. 
64. Shuck J, Snow N. Injury to the Chest Wall. In: Moore E, Mattox K, Feliciano D, 
eds. Trauma. 2 ed. Norwalk, Conn: Appleton and Lange; 1991:321. 
65. Dittmann M, Steenblock U, Kranzlin M, Wolff G. Epidural analgesia or 
mechanical ventilation for multiple rib fractures? Intensive Care. Med. 1982;8:89-
92. 
66. Gibbons J, James, Quail A. Relief of pain in chest injury. Br J Anaesth. 
1973;45:1136-1138. 
67. Cuschieri R, MorTan C, Howie J, McArdel C. Postoperative pain and pulmonary 
complications. Br J Surg. 1985;72:495-498. 
68. Liu S, Carpenter R, Neal J. Epidural anesthesia and analgesia: their role in 
postoperative outcome. Anesthesiology. 1995;82:1474‐ 1506. 
69. Kerr-Valentic M, Arthur M, Mullins R, Pearson T, Mayberry J. Rib fracture pain 
and disability: can we do better? . Journal of Trauma. 2003;54:1058-1064. 
70. Karmakar M, Critchley L, Ho A, Gin T, Lee T, Yim A. Continuous thoracic 
paravertebral infusion of bupivacaine for pain management in patients with 
multiple fractured ribs. Chest. 2003;132(2):424-431. 
 218 
71. Pansard J, Mankikian B, Betrand M, Kieffer E, Clergue F, Viars P. Effects of 
thoracic extradural block on diaphragmatic electrical activity and contractility 
after upper abdominal surgery. Anesthesiology. 1993;78:63-71. 
72. Kennedy B. Intrathecal morphine and multiple fractured ribs. Br J Anaesth. 
1985;57:1266-1267. 
73. Ingalls N, Horton Z, Bettendorf M, Rodriguez C. Randomized, double-blind, 
placebo-controlled trial using lidocaine patch 5% in traumatic rib fractures. J Am 
Coll Surg. 2010;210:205-209. 
74. Rauchwerger J, Candido K, Deer T, Frogel J, Iadevaio R, Kirschen N. Thoracic 
Epidural Steroid Injection for Rib Fracture Pain. Pain Practice. 2013;13(5):416-
421. 
75. Sloan J, Muwanga C, Waters E, Dove A, Dave S. Multiple rib fractures: 
transcutaneous nerve stimulation versus conventional analgesia. Journal of 
Trauma. 1986;26:1120-1122. 
76. O'Kelly E, Garry B. Continuous pain relief for multiple fractured ribs. Br J 
Anaesth. 1981;53:989-991. 
77. Haenel J, Moore F, Moore E, Sauaia A, Read R, Burch  J. Extrapleural 
bupivacaine for amelioration of multiple rib fracture pain. Journal of Trauma. 
1995;38:22-27. 
78. Moon M, Luchette F, Gibson S, et al. Prospective, randomized comparison of 
epidural versus parenteral opioid analgesia in thoracic. Annals of Surgery. 
1999;229(5):684-692. 
79. Egbert L, Bendixen H. Effect of morphine on breathing pattern: A possible factor 
in atelectasis. JAMA. 1964;188:485-488. 
80. Brown D. Spinal, epidural, and caudal anesthesia. In: RL M, ed. Anesthesia. 4 ed. 
New York: Churchill Livingstone; 1994:1505-1533. 
81. Rawal N, Sjostrand U, Dahlstrom B, Nydahl P, Ostelius J. Epidural morphine for 
postoperative pain relief: A Comparative study with intramuscular narcotic and 
intercostal nerve block. Anesth Analg. 1982;61:93-95. 
82. Wisner D. A stepwise logistic regression analysis of factors affecting morbidity 
and mortality after thoracic trauma: effect of epidural analgesia. Journal of 
Trauma. 1990;30(7):799-805. 
83. Luchette F, Radafshar S, Kaiser R, Flynn W, Hassett J. Prospective evaluation of 
epidural versus intrapleural catheters for analgesia in chest wall trauma. Journal 
of Trauma. 1994;36:865-870. 
84. Dittmann M, Keller R, Wolff G. A rationale for epidural analgesia in the 
treatment of multiple rib fractures. Intensive Care Med. 1978;4:193-197. 
85. Dittmann M, Ferstl A, Wolff G. Epidural analgesia for the treatment of multiple 
rib fractures. European Journal of Intensive Care Medicine. 1975;1:71-75. 
86. Ritsema T, Kelen G, Pronovost P, Pham J. The national trend in quality of 
emergency department pain management for long bone fractures. Acad Emerg 
Med. 2007;14:163-169. 
87. Rodgers A, Walker N, Schug S, et al. Reduction of perioperative mortality and 
morbidity with epidural or spinal anesthesia: results from an overview of 
randomized trials. BMJ. 2000;321:1493. 
 219 
88. Block B, Liu S, Rowlingson A, Cowan A, Cowan JJ, Wu C. Efficacy of post- 
operative epidural analgesia. JAMA. 2003;290:2455-2463. 
89. Ullman D, Wimpy R, Fortune J, Kennedy T, Greenhouse B. The treatment of 
patients with multiple rib fractures using continuous thoracic epidural narcotic 
infusion. Regional Anesthesia. 1989;14:43-47. 
90. Simon B, Cushman J, Barraco R, et al. EAST Practice Management Guidelines 
Work Group. Pain management guidelines for blunt thoracic trauma. Journal of 
Trauma. 2005;59:1256-1267. 
91. Balcı A, Eren S, Çakır Ö, Eren M. Open Fixation in Flail Chest: Review of 64 
Patients. Asian Cardiovasc Thorac Ann. 2004;12:11-15. 
92. Sahin S, Uckunkaya N, Soyal S. The role of epidural continuous pain treatment 
on duration of intubation, ventilation and ICU stay in flail chest patients. Agri 
Dergisi. 1993;5:18-20. 
93. Shinohara K, Iwama H, Akama Y, Tase C. Interpleural block for patients with 
multiple rib fractures: comparison with epidural block. J Emerg Med. 
1994;12:441–644. 
94. Pierre E, Martin P, Frohock J, Varon A, Barquist E. Lumbar epidural morphine 
versus patient-controlled analgesia morphine in patients with multiple rib 
fractures. Anesthesiology. 2005;103:A289. 
95. Parris R. Epidural analgesia/anaesthesia versus systemic intravenous opioid 
analgesia in the management of blunt thoracic trauma. Emergency Medical 
Journal: Best Evidence Topic Reports. 2007;24(12):848-849. 
96. Kieninger A, Bair H, Bendick P, Howells G. Epidural versus intravenous pain 
control in elderly patients with rib fractures. Am J Surg. 2005;189:327-330. 
97. Kim Y, Cho H, CS Y, CK L, TY L, JP S. Thoracic Epidural Anesthesia and 
Analgesia (TEA) in Patients with Rib Fractures. Korean J Thorac Cardiovasc 
Surg. 2011;44:178-182. 
98. Allen M, Halgren L, Nichols F, et al. A Randomized Controlled Trial of 
Bupivacaine Through Intracostal Catheters for Pain Management After 
Thoracotomy. Ann Thorac Surg. 2009;88(3):903-910. 
99. Johnston J, McCaughey W. Epidural morphine. A method of management 
of multiple fractured ribs. Anesthesia. 1980;35(2):155-157. 
100. Quality Assessment of Controlled Intervention Studies. 2014; 
http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-
reduction/tools/rct. Accessed December 5, 2014. 
101. Ward A, Gillatt D. Delayed diagnosis of traumatic rupture of the spleen: a 
warning of the use of thoracic epidural analgesia in chest trauma. Injury. 
1989;20:178-179. 
102. Mayall M, Calder I. Spinal cord injury following an attempted thoracic epidural. 
Anaesthesia. 1999;54:990-994. 
103. Bauer M, George III J, Seif J, Farag E. Recent Advances in Epidural Analgesia. 
Anesthesiology Research and Practice. 2012;2012:14. 
104. Ruppen W, Derry S, McQuay H, Moore R. Incidence of epidural hematoma, 
infection, and neurologic injury in obstetric patients with epidural 
analgesia/anesthesia. . Anesthesiology. 2006;105(2):394-399. 
 220 
105. Sethna N, Clendenin D, Athiraman U, Solodiuk J, Rodriguez D, Zurakowski D. 
Incidence of epidural catheter-associated infections after continuous epidural 
analgesia in children. Anesthesiology. 2010;113(1):224-232. 
106. Wheatley R, Schug S, Watson D. Safety and efficacy of postoperative epidural 
analgesia. British Journal of Anesthesia. 2001;87:47-61. 
107. Auroy Y, Narchi P, Messiah A, Litt L, Rouvier B, Samii K. Serious complications 
related to regional anesthesia: results of a prospective survey in France. 
Anesthesiology 1997;87:479–486. 
108. Wulf H. Epidural anesthesia and spinal haematoma. Canadian Journal of 
Anaesthesia. 1996;43:1260-1271. 
109. Kindler C, Seeberger M, Staender S. Epidural abscess complicating epidural 
anesthesia and analgesia. An analysis of the literature. Acta Anaesthesiol Scand. 
1998;42:614-620. 
110. Kvalsvik O, Borchgrevink P, Gisvold S. Epidural abscess following continuous 
epidural analgesia in two traumatized patients. Acta Anaesthesiol Scand. 
1998;42:732-735. 
111. Moen V, N, Irestedt L. Severe neurological complications after central neuraxial 
blockades in Sweden 1990–1999. Anesthesiology. 2004;101(4):950-959. 
112. Lafferty P, Anavian J, Will R, Cole P. Operative treatment of chest wall injuries: 
indications, technique, and outcomes. J Bone Joint Surg Am. 2011;93(1):97-110. 
113. Shorr R, Critteden M, Indeck M, Hartunian S, Rodriguez A. Blunt thoracic 
trauma. Analysis of 515 patients. Ann Surg. 1987;206(2):200-205. 
114. Shorr R, Rodriguez A, Indeck M, Crittenden M, Hartunian S, Cowley R. Blunt 
chest trauma in the elderly. Journal of Trauma. 1989;29:234-237. 
115. Mackersie R, Shackford S, Hoyt D, Karagianes T. Continuous epidural fentanyl 
analgesia: ventilatory function improvement with routine use in treatment of blunt 
chest trauma. Journal of Trauma. 1987;27:1207-1912. 
116. Shannon R. Intercostal and abdominal muscle afferent influence on medullary 
dorsal respiratory group neurons. Respir Physiol. 1980;39:73-94. 
117. Eason M, Wyatt R. Paravertebral thoracic block: a reappraisal. Anaesthesia. 
1979;34:638-642. 
118. Gilbert J, Hultman J. Thoracic paravertebral block: a method of pain control. Acta 
Anaesthesiol Scand. 1989;33:142-145. 
119. Karmakar M, Kwok W, Kew J. Thoracic paravertebral block: radiological 
evidence of contralateral spread anterior to the vertebral bodies. Br J Anaesth. 
2000;84:263-265. 
120. Karmakar M. Thoracic paravertebral block. Anesthesiology. 2001;95:771-780. 
121. Karmakar M, Chui P, Joynt G, Ho A. Thoracic paravertebral block for 
management of pain associated with multiple fractured ribs in patients with 
concomitant lumbar spinal trauma. Reg Anesth Pain Med. 2001;26:169-173. 
122. McKnight C, Marshall M. Monoplatythela and paravertebral block. Anaesthesia. 
1984;39:1147. 
123. Williamson S, Kumar C. Paravertebral block in head injured patient with chest 
trauma. Anaesthesia. 1997;52:284-285. 
124. Lonnqvist P, MacKenzie J, Soni A, Conacher I. Paravertebral blockade: failure 
rate and complications. Anaesthesia. 1995;50:813-815. 
 221 
125. Karmakar M, Ho A. Thoracic and lumbar paravertebral block. In: A H, ed. The 
New York School of Regional Anesthesia textbook of regional anesthesia and 
acute pain management. New York: McGraw-Hill; 2007:583-597. 
126. Ablondi M, Ryan J, O’Connell C, Haley R. Continuous intercostal nerve blocks 
for post operative pain relief. Anesthes Analges Curr Res. 1966;45:185-190. 
127. Shafei H, Chamberlain M, Natrajan K, Khan M, Gandhi R. Intrapleural 
bupivacaine for early post-thoracotomy analgesia: Comparison with bupivacaine 
intercostal block and cryofreezing. Thorac Cardiovasc Surg. 1990;38:38-41. 
128. Pedersen V, Schulze S, Hoier-Madsen K, Halkier E. Air-flow meter assessment of 
the effect of intercostal nerve blockade on respiratory function in rib fractures. 
Acta Chir Scand. 1983;149:119-120. 
129. Nunn J, Slavin G. Posterior intercostal nerve block for pain relief after 
cholecystectomy: Anatomical basis and efficacy. Br J Anaest. 1980;52:253-260. 
130. Murphy D. Intercostal nerve blockade for fractured ribs and postoperative 
analgesia: description of a new technique. Reg Anesth. 1983;8:151-153. 
131. Baxter A, Flynn J, Jennings F. Continuous intercostal nerve blockade. Br J 
Anaesth. 1984;56:665-666. 
132. Crossley A, Hosie H. Radiographic study of intercostal nerve blockade in healthy 
volunteers. Br J Anaesth. 1987;59:149-154. 
133. Mowbray A, Wong K, Murray J. Intercostal catheterization: an alternative 
approach to the paravertebral space. Anaesthesia. 1987;42:958-961. 
134. Shanti C, Carlin A, Tyburski J. Incidence of pneumothorax from intercostal nerve 
block for analgesia in rib fractures. Journal of Trauma. 2001;51:536-539. 
135. Reiestad S, Kvalheim L. Interpleural catheter management of post operative pain. 
Anesthesiology. 1984;61:A231. 
136. Reiestad F, Stromskag K. Interpleural catheter in the management of 
postoperative pain: A preliminary report. Reg Anesth. 1986;11:89-91. 
137. Rocco A, Reiestad F, Gudman J, McKay W. Interpleural administration of local 
anesthetics for pain relief in patients with multiple rib fractures: Preliminary 
report. Reg Anesth. 1987;12:10-14. 
138. Stomskag K, Reiestad F, Holmqvist E, Ogenstad S. Intrapleural administration of 
0.25%, 0.375%, and 0.5% bupivacaine with epinephrine after cholecystectomy. 
Anesth Analg. 1988;67:430-434. 
139. Bachmann-Mennenga B, Biscoping J, Kuhn D, et al. Intercostal nerve block, 
interpleural analgesia, thoracic epidural block or systemic opioid application for 
pain relief after thoracotomy? Eur J Cardiothorac Surg. 1993;7:12-18. 
140. Short K, Scheeres D, Mlakar J, Dean R. Evaluation of intrapleural analgesia in the 
management of blunt traumatic chest wall pain: a clinical trial. Am Surg. 
1996;62:488-493. 
141. Ferrante F, Chan V, Arthur G, Rocco A. Interpleural analgesia after thoracotomy. 
Anesth Analg. 1991;72:105-109. 
142. Richardson J, Sabanathan S, Mearns A, Shah R, Goulden C. A prospective, 
randomized comparison of interpleural and paravertebral analgesia in thoracic 
surgery. Br J Anaesth. 1995;75:405-408. 
143. el-Baz N, Faber L, Ivankovich A. Intrapleural infusion of local anesthetic: a word 
of caution. Anesthesiology. 1988;68:809-810. 
 222 
144. Lauder G. Interpleural analgesia and phrenic nerve paralysis. Anaesthesia. 
1993;48:315-316. 
145. Shantha T. Unilateral bronchospasm after interpleural analgesia. Anesth Analg. 
1992;74:291-293. 
146. Gomez M, Symreng T, Johnson B, Rossi N, Chiang C. Intrapleural bupivacaine 
for intraoperative analgesia: a dangerous technique. Anesth Analg. 1988;67:S78. 
147. Seltzer J, Larijani G, Goldberg M, Marr A. Intrapleural bupivacaine: a kinetic and 
dynamic evaluation. Anesthesiology. 1987;67:798-800. 
148. El-Naggar M, Schaberg F, Phillips M. Intrapleural regional analgesia for pain 
management in cholecystectomy. Arch Surg. 1989;124:568-570. 
149. Rosenberg P, Scheinin B, Lepantalo M, Lindfors O. Continuous intrapleural 
infusion of bupivacaine for analgesia after thoracotomy. Anesthesiology. 
1987;67:811-813. 
150. Dickson G, Sutcliffe A. Intrathecal morphine and multiple fractured ribs. Br J 
Anaesth. 1986;58:1342-1343. 
151. Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive 
paravertebral injections with local anesthetics and steroids for the prevention of 
postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg. 
2009;109:1651-1655. 
152. Nagaro T, Yorozuya T, Kamei M, Kii N, Arai T, Abe S. Fluoroscopically guided 
epidural block in the thoracic and lumbar region. Reg Anesth Pain Med. 
2006;31:409-416. 
153. Moore D, Bridenbaugh L. Intercostal nerve block in 4333 patients: indications, 
technique, and complications. Anesth Analg. 1962;41:1-11. 
154. Moore D, Bush W, Scurlock J. Intercostal nerve block: a roentgenographic 
anatomic study of technique and absorption in humans. Anesth Analg. 
1980;59:815-825. 
155. Dittmann M, Steenblock U, Kranzlin M, Wolff G. Thoracic Epidural Analgesic 
(TEA) or Controlled Ventilation in the Treatment of Patients with Multiple Rib 
Fractures. Langenbecks Arch Chir. 1980;353:139-142. 
156. Kavanagh B, Katz J, Sandler A. Pain control after thoracic surgery: a review of 
current techniques. Anesthesiology. 1994;81:737‐ 759. 
157. Ascension Health Annual Report. 2014; 
https://http://www.ascensionhealth.org/annualreport/index.php?page=financial. 
Accessed December 14, 2014. 
158. Ascension Health Website. 2014; 
http://www.ascensionhealth.org/index.php?option=com_content&view=article&i
d=31&Itemid=144. Accessed December 16, 2014. 
159. Gamble M. 15 Largest Nonprofit Health Systems | 2014. Becker’s Hospital 
Review. Vol August2014:14. 
160. St. Vincent Health Website. 2014; http://www.stvincent.org/About-Us.aspx. 
Accessed December, 16, 2014. 
161. Demirhan R, Onan B, Oz K, Halezeroglu S. Comprehensive analysis of 4205 
patients with chest trauma: a 10-year experience. Interactive Cardiovascular and 
Thoracic Surgery. 2009;9(3):450-453. 
 223 
162. Bhatnagar A, Mayberry J, Nirula R. Rib fracture fixation for flail chest: what is 
the benefit? Journal of the American College of Surgeons. 2012;215(2):201-205. 
163. Marasco S, Davies A, Cooper J, et al. Prospective randomized controlled trial of 
operative rib fixation in traumatic flail chest. Journal of the American College of 
Surgeons. 2013;216(5):924-932. 
164. Tanaka H, Yukioka T, Yamaguti Y, et al. Surgical stabilization of internal 
pneumatic stabilization? A prospective randomized study of management of 
severe flail chest patients. The Journal of Trauma. 2002;52(4):727–732. 
165. Johnstone R, Martinec C. Costs of anesthesia. Anesthesia and Analgesia. 
1993;76(4):840-848. 
166. Menditto V, Gabrielli B, Marcosignori M, et al. A management of blunt thoracic 
trauma in an emergency department observation unit: Pre-post observational 
study. The Journal of Trauma. 2012;72(1):222-228. 
167. Ahmed Z, Mohyuddin Z. Management of flail chest injury: internal fixation 
versus endotracheal intubation and ventilation. Journal of Thoracic and 
Cardiovascular Surgery. 1995;110(6):1676-1680. 
168. Duch P, Moller M. Epidural analgesia in patients with traumatic rib fractures: a 
systematic review of randomised controlled trials. Acta Anaesthesiologica 
Scandinavica. 2015;59:698-709. 
169. Govindarajan R, Bakalova T, Michael R, Abadir A. Epidural buprenorphine in 
management of pain in multiple rib fractures. Acta Anaesthesiol Scand. 
2002;46:660–665. 
170. Topcu I, Ikici Z, Sakarya M. [Comparison of clinical effectiveness of thoracic 
epidural and intravenous patient-controlled analgesia for the treatment of rib 
fractures pain in intensive care unit]. Ulus Travma Acil Cerrahi Derg. 
2007;13(3):205-210. 
171. Sandtner W, Poigenfurst J, Glatzl A, Thonke N. [Catheter epidural analgesia in 
serial rib fractures]. Der Unfallchirurg. 1989;92(4):159-163. 
172. Pérez Gallardo A, Lajara Montell A, Manzanos Luna A. Hemodynamic 
repercussion of epidural bupivacaine in thoracic injuries. Rev Esp Anestesiol 
Reanim. 1991;38(6):361-364. 
 
